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Abstract 
Adolescents with high functioning autism spectrum disorders (ASD) are 
commonly diagnosed with at least one comorbid anxiety disorder (Kerns et al., 2015; 
Wood et al., 2014), with multiple studies reporting prevalence rates of anxiety 
disorders ranging from 42 to 85% for individuals with ASD . Despite indicators that 
anxiety in adolescents with ASD is more acute and multi-faceted, with simultaneous 
social, emotional, physical and hormonal changes taking place during this 
developmental stage, researchers have primarily concentrated on studying children 
with ASD.  
In the past, therapists have refrained from using cognitive behavioural therapy 
(CBT) with youth with ASD due to unique challenges that are likely to hinder 
therapeutic engagement and successful treatment outcomes, such as communication 
and cognitive deficits . However, in recent years, researchers have been successful in 
modifying traditional CBT programs to reduce anxiety in children with ASD . To date, 
randomised controlled trials investigating CBT for early and older adolescents with 
ASD and anxiety remain scarce.  
This thesis contains two connected studies that seek to address this gap.  Study 
one evaluated the efficacy of using a manualised, family-based group cognitive-
behavioural therapy (CBT) to reduce anxiety symptoms in adolescents aged between 
12 and 18 years (M = 14.23) (the Cool Kids Child Anxiety Program: ASD Adaptation; 
. Forty-nine participants were randomly assigned to either a waitlist (WL) or CBT 
intervention condition. Adolescents in the CBT intervention group, along with one of 
their primary caregivers attended 12 CBT sessions. At post-treatment, adolescents 
randomised to the CBT condition demonstrated significant reductions in anxiety 
severity compared to those in the WL condition. This was determined by diagnostic 
status, clinical severity ratings (CSRs), and parent/adolescent ratings. Furthermore, 
parents in the CBT group reported a significant increase in measures of family quality 
of life. For the CBT group, all treatment gains were maintained at six-month follow-
up with 79.2% of the CBT group demonstrating remission of their primary anxiety 
disorder diagnosis.  
The aim of Study two was to determine the social validity of group CBT 
treatment using both quantitative and qualitative methodologies. Adolescents reported 
that the program was easy to understand, and that the skills they learnt were useful. In 
addition, parents reported high satisfaction with the content covered in the program. 
Qualitatively, more than half of the adolescents reported benefits from interacting with 
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others who were experiencing similar difficulties although they expressed a preference 
for less writing in the workbook. Parents reported feeling “empowered,” with a new 
ability to assist their adolescent in managing his/her anxiety.  
Although this research has several limitations, collectively, these novel and 
clinically significant findings contribute toward establishing the efficacy for group, 
manualised, family-based CBT treatment for both adolescents, including older 
adolescents with ASD and comorbid anxiety. The broader implication of the results 
for clinicians is that the Cool Kids Child Anxiety Program: ASD Adaptation  is an 
easily adaptable and cost-effective group treatment for this previously neglected 
population. 
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Chapter 1: Introduction and Literature Review 
1.1 Overview 
This thesis is comprised of two connected studies that aim to increase 
understanding and knowledge of how anxiety presents and can be treated in 
adolescents with high functioning ASD and comorbid anxiety. Despite the high 
prevalence of anxiety disorders in these adolescents (, and a recent surge of research 
in the area of ASD and anxiety generally, the relationship between anxiety and ASD 
remains unclear.  
In an attempt to investigate anxiety in adolescents with ASD, the history, 
diagnosis, and prevalence of autism will be explored in this chapter. An important first 
step is to define the presentation and trajectory of anxiety in typically developing 
adolescents. Comparatively, does anxiety in youth with ASD differ? Furthermore, can 
anxiety be considered a separate entity to ASD or does it derive and/or develop from 
the ASD core deficits? Here it is argued that the nature of anxiety in those with ASD 
manifests differently to youth of typical development. There appears to be unique 
factors to ASD that may aid in the growth and continuance of anxiety symptomology 
and these are examined. 
In chapter 2, interventions aimed at reducing anxiety in youth with ASD are 
reviewed. It is well documented that specific barriers to participation and engagement 
in therapy are common for this client group and therefore these are investigated, along 
with the modifications that can be implemented to lead to more successful engagement 
and treatment outcomes. The research on psychological interventions for anxiety in 
individuals with ASD is the main focus of this review.  
One limitation of the literature has been the notable absence of RCTs 
evaluating the efficacy of group CBT to reduce anxiety, in older adolescents with ASD 
and comorbid anxiety. Chapter 3 presents study one: Chilled out: A family-based, 
group CBT approach for treating anxiety in adolescents with high functioning ASD. 
Group treatment is an economical alternative to individual therapy, which is often 
expensive for parents and therefore difficult to access. In addition, group treatments 
may provide therapeutic benefits . The findings of this study have the potential to 
inform clinical practice and treatment, and improve the quality of life for adolescents 
with ASD and their families. 
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Chapter 4 provides a detailed description and the results of study 2, which 
explores the social validity of the intervention. The thoughts, experiences and voices 
of the participants are presented and contribute to the overall evaluation and 
effectiveness of the program.  
Conclusions will be drawn in chapter 5 through discussion of the key findings 
from the two studies, theoretical and clinical implications, study strengths and 
limitations and recommendations for future research. 
1.2 History, Definition and Prevalence of ASD 
1.2.1 History of autism spectrum disorders. There has been an influx of 
research since Kanner , an Austrian psychiatrist recruited to John Hopkins Hospital in 
North America, adopted this term to describe the presentation of eleven children from 
his clinic. He documented these children as having early infantile autism, or “inborn 
autistic disturbances of affective contact” (Kanner, 1943, p. 50), with more interest in 
objects than people and an overriding preference for aloneness (Kanner, 1943). In 
addition, the children he observed demonstrated language delays, an inability to use 
language for communication, literalness, and a strong need for “‘sameness” (Kanner, 
1943).  
In 1945, although not widely recognised at the time, Austrian psychiatrist, 
Hans Asperger, had studied a small group of children with similar presentations. Forty 
years later  drew upon this work and devised the classification “Asperger’s Syndrome” 
to define the children with ASD (without intellectual impairment) that she was 
working with (Wing, 1981). More recently it was recognised that in 1926 a Russian 
neurology student, Ssucharawa published a research paper with a description of a child 
that would today be described as having Asperger’s syndrome (McDonald, 2010). At 
the time however, Ssucharawa’s description was originally known as Schizoid 
Personality Disorder (McDonald, 2010).  
With an increase in studies investigating the causes and features of autism, the 
idea that autism was embedded within the group of schizophrenia disorders was 
discounted due to differing onset, clinical presentation, and family history (Volkmar 
& McPartland, 2014). Similarly expurgated was parenting as a cause of autistic 
behaviours (Volkmar & McPartland, 2014). As of consequence, the employment of 
behavioural techniques over psychoanalytic practices for treatment of autism occurred. 
Here, the view that parents causing autism was for the most part discounted, and the 
notion that they could be used to assist in their child’s therapy was introduced 
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(McDonald, 2014). Studies began to demonstrate the effectiveness of structured 
behavioural treatment compared to unstructured psychotherapy and this guided 
treatment for children with ASD (Lovaas, 1987; McDonald, 2014; Schopler & 
Mesibov, 1984). 
1.2.2 Autism as a diagnosis. In 1980, Autistic Disorder, a label closely fitting 
Kanner’s observations, was added to the Diagnostic and Statistical Manual 3rd edition 
(DSM-III) within the Pervasive and Developmental Disorders category (Association, 
1980). In response to this classification, Wing (1981) explained that the presentation 
of the individuals that she had studied more closely resembled those described by 
Asperger (Asperger, 1944 in Feinstein, 2010) than those proclaimed by Kanner (1943). 
Wing’s (1981) article greatly informed the formulation of Asperger’s 
Syndrome/Disorder as a sub-classification within the spectrum of Autism in both the 
International Classification of Diseases (ICD-10; World Health Organization, 1992) 
and the Diagnostic and Statistical Manual of Mental Disorders (4th ed; DSM-IV; 
American Psychiatric Association, 2000; Attwood, 2007; McDonald, 2014). Here, the 
categories of “Childhood Disintegrative Disorder”, “Rett’s Disorder” and “Asperger’s 
Disorder” were added under the umbrella classification of “Pervasive Developmental 
Disorders” (Feinstein, 2010).  
More recently, the fifth edition of the Diagnostic and Statistical Manual of 
Mental Disorders (5th ed.; DSM-5; American Psychiatric Association, 2013) has seen 
three separate diagnosis (Autistic Disorder, Asperger Syndrome and Pervasive 
Developmental Disorder-Not Otherwise Specified (PDD-NOS), integrated into a 
single label, Autism Spectrum Disorder (Esler & Ruble, 2015). The diagnosis Autism 
Spectrum Disorder now encompasses two domains which include deficits in social 
communication and interaction, and restricted and repetitive patterns of behaviour, 
interests or activities. Sensory hyper-or hypo-reactivity behaviours have now been 
recognised and included in the diagnostic criteria under the latter domain (American 
Psychiatric Association, 2013).  
Diagnostically, the manner in which children may differ in their presentation 
now relies upon two clinical features. The first is a rating given to the severity of 
symptoms within the two domains of deficits. These range from Level 1 (which 
indicates that support is required) to Level 3 (indicating that the individual requires 
very substantial support). Secondly, clinical specifiers are acknowledged such as, 
intellectual disability, ADHD, anxiety disorders, and specific language disorder 
(American Psychiatric Association, 2013). This supplementary information provides 
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a deeper clinical picture of the person with ASD compared to previous diagnostic 
criteria (Volkmar & McPartland, 2014).  
1.2.3 Terms. Currently, within the ASD community there is discussion over 
the correct terms to use to refer to individuals with ASD. Some individuals with ASD 
have rejected the term disorder and prefer simply “autism” or “autism spectrum 
condition”. Other individuals with ASD prefer identity-first language such as the term 
“autistic.” This depicts ASD as part of who they are rather than a disorder or temporary 
condition that they have. While acknowledging the important voices of adults on the 
autism spectrum who prefer identity-first language, in accordance with the DSM-5 and 
literature in this area, the term autism spectrum disorder (ASD) will be used in this 
thesis. For the purposes of this study, this term will refer collectively to individuals 
diagnosed with an autism spectrum disorder without intellectual disability, unless 
otherwise specified.  
1.2.4 Prevalence of ASD. Over the past two decades there has been a dramatic 
rise in the identification of ASDs (Baxter et al., 2015; White et al., 2009). The 
broadening of the diagnostic criteria and improved sampling methods are purported to 
be the main reasons for this (Rutter, 2011; White et al., 2009). Other contributing 
factors include, improved diagnostic instruments that assist in differentiating types of 
ASD, separating ASD from other psychiatric disorders, and increased awareness and 
recognition of ASD (Elsabbagh et al., 2012; White et al., 2009). The question of 
whether there has been an increase in incidence of ASD or whether the above factors 
explain the dramatic rise in prevalence is still up for debate (Baxter et al., 2015). 
Both nationally and internationally prevalence has been reported to be between 
50-100 individuals in every 10,000 (Randall et al., 2015; Williams, MacDermott, 
Ridley, Glasson, & Wray, 2008). For a systematic review of epidemiology of ASD see 
Elsabbagh et al. (2012). Within Australia, approximately 164,000 people were 
estimated to have ASD which equates to approximately 1 in 150 people. (Australian 
Bureau of Statistics, 2016). In a recent study by the Centers for Disease Control and 
Prevention (CDC; Christensen et al., 2016), prevalence rates of ASD in the United 
States have been reported to be 1 in 68 children (1 in 42 boys and 1 in 189 girls). 
Higher rates of prevalence of ASD in males are consistently reported (Randall et al., 
2015).  
  
18 
1.3 Anxiety  
1.3.1 Anxiety defined. Silverman and Field (2011) define anxiety as, “…a set 
of emotional reactions arising from the anticipation of a real or imagined threat to 
self.” (p. 25). Anxiety is not necessarily pathologic, for example it can be adaptive in 
its facilitation of avoiding danger (Beesdo-Baum & Knappe, 2012), however the extent 
to which anxiety interferes with daily functioning determines whether an individual is 
diagnosed with an anxiety disorder. Diagnostic criteria for anxiety disorders are 
defined in the DSM-5 (APA, 2013) and the ICD-10 (World Health Organization, 
1992). Common clinical features in children and adolescents can include extensive 
anxiety, fearful responses to objects or situations, difficulty separating from parents, 
extreme avoidance, somatic and physiological symptoms, troubling thoughts, 
problems concentrating, sleep problems, irritability, and tiredness/fatigue (Beesdo-
Baum & Knappe, 2012; Reaven, 2009).  
While sometimes interpreted as the same, there is a noticeable difference 
between fear and anxiety (Silverman & Field, 2011). While fear can be described as 
an avoidance or discomfort reaction to specific stimuli that poses threat to well-being 
(e.g., snakes or flying), anxiety can be typified by a more dispersed reaction to a more 
generalized worry (e.g., fretting about the future) (Silverman & Field, 2011). The types 
of stimuli that elicit fear may change across the lifespan and these changes correspond 
to developments in the individual’s cognitive and social competencies and concerns 
(Carr, 2006).  
Anxiety is often conceptualised by physiological, behavioural, and cognitive 
responses (Fonseca & Perrin, 2011). In the occurrence of anxiety-provoking stimulus 
or situations, physiological symptoms include somatic complaints such as nausea, 
headaches, sweating, and muscle tension (Fonseca & Perrin, 2011; Ozsivadjian, Knott, 
& Magiati, 2012). Cognitive symptoms often reflect catastrophic predictions and 
expectations about failure to cope. The behavioural response may result in escaping or 
avoiding situations, “freezing”, and/or experiencing distress when enduring an 
anxiety-producing situation. Additional behavioural responses may include agitation 
or restlessness (e.g., pacing), hypervigilance, clinginess with parent, checking or 
urgently demanding assistance (Fonseca & Perrin, 2011). 
1.3.2 Anxiety prevalence in the general population. While noticeably behind 
adult anxiety research in terms of assessment and treatment, the past 30 years has seen 
considerable growth in child and adolescent anxiety research (Mohr & Schneider, 
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2013). Approximately 20% of young people score beyond the clinical cut-offs for one 
or more anxiety disorders (most frequently occurring are separation anxiety disorder, 
social phobia and specific phobia), with relatively equal prevalence among boys and 
girls (Rockhill et al., 2010). Research has shown that anxiety emerging prior to 18 
years of age is likely to persist into adulthood (Verhulst, van der Ende, & Koot, 1996) 
with an increased risk in regards to future depression, reduced educational outcomes, 
problems with relating to both family and peers, low engagement with extracurricular 
activities, substance abuse and subsequent adult mental health problems (Bennett et 
al., 2013; Mohr & Schneider, 2013; Silverman & Field, 2011).  
1.4 Anxiety in Adolescents with ASD 
1.4.1 Diagnostic overlap. Anxiety is a common element associated with 
heightened impairment above and beyond inherent ASD symptomology (Nadeau et 
al., 2013). For people with ASD, the assessment of anxiety disorders is complicated, 
with comorbid anxiety often unrecognised or mislabelled (Kerns et al., 2015). The 
main challenge lies in differentiating comorbid anxiety from the characteristics of 
ASD (Kerns et al., 2015) where diagnostic overshadowing—the inclination to override 
co-occurring psychiatric symptoms when there is a predetermined disability diagnosis 
– can occur (Mason & Scior, 2004). Therefore, it is important for conceptualisation 
and treatment to establish whether presenting psychiatric problems derive from core 
or secondary ASD deficits or whether they represent true psychiatric symptoms 
(MacNeil, Lopes, & Minnes, 2009). Symptoms that may be overlapping between ASD 
and anxiety include social awkwardness and avoidance, communication difficulties, 
obsessive and ritualised behaviour, and problems with reciprocating emotions (Kerns 
et al., 2015). Certainly, Wood & Gadow (2010) have questioned whether the core 
symptoms of ASD are misidentified as co-occurring anxiety and consequently, they 
have proposed a guideline for assessing comorbidity (Wood & Gadow, 2010). In 
addition, they suggest that the extreme stress deriving from ASD may put individuals 
with ASD at risk of anxiety.  
Due to the diagnostic overlap, Kerns and Kendall (2012) conducted a review 
of literature in this area. Across studies, including international populations, children, 
adolescents and adults with varying ASD diagnoses, and numerous measures 
employed (e.g., Child and Adolescent Psychiatric Assessment, Social Anxiety Scale 
for Adolescents, Child Behavior Checklist), anxiety symptomology was not 
substantiated for all of their participants. These authors deduced that if anxiety were a 
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core feature of ASD then it would occur across ASD subtypes. In addition, they found 
that differences in behavioural and familial presentations of ASD and anxiety 
problems indicates independence of these symptomologies (Kerns & Kendall, 2012). 
Despite the scarcity of anxiety measures specific to ASD, these authors concluded that 
rather than being an integral part of ASD, it is more probable that it co-occurs with 
ASD. Unlike comorbidity, the term concurrent or co-occurring anxiety is used to 
emphasise that ASD and anxiety are not necessarily separate entities and therefore 
may fit well with the diagnostic overlap present in this complex population (Kerns & 
Kendall, 2012). 
1.4.2 Prevalence and type of anxiety disorders in ASD. Recent research has 
revealed that children and adolescents with ASDs have significantly higher anxiety 
levels than their typically developing peers (Farrugia & Hudson, 2006; Gillott et al., 
2001; van Steensel, Bogels, & Perrin, 2011), higher anxiety than adolescents with 
conduct disorder, (Green & Ben-Sasson, 2010) and individuals with ASD and an 
intellectual disability (Muris, Steerneman, Merckelbach, Holdrinet, & Meesters, 
1998), and equivalent anxiety levels to non-ASD adolescents with an anxiety disorder 
(Farrugia & Hudson, 2006). In fact, multiple studies report prevalence rates to range 
between 11 and 84%, and averaging approximately 40-55% (Gillott et al., 2001; Peter 
Muris et al., 1998; White et al., 2009). These figures are far higher than those derived 
from studies on the prevalence of anxiety disorders in the general paediatric population 
(5-10%, see Costello, Egger, & Angold, 2005; 31.9%, see Merikangas et al., 2010).  
While the majority of children and adolescents with ASD meet the criteria for 
more than one disorder, the most commonly diagnosed anxiety disorders are specific 
phobia (30-44%), generalised anxiety disorder (15-35%), separation anxiety disorder 
(9-38 %), social phobia (17-30%), agoraphobia (1-17%), and panic disorder (1-2 %) 
(Rudy, Lewin, & Storch, 2013). Presently, developmental issues surrounding anxiety 
in ASD youth are not well understood (Davis et al., 2011) however, findings from 
some studies suggest that anxiety may become more acute with age (Wood et al., 2014; 
Lecavalier, 2006; White et al., 2010). In addition,  specific phobias are more prominent 
in children with ASD, whereas an emergence of disorders such as OCD, social phobia, 
and panic disorder are more common during adolescence (Bellini, 2006; Rudy et al., 
2013; White et al., 2009). Furthermore and similar to research findings on children, 
older adolescents with ASD have been found to have higher levels of anxiety than their 
typically developing peers (Bellini, 2006; Farrugia & Hudson, 2006; Kim, Szatmari, 
Bryson, Streiner, & Wilson, 2000). This is not surprising given that simultaneous 
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social, emotional, physical and hormonal changes are taking place during adolescence 
(White, Oswald, Ollendick, & Scahill, 2009). Compounded by core social, 
communicative, and cognitive deficits, the adolescent with ASD is often confronted 
with challenges across their school, home, and social life (Khouzam, El-Gabalawi, 
Pirwani, & Priest, 2004). The accumulation of these factors is likely to intensify 
anxiety levels and consequently affect adjustment at high school, where change is 
constant and social relationships are difficult to navigate. As anxiety increases, the 
adolescent may become more withdrawn, engage more often in ritualised or repetitive 
behaviours, and become irritable and aggressive (Tantam, 2003). It is therefore 
imperative to study anxiety from a developmental perspective, as an array of factors 
may impede an adolescent’s functioning (Farrugia & Hudson, 2006). 
A study by Kuusikko et al.  (2008) compared social anxiety and internalising 
symptoms in 54 ASD adolescents and a community sample of 305 adolescents and 
found that those who had ASD scored higher on all outcome measures (self and 
parental reports) than the community adolescent participants. As age increased, 
adolescents with ASD tended to engage in more avoidant behaviour and social anxiety 
was more common. In contrast, in the community sample, behavioural avoidance 
decreased with age. Other studies which have found individuals with comorbid ASD 
and anxiety are at increased risk for displaying externalising behaviour problems 
(Davis et al., 2011), social avoidance (Gillott et al., 2001; Rudy et al., 2013), problems 
initiating and maintaining peer relationships, sleep difficulties, disruptions in family 
functioning and decreased overall quality of life (Higgins, Bailey, & Pearce, 2005; 
Rao & Beidel, 2009; Rudy et al., 2013; van Steensel, Bögels, & Dirksen, 2012).  
If left untreated, adolescents are at risk of severe educational difficulties, 
problems gaining meaningful employment, minimal adult relationships, substance use 
difficulties, and additional psychiatric symptomology (Howlin & Moss, 2012; Reaven, 
2009; Reaven, Blakely-Smith, Leuthe, Moody, & Hepburn, 2012; Tantam, 1991; 
Velting, Olivia, Setzer, & Albano, 2004). The more established behaviour patterns 
become, the more difficult they are to change (Howlin, 2000), and the more likely they 
are to become chronic, and continue into adulthood (Binnie & Blainey, 2013; Buck et 
al., 2014; Joshi et al., 2013).  
While further research is needed to determine the developmental effects of 
anxiety in adolescents with ASD, it is clear that anxiety can be invasive, may increase 
in severity with age, and has the potential to intensify social and functional 
impairments (Kuusikko et al., 2008; White et al., 2015). With the growing prevalence 
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of children diagnosed with ASD, along with the high incidence of comorbid anxiety, 
research focusing on the management of anxiety among this population is pertinent. 
1.4.3 Nature and presentation of anxiety in individuals with ASD. While 
lacking consensus, there is some evidence to suggest that the presence of anxiety in 
adolescents with ASD is directly associated with age, functioning status, 
communication skills, and intelligence (Rudy, Lewin, & Storch, 2013).  
Despite limited research on the triggers and presentation of anxiety in youth 
with ASD, emerging evidence suggests that triggers are markedly different than those 
associated with typically developing youth (Ozsivadjian et al., 2012). In an attempt to 
isolate factors that underpin anxiety in this population, an exploratory study by 
Ozsivadjian et al., (2012) used focus groups to identify common triggers across youth 
with ASD and anxiety. Triggers included social or language-related difficulties, 
situational change or change in routines, sensory issues, specific fears, obsessions, and 
high expectations in performance or organization. School related anxieties were 
pervasive across all anxiety groups. In addition, these authors identified five common 
categories for the manner in which anxiety expresses itself in youth with ASD: 
challenging behaviours/ “meltdowns” (verbally and physically aggressive behaviour 
were frequently mentioned); avoidance/ escape; hyperactivity/ heightened arousal; 
sensory behaviours; and increased repetitive behaviours; with challenging behaviours 
being the most pervasive. Whilst some presentations mirrored those of typically 
developing youth (e.g., avoidance/ escape, increased arousal, meltdowns), the 
expression of anxiety was found to be unique at times to those with ASD (e.g., 
language and sensory related, rigidity in routines, and heightened challenging 
behaviours). These expressions of anxiety may heighten core ASD difficulties while 
highlighting the challenges associated with interacting appropriately in social 
situations, repetitive questioning, ritualised behaviour and overall functioning 
(Reaven, Blakely-Smith, Leuthe, et al., 2012).  
Parents in a study by Ozsivadjian et al. (2012) noticed anxiety less pre-
emptively (for example, before situational of behavioural expressions occur) and more 
when it was expressed in the form of maladaptive coping behaviours. In addition, they 
often attributed behaviours to the core deficits of ASD (e.g., rigidity) rather than to 
symptoms of anxiety. The difficulties inherent in ASD, particularly in understanding, 
identifying and expressing feelings, and in using pragmatic language, may well explain 
why behavioural forms of coping in times of high distress are employed over verbal 
expressions of anxiety (Ozsivadjian et al., 2012). While typically developing anxious 
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children may experience some difficulty in expressing their feelings, for youth with 
ASD, the expression of anxiety is likely to be quite different due to the severe social 
and communication challenges they face. Developing a deeper understanding about 
the factors that trigger and maintain anxiety in those with ASD will be valuable in 
determining autism-specific assessment, treatment, and implementation of 
interventions for anxiety in this population.  
1.5 Risk Factors for Anxiety  
Literature in the area of anxiety in typically developing children and 
adolescents has identified numerous factors that may contribute to the development 
and maintenance of anxiety symptoms. There is no reason to suggest that these 
etiological factors are not shared by those with ASD and co-occurring anxiety. For 
example, genetic influences, temperament, parenting style and parental anxiety, 
cognitive biases, social learning paradigms and negative or traumatic life events all 
have the potential to influence symptom development (Reaven & Blakeley-Smith, 
2013). There may however, be factors contributing to the development of anxiety 
symptoms that are unique to youth with ASD and that need to be considered when 
designing interventions for this population. The core deficits of ASD have the potential 
to increase anxiety and it may be that some of these relationships are bidirectional 
(Mazefsky & Herrington, 2014). 
1.5.1 Family history of anxiety and depression. A strong familial 
psychopathology has been determined in family and epidemiologic studies. Family 
studies have linked ASD and anxiety disorders showing that anxiety disorders amongst 
people with ASD and their family members occur more frequently than in family 
members of typically developing youth who have other developmental problems, such 
as Down Syndrome (see Bolton, Pickles, Murphy, & Rutter, 1998; Kerns & Kendall, 
2012). Furthermore, mother’s anxiety levels have been found to be directly associated 
with increased anxiety in children with ASD (Mazefsky, Conner, & Oswald, 2010); 
higher levels of restrictive behaviours in young people with ASD is significantly 
associated with OCD traits in parents compared to ASD youth with lower restrictive 
behaviours (Hollander, King, Delaney, Smith, & Silverman, 2003; Kerns & Kendall, 
2012); and having psychiatric difficulties, other than ASD, amongst family members 
was a predictor of psychiatric problems, including anxiety, in ASD participants 
(Gadow, DeVincent, & Schneider, 2008; Kerns & Kendall, 2012). This latter finding 
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gives sustenance to the notion that anxiety symptomology may well be a separate 
entity to ASD. While emerging, there has been an absence of literature on the role that 
familial mental health may play in the mental health of young people with ASD. It 
may be that researchers have bypassed this topic due to the early work in this field that 
blamed mothers for their child’s ASD symptomology (Reaven & Blakeley-smith, 
2013). 
1.5.2 Cognitive differences.   
It has been proposed that the core features of ASD are underpinned by 
cognitive differences. A number of cognitive theories exploring the mechanisms 
underlying these differences have been proposed (Syriopoulou Delli, Varvaris, & 
Geronta, 2017). One such model is the theory of mind hypothesis, which, together with 
the theory of weak central coherence, may explain many of the difficulties and abilities 
associated with ASD. It has been argued however, that the repetitive behaviours and 
restricted interests observed in individuals with ASD may be best explained by a third 
cognitive theory, that of executive dysfunction (Brunsdon & Happé, 2014). 
Having an under-developed theory of mind, individuals with ASD may have 
difficulties in deciphering the thoughts and feelings of other people, may have 
difficulty with empathising and often feel confused by other people’s behaviour 
(Baron-Cohen, 1989; Frith, 2012). Neuroimaging studies have now illustrated that 
individuals with Asperger’s disorder show significantly less activation in the brain 
regions (medial prefrontal cortex, superior temporal sulcus at the temporoparietal 
junction and temporal poles) that are important for “mentalising” in neurotypical 
individuals (Castelli, Frith, Happé, & Frith, 2002). The predominant view in the 
developmental literature is that, although somewhat complicated by developmental 
factors and type of theory of mind task, individuals with ASD demonstrate an apparent 
inability to think about thought. 
According to the theory of weak central coherence theory, difficulty occurs in 
the operation of central systems that are normally responsible for integrating individual 
pieces of information to establish meaning.  For individuals with ASD this piecemeal 
approach to stimulus processing means that they are extraordinarily capable of 
attending to details, but demonstrate considerable challenges perceiving or 
understanding the overall picture, or “gist” (Attwood, 2007; Plaisted, Saksida, 
Alcántara, & Weisblatt, 2003). Proponents of this theory argue that other ASD features 
such as hyper- or hypo-arousal to sensory stimuli, extreme sensitivity to small changes 
in the environment, and circumscribed interests can also be explained by weak central 
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coherence (Hoy, Hatton, & Hare, 2004). The rigid thinking style inherent in this 
population may derive from weak central coherence, which inhibits their ability to 
learn from mistakes, cope with being wrong, and to adapt their behaviour to meet the 
demands of their environment (Burnette et al., 2005). Some studies however have 
failed to demonstrate differences in visual processing tasks between individuals that 
have ASD and those without ASD and therefore further research is required to 
substantiate this theory (Brian & Bryson, 1996; Ozonoff, Pennington, & Rogers, 
1991).  For example, Syriopoulou Delli, Varvaris, and Geronta (2017) recently found 
children with ASD performed similarly to typically developing children in terms of 
local processing ability with these authors suggesting that differences may be a 
preferred personal processing style as opposed to a universal feature of ASD. 
When compared to children and adults with other developmental disabilities 
(e.g., ADHD, conduct disorder and Tourette syndrome), executive function abilities in 
children and adults with ASD have been found to be more severely impaired 
(Bennetto, Pennington, & Rogers, 1996; Hollocks, Ozsivadjian, Matthews, Howlin, & 
Simonoff, 2013; Sally Ozonoff & Miller, 1995). These abilities include functions such 
as planning, working memory, impulse control, inhibition, self-monitoring, 
generativity and mental flexibility (Hollocks et al., 2014). It has been proposed that 
executive impairment reflects abnormalities in the frontal lobe and is accountable for 
repetitive and restricted behaviour in ASD (Happe, 1999). The literature on executive 
dysfunction as a causal factor in autism spectrum disorders is controversial however, 
it has been demonstrated that executive function deficits do play a role in the social 
and cognitive deficits observed in school-age children with ASD (Griffith, Pennington, 
Wehner, & Rogers, 1999; Ozonoff, Rogers, & Pennington, 1991).  
Currently, there is a lack of research exploring the manner in which cognitive 
deficits may contribute to the development or maintenance of anxiety symptoms in 
adolescents with ASD (Farrugia & Hudson, 2006). Research is needed to explore these 
cognitive processing styles, often absent in typically developing individuals, to 
determine how they may be contributing to, or moderating, the possible atypical, or 
distinct, symptoms of anxiety in those with ASD.   
 1.5.2 Sensory over-responsivity. Individuals with ASD are often reported to 
have sensory over-responsivity, that is, they may react strongly and negatively and/ or 
develop fears to certain stimuli including visual and auditory information, touch, tastes 
and smells  (Kerns & Kendall, 2012). For example, some children have a low tolerance 
to tags in clothing or seams in socks, or dislike being touched unexpectedly (Green & 
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Ben-Sasson, 2010). Other children may develop a specific phobia (e.g., balloons 
popping or thunderstorms) due to their sensitivity to noise. Research indicates that 
approximately 56-70% of children with ASD experience sensory over-responsivity, 
compared to 10-17% in the general population (Baranek, David, Poe, Stone, & 
Watson, 2006). It has been suggested that an overreaction to aversive sensory stimuli 
among individuals with ASD causes them to pay attention to, and have difficulty 
disengaging from such stimuli (Liss, Saulnier, Fein, & Kinsbourne, 2006). The 
relationship between sensory over-responsivity and the possible development and 
maintenance of anxiety is not yet understood. Further research is required in this 
important area. 
1.5.3 Overactive fear response. Emerging evidence suggests that individuals 
with ASD may have a neurobiological risk for an overactive fear response. Some 
studies have found that youth with ASD have larger amygdala volumes than their 
typically developing peers. This is of interest because amygdala volume is positively 
related to severity of anxiety and social-communication problems (Green et al., 2013). 
1.5.4 Social functioning. It has been proposed that the atypical social 
behaviour of individuals with ASD may actually be a primary contributing factor in 
the development of anxiety itself, which in turn, may exacerbate an adolescent’s social 
impairment (Cappadocia & Weiss, 2011; White, Bray, & Ollendick, 2012). In the past, 
the social deficits of ASD have been believed to arise from low levels of social 
motivation. Emergent information from neuroimaging, psychophysiological, and 
behavioural studies however, are now associating this inherent social disability with 
heightened arousal and avoidance of social situations for certain young people with 
ASD (Dalton, Nacewicz, Alexander, & Davidson, 2007; White et al., 2013). 
Particularly in response to social-emotional information, heightened arousal may 
interfere with accurately interpreting social cues and appropriate reactions to others, 
suggesting that anxiety itself may be contributing to the social disability present in 
ASD (Kerns & Kendall, 2012; White et al., 2013). For adolescents, a lack of peer 
relationships, combined with an inability to comprehend many social situations and 
impaired functioning in reciprocal interactions, may substantially increase anxiety 
levels (Tse, Strulovitch, Tagalakis, Meng, & Fombonne, 2007). Social anxiety can 
lead to fear and avoidance of social situations, providing limited opportunities to 
practice important social skills (Reaven, Blakely-Smith, Leuthe, et al., 2012; Rudy et 
al., 2013; White et al., 2009) and affect academic success (Rotheram-Fuller & 
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MacMullen, 2011). Currently however, the question of whether a bidirectional 
relationship exists between anxiety and social functioning, or whether one actually 
mediates the other, remains unanswered (White et al., 2010).  
1.5.5 Resistance to change. Individuals with ASD commonly experience 
change and transition related anxiety. Typically developing children who are assessed 
as behaviourally inhibited, which includes finding adjustment to new situations 
difficult, are more prone to developing anxiety disorders (Muris & Ollendick, 2005). 
In a study of 31 adolescents with ASD, one-third were found to meet the criteria for 
transition-related anxiety on the Autism Comorbidity Interview (ACI; Lainhart, 
Leyfer, & Folstein, 2003). While this sample was small it does suggest that resistance 
to change may present a risk for anxiety (Mazefsky & Herrington, 2014). In 
confirmation of this, Rodgers, Glod, Connolly, and McConachie (2012) compared 
adolescents with ASD with a diagnosis of anxiety and those without, and found that 
those who experienced more resistance to change had higher levels of anxiety. Of 
interest, resistance to change was not correlated with anxiety in the low-anxiety group 
(Kerns & Kendall, 2012).  
1.5.6 Repetitive behaviours. Perseverative symptoms of ASD have been 
found to more strongly correlate with anxiety then social or communication symptoms 
(Guttmann-Steinmetz, & Crowell, 2010). It is however, unclear as to whether 
repetitive behaviours increased due to the presence of anxiety or vice versa. Indeed, 
while distress rather than anxiety symptoms were investigated by Mazefsky, 
McPartland, Gastgeb, and Minshew (2013) repetitive behaviours were observed to rise 
in times of distress and function as way of coping. While research is needed, similar 
to the relationship between social functioning and anxiety, it is probable that a 
bidirectional relationship between repetitive behaviours and anxiety may exist (Kerns 
& Kendall, 2012; Mazefsky et al., 2014). 
1.5.7 Attention Deficit Hyperactivity Disorder (ADHD). Prevalence of 
ADHD in the ASD population is high and ranges between 17 and 83% (Frazier et al., 
2001; Hanson, Hanson, Ramsey, & Glymour, 2013; Leyfer et al., 2006; Yoshida & 
Uchiyama, 2004). Researchers in this area have discovered that children with a 
diagnosis of ADHD demonstrate more ASD symptoms in comparison to typically 
developing children, and equally, that children diagnosed with ADHD have more ASD 
symptomology than their peers of typical development (Hattori et al., 2006). Limited 
research exists on the impact that ADHD symptoms have on treatment outcomes for 
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youth with ASD and anxiety. However, Antshel and colleagues (2011) provided a 
social skills intervention to 83 children (M = 9.5 years) and based on parent-reports, 
children with ASD and children with ASD and comorbid anxiety, improved in social 
skills. However, children with ASD and comorbid ADHD failed to improve. These 
latter findings confirm those previous that demonstrated limited treatment outcomes 
when social skills interventions are employed for children with ADHD (Antshel et al., 
2011; Kavale & Forness, 1996; Kolko, Loar, & Sturnick, 1990). Whether ADHD 
negatively moderates anxiety treatment efficacy is yet to be studied. 
1.6 Family Quality of Life  
Research findings have demonstrated that parents of children and adolescents 
with ASD experience increased stress, anxiety and depression, and family problems 
when likened to parents of typically developing children or children with other 
disabilities (Abbeduto et al., 2004; Bouma & Schweitzer, 1990; Donovan, 1988; 
Hartley, Seltzer, Head, & Abbeduto, 2012; Kerns et al., 2015; Lai, Goh, Oei, & Sung, 
2015; Lee, Harrington, Louise, & Newschaffer, 2008; Pozo, Sarriá, & Brioso, 2014; 
Smith, Greenberg, & Seltzer, 2012). Having a child with an additional anxiety 
diagnosis can elevate levels of family distress (Kerns et al., 2015) and heighten parent 
accommodation. Here, parents of children with anxiety problems frequently use their 
time and energy to accommodate their child’s symptoms, and this has been linked with 
elevated levels of parental stress and psychiatric symptomology (Kerns et al., 2015). 
Parents may adjust their routines to accommodate their child’s “rules” for different 
tasks and unique preferences (Ausderau & Juarez, 2013). In addition, parents may 
reduce demands placed upon their child parents avoid participating in situations that 
may cause their child distress and instead plan activities in order to decrease the 
possibility of challenging behaviour (O’Nions, Happé, Evers, Boonen, & Noens, 
2018). In addition, parents of children with ASD have been reported to spend an 
excessive amount of time, with little impact, attempting to reassure their adolescent in 
response to anxiety symptoms, such as, their intense fears concerning an event, or their 
refusal to attend school (White et al., 2009). Positively, a preliminary research finding 
indicates that utilising CBT to reduce anxiety in young people with ASD results in a 
significant reduction in parental stress (Ooi et al., 2008).  
The culminating stress placed upon families with a child with ASD is likely to 
negatively impact upon a family’s quality of life (Chalfant et al., 2007; Ooi et al., 
2008). While there has been a growth in research exploring family quality of life of 
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families with a child with a disability in general, research investigating the family 
quality of life for parents with a child with ASD is still in its infancy (Eapen, Crncec, 
Walter, & Tay, 2014; Lee, Harrington, Louise, & Newschaffer, 2008). Nonetheless, 
family quality of life has been identified as a likely mediator of psychological 
adjustment and treatment outcome for people with ASD, and is therefore an important 
component to consider in treatment planning and evaluation (Eapen et al., 2014).  
1. Conclusion 
This chapter reviewed the historical and diagnostic journey of ASD and its 
prevalence, in addition to examining the relationship between anxiety and ASD. In 
particular, the atypical nature in which anxiety may manifest, its prevalence, 
developmental trajectory, functional impairment, risk factors and impact on adult 
outcomes within this population.  
Anxiety within typically developing youth has been extensively studied. 
Despite the high prevalence of anxiety amongst youth with ASD, the overlap of 
symptomology between ASD and anxiety has contributed to the dearth of research into 
anxiety assessment, prevalence, presentation, and treatment for individuals with ASD 
(Kerns et al., 2015; White et al., 2015). While there has been a shift in attention in 
recent years, this has for the most part, been limited to children with ASD (Sung et al., 
2011; White et al., 2013). The inadequate study of anxiety in adolescents with ASD is 
noteworthy given that anxiety has been postulated to present more acutely for this age 
group. Furthermore, the presence of these symptoms at this time may be particularly 
impairing, placing individuals at risk for the development of other psychiatric 
disorders, limited social support, education and employment difficulties (Howlin, 
2000). The impact of comorbid anxiety has additionally been found to contribute to 
increased internalising and externalising behaviour, high levels of parental stress and 
diminished family of quality of life (Kerns et al., 2015). 
There are a number of etiological factors that may be unique to the 
development and maintenance of anxiety in youth with ASD. For example, there are 
elevated rates of familial psychopathology in families where there is an ASD child or 
adolescent, increased sensory dysfunction, possible overactive fear response, along 
with core ASD deficits. Our understanding of how these processes may underlie or 
increase anxiety is limited and further research is required. Due to the atypical pathway 
in which anxiety manifests, it has been suggested that assessment measures and 
treatment protocols aimed at typically developing youth may not be appropriate or 
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effective in assessing and reducing anxiety in individuals with ASD (White et al., 
2015). The following chapter will explore the problems encountered with anxiety 
measures standardised to typically developing youth and review the literature on 
treatments targeted at reducing anxiety within this unique population. 
  
31 
Chapter 2: Interventions for Anxiety in Adolescents with ASD 
2.1 Introduction 
Researchers have provided strong support for the treatment of childhood 
anxiety disorders in typically developing children, comprising of cognitive 
behavioural therapies, selective serotonin reuptake inhibitors (SSRIs), or a 
combination of both (Vasa et al., 2014; Walkup et al., 2008). In contrast, empirically 
supported anxiety-based treatments for youth with ASD are limited, despite the high 
prevalence of anxiety and subsequent negative effect on quality of life (Lang, 
Regester, Lauderdale, Ashbaugh, & Haring, 2010b; Selles & Storch, 2013). Outlined 
below are a number of factors that have contributed to the lack of evidence-based 
treatment studies in this area. 
Individuals with ASD are often clinically unique and challenging in their 
presentation which is likely to hinder therapeutic engagement and successful treatment 
outcomes (Selles & Storch, 2013). For example, some of the barriers to treatment may 
include negative or dysregulated emotional systems, difficulties in social, attention, 
and adaptive skills, cognitive and communication deficits, comorbidity of disruptive 
behaviour disorders, narrow interests and poor insight, lack of motivation and abstract 
thinking ability, and difficulty in skill generalisation (Kerns et al., 2015; Ozsivadjian, 
Knott, & Magiati, 2012; Scattone & Mong, 2013). It is not surprising that professionals 
may feel perplexed as to how best meet their needs (Selles et al., 2014; Wood et al., 
2009). In addition, the idiosyncratic nature of ASD denotes that individuals often differ 
clinically from one another. For example, where aggression may be the most pressing 
clinical issue for one individual with ASD, hyperactivity may be the main presenting 
concern for another (McLeod, Wood, & Klebanoff, 2015). As such, manualised 
programs targeting a particular type of symptom, such as anxiety, may or may not be 
a good fit for an individual presenting for intervention (McLeod et al., 2015). 
Therefore, anxiety strategies that have been successful in typically developing 
populations may lack effectiveness and need to be modified for individuals with ASD. 
In this chapter, an overview of interventions aimed at reducing anxiety in youth 
with ASD will be provided. It is well documented that specific barriers to participation 
and engagement in therapy are common for this client group (Ozsivadjian & Knott, 
2011; Scattone & Mong, 2013). These will be explored, along with modifications and 
adaptations to better address the unique characteristics of these individuals. Briefly, 
research on the efficacy of CBT for typically developing youth will be discussed, prior 
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to examining empirical evidence of CBT for anxiety in ASD youth, with a particular 
focus on group-based CBT.  
2.2 Assessment  
Currently, assessment measures developed and standardised for youth with 
ASD are lacking, with no commercially available anxiety measures developed 
specifically for people with ASD (White, Schry, & Maddox, 2012). This creates 
problems when assessing and interpreting changes and treatment response in 
intervention research (Ozsivadjian & Knott, 2011; Ozsivadjian et al., 2012). 
Assessment can also aid in identifying when treatment delivery may require 
modifications (Mazefsky & White, 2013). For these reasons, in conjunction with being 
aware of symptom overlap, researchers in this field are acknowledging that caution 
needs to be taken when using measures that lack information on psychometric 
properties for children with ASD (Mazefsky & White, 2013; McLeod et al., 2015). 
While there exists evidence-based assessment tools to accurately measure the core 
deficits of ASD, fewer assessment tools exist for co-occurring clinical problems 
frequently observed in those with ASD, such as anxiety (McLeod et al., 2015). 
In the general clinical and psychiatric population, while a multi-informant 
approach to assessment is ideal, agreement among parents and children has often been 
reported to be reasonably low (De Los Reyes & Kazdin, 2005; Reuterskiöld, Öst, & 
Ollendick, 2008). Many researchers have replicated the finding that discrepancies 
often exist among the ratings of different informants, however they have failed to 
explain why these differences consistently occur (De Los Reyes & Kazdin, 2005). 
Within ASD research, this discrepancy between parent-and child-report measures may 
be even more distinct (Lopata et al., 2010; Mazefsky, Kao, & Oswald, 2011). For 
example, low agreement occurred between parent and child self-reports on the Autism 
Comorbidity Interview—Present and Lifetime (Mazefsky et al., 2011). Similarly, in a 
sample of 8-13 year old children with and without ASD, May and colleagues (2015) 
found greater agreement between parent and child reports using the Spence Children’s 
Anxiety Scale (SCAS) for the parent and children in the typically developing group 
compared to those in the ASD group. Conversely, other studies have demonstrated 
relatively good parent-child agreement among various anxiety measures (Blakely-
Smith, Reaven, Ridge, & Hepburn, 2012; Burrows et al., 2018; Farrugia & Hudson, 
2006; Magiati, Chan, Tan, & Poon, 2014; Ozsivadjian, Hibberd, & Hollocks, 2014). 
For example, moderate-to-strong agreement was found among parent and child ASD 
  
33 
dyads on a number of domains in the Screen for Child Anxiety Related Emotional 
Disorders (SCARED; Blakely-Smith et al., 2012). There was greater agreement 
between parent and child dyads in the areas of Separation, School Avoidance, and 
Total Anxiety when children demonstrated greater verbal ability (Blakely-Smith et al., 
2012). 
These researchers, along with others, have found that parents rate their child’s 
anxiety symptoms or social worries more highly than their child’s reports (Blakely-
Smith et al., 2012; Gillott et al., 2001; Christopher Lopata et al., 2010; Russell & 
Sofronoff, 2005; van Steensel, Deutschman, & Bögels, 2012). In contrast, with a 
slightly older population of adolescents with ASD, good parent-teen agreement has 
been found (Farrugia & Hudson, 2006; Hurtig et al., 2009). For example, Farrugia and 
Hudson (2006) revealed substantial parent-teen agreement on the Total Anxiety Scores 
on the SCAS (r = .697). These findings may suggest that accurate self-reporting is 
positively related to development. However, White, Schry, and Maddox, (2012) used 
the child and parent versions of the Multidimensional Anxiety Scale for Children with 
12-17 year olds with ASD and found them not to be significantly correlated. The 
authors questioned the validity of self-report measures of the adolescents in their study 
given that only 23% self-reported clinically elevated levels of anxiety despite all being 
diagnosed with an anxiety disorder. 
It may be that communication and cognitive deficits, impaired introspection 
and emotion identification, and impaired verbal expression, aid difficulties in accurate 
self-reporting (Blakely-Smith et al., 2012; Leyfer et al., 2006). Nevertheless, it has 
been proposed that self-reports should be obtained from youth with ASD where 
possible since they have the potential to provide valuable information. This was 
confirmed in a study which found that self-reports by adolescents with ASD had equal 
or better internal reliability scores when compared with non-ASD standardisation 
samples, suggesting that the adolescents comprehended the questions and were 
consistent in their responses (Mazefsky et al., 2011).  
In contrast, a number of studies focusing on anxiety or depression have 
postulated that youth with ASD commonly underreport their symptoms (Mazefsky et 
al., 2011; Russell & Sofronoff, 2005; White, Schry, & Maddox, 2012). Underreporting 
of symptoms may be useful clinical information as it may indicate a need to increase 
self-awareness and to infer feelings about oneself and others. In light of inconclusive 
evidence, the research field refrains from recommending self- or parent- report 
questionnaires for use with children with ASD to measure anxiety or depression. 
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However, some self-report measures have been used in ASD samples such as the 
Screen for Child Anxiety Related Emotional Disorders (SCARED; Birmaher et al., 
1997), the Mood and Feelings Questionnaire (MFQ; Angold & Costello, 1987) and 
the Spence Children’s Anxiety Scale (SCAS; Spence, 1998). For best practice 
measures in assessing anxiety symptomology, it has been suggested that researchers 
use multiple sources of information, such as parent and child interviews, reliable and 
valid rating scales, and behavioural observations with this population (White and 
Roberson-Nay, 2009). 
2.3 Types of Interventions 
Research investigating anxiety-based treatments in the ASD population is still 
emerging. Currently, for school-aged children and adolescents with ASD, no 
psychosocial or medication treatments for anxiety have been accepted as meeting the 
American Psychological Association (APA) guidelines for efficacy (Chambless & 
Hollon, 1998; Kerns et al., 2016). A review of psychopharmacological and non-
psychopharmacological treatments for anxiety in youth with ASD follows. 
2.3.1 Psychopharmacological interventions.  For typically developing youth, 
the first-line psychopharmacological treatment of anxiety disorders is SSRIs (Selles & 
Storch, 2013). Currently, no psychotropic drugs are approved to treat anxiety in youth 
with ASD, and little is known about patterns of pharmacological treatment in the ASD 
population and associated co-morbidities (Murray et al., 2014). While typically safe 
and well tolerated, for youth with ASD, SSRIs have been linked to possible side effects 
with an elevated risk of an adverse reaction when compared to typically developing 
populations (Selles & Storch, 2013; West, Brunssen, & Waldrop, 2009).  Reported 
side effects include physical (e.g., headache, nausea, diarrhoea) and behavioural 
symptoms (e.g., agitation, aggression, hyperactivity and suicide ideation; King, 
Hollander, & Sikich, 2009; McDougle, Kresch, & Posey, 2000; West et al., 2009). 
Similar to those of typical development, youth with ASD share a vulnerability to 
behavioural activation with certain SSRIs, such as impulsivity, behavioural activation, 
heightened activity level or disinhibition without manic symptoms (King et al., 2009; 
Reinblatt et al., 2009; Selles & Storch, 2013). With the high rates of children and 
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adolescents with ASD experiencing psychiatric comorbidities, there is an urgent need 
for future research to focus on anxiety treatment for this client population. 
2.3.2 Cognitive Behavioural Therapy theory. Cognitive behavioural therapy 
(CBT) is a brief, structured form of psychotherapy based on empirical evidence and 
theory from learning and cognition designed to create changes in thinking, feeling, and 
behaviour (Anderson & Morris, 2006; Scarpa, White, & Attwood, 2013). The central 
tenet of cognitive therapy is that a person’s cognition is a mediator between stimuli 
(an event) and emotions (Beck, 2005). Therefore, a stimulus elicits a thought, belief, 
evaluation, or judgment that elicits an emotion. Important here is that emotions are not 
caused as a direct result of a stimulus. It is the manner in which a person appraises the 
stimulus that elicits an emotional reaction (O’Donovan, Casey, Veen, & Boschen, 
2013). Anxiety disorders often arise from multifaceted sets of negative beliefs 
concerning the self or the outside world (Beck, Emery, & Greenberg, 1985). They are 
triggered by particular feared stimuli or situations ascending from threat-oriented 
cognitive schemas. Since such schemas are often developed during the course of 
threatening and stressful experiences, assumptions are made regarding the perilous 
nature of certain situations or events, for example, “I can be bitten by a shark in the 
ocean, therefore I must never swim in the ocean.” Here, schemas envelop cognitive 
distortions whereby safety-related situations may be minimised and threat-related 
adverse situations are maximised (Beck, Emery, & Greenberg, 1985). In addition, core 
beliefs can elicit maladaptive compensatory behaviours (O’Donovan et al., 2013). For 
example, an individual may believe that others do not like them and this may lead to 
social withdrawal. With social opportunities avoided, their belief that others do not 
like them is not challenged and is likely to be reinforced. 
Cognitive behavioural therapy (CBT) helps individuals to identify their 
distressing feelings and thoughts and to challenge their assumptions about anxiety-
provoking events or stimuli (Beck et al., 1985). During CBT, cognitions are monitored 
and individuals evaluate how realistic their thoughts are. Beck’s (1985) theory pertains 
that dysfunctional behaviour arises from dysfunctional thinking and therefore by 
implementing changes in thinking, behaviour change is likely to occur. Since CBT 
focuses on cognitive restructuring and psychoeducation, somatic management skills 
and behavioural components (such as graded exposure), a reduction in anxiety is often 
the result (Rapee et al., 2009). Figure 1 shows how CBT assists individuals to identify 
and evaluate their automatic thoughts and the association this has on behaviour.  
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Figure 1.The Cognitive Model (Beck Institute for Cognitive Behavior Therapy, 2016).  
Hundreds of empirically-based studies have refined, enhanced and assessed 
CBT over time (Clark & Beck, 2010). Currently, it is viewed as the treatment with the 
greatest empirical support for numerous internalising disorders in youth (Barrett, 
Farrell, Pina, Peris, & Piacentini, 2008; David-Ferdon & Kaslow, 2008).  
2.3.3 Cognitive Behaviour Therapy for anxiety in typically developing 
adolescents. CBT is currently regarded as the primary non-psychopharmacological 
treatment for anxiety and depression in typical individuals (Scattone & Mong, 2013). 
Treatment of anxiety in typically developing anxious youth has been well researched, 
with CBT being the empirically supported treatment of choice (Barrett, Duffy, Dadds, 
& Rapee, 2001). For adolescents, CBT provides coping strategies to target 
maladaptive thoughts, feelings, and behaviours in order to change distorted thinking 
and reduce physiological arousal. Over time, the adolescent is able to face anxiety-
provoking situations (Green & Wood, 2013). In comparison to adult CBT programs, 
those designed for children and adolescents are more action-oriented, developmentally 
aligned to capabilities and interests, and include additional reinforcement (Moree & 
Davis, 2010). Furthermore, treatment protocols may include education around 
assertiveness, problem solving, and social skills (Rapee et al., 2009). The fundamental 
purpose of these therapeutic elements is to specifically alter the central processes that 
have been theorised to maintain anxiety in youth (Rapee et al., 2009). Since the Coping 
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Cat program by (Kendall, 1994) was investigated, numerous studies have provided 
efficacious support for CBT with young people. Following skills-based treatment 
protocols, there is approximately 55-60% diagnostic remission of anxiety diagnosis in 
typically developing children, compared to approximately 30% of youth in 
comparison conditions (Rapee et al., 2009). However, the mediators and moderators 
central to the effectiveness of CBT programs for youth with anxiety remain 
underexplored (Prins & Ollendick, 2003).  
Unlike adult treatment research, which is mostly disorder-specific, whether 
children with one type of anxiety demonstrate better response to psychological 
treatment compared to those with different forms of anxiety is still poorly understood 
(Hudson et al., 2015a). However, it has been suggested that children with GAD and 
separation anxiety disorder may respond better to CBT than those with social anxiety 
disorder (Hudson, 2015). Further, higher pre-treatment severity of child anxiety or 
having a comorbid non-anxiety diagnosis has predicted poorer treatment outcome 
(e.g., Hudson et al., 2015a; Liber et al., 2010; Rapee et al., 2009; Wergeland et al., 
2016).  
Gender has also been studied in child anxiety outcome studies with mixed 
results. Whilst female gender has been associated with poorer treatment effects in an 
earlier study by Hudson and colleagues (2013), a later study found no effect of gender 
on treatment outcome (Hudson et al., 2016). In addition, these authors found that age 
did not significantly predict treatment outcome. However, the participants in this study 
were aged less than 13 years. Other studies (e.g., Wergeland, 2016), reviews (e.g., 
(Knight, McLellan, Jones, & Hudson, 2014; Lundkvist-Houndoumadi, Hougaard, & 
Thastum, 2014), and meta-analyses (Bennett et al., 2013) have not found treatment 
outcome to be predicted by age and gender (Wergeland, 2016). 
Parental psychopathology has been associated with significantly poorer 
treatment outcomes (Berman et al., 2000; Crawford & Manassis, 2001; Rapee, 2000), 
however two large systematic reviews of the literature have since failed to find 
conclusive evidence for this (Knight, Hudson, McLellan, & Jones, 2014; Lundkcist-
Houndoumadi, Hougaard, & Thastum, 2014). Further, family involvement in CBT 
treatment programs for anxious children has been studied, with inconclusive results 
(Barmish, Andrea & Kendall, 2005). A number of studies comparing family CBT to a 
waitlist condition have however, demonstrated that family CBT is superior to waitlist 
(e.g., Rapee, Abbott & Lyneham, 2006; Shortt, Barrett, & Fox, 2001). Since the type 
of family involvement varies widely across studies it is difficult to isolate the 
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components that aid positive treatment response (Rapee, Schniering, & Hudson, 
2009). While large studies of client data across sites can elicit common clinical 
predictors in response to CBT treatment, there is considerable heterogeneity in the 
samples, differences in recruitment, assessment and treatment, and a strong absence of 
adolescents, with results predominantly generalised to children. Therefore, a need still 
exists to identify predictors of treatment outcome as well as identifying children and 
adolescents who are at risk of poorer outcomes in order to assist in developing more 
effective treatment for these youth. 
2.3.4 CBT for anxiety in adolescents with ASD: Barriers to treatment. 
Until recently, clinicians have been hesitant in applying CBT to anxious adolescents 
with ASD due to the unique cognitive profile and core deficits inherent in this client 
group (Chalfant et al., 2007; Moree & Davis, 2010). Traditional CBT treatment 
programs rely heavily upon the client’s strong linguistic and abstract thinking abilities, 
which are often in contrast to the visual and concrete learning style of ASD individuals 
(Reaven, 2009). For example, Socratic questioning and verbal psychoeducation 
routinely used in CBT programs, assists in linking thoughts, feelings and behaviours 
but can prove problematic for those with ASD (Castelli et al., 2002; Rotheram-Fuller 
& MacMullen, 2011). Of particular concern is that these individuals often lack Theory 
of Mind (TOM), that is, they have difficulty in recognising emotions in themselves 
and others, which inhibits their ability to infer and shift their cognitive style (Baron-
Cohen, 1989; Chalfant et al., 2007). Since this is an important requirement of CBT, 
Chalfant et al. (2007) explored TOM in these individuals further. These authors found 
that with the implementation of certain modifications (such as visual aids), individuals 
with ASD do actually have the capacity to identify their own thoughts and those of 
others (Chalfant et al., 2007). Since recognising when they are anxious is an integral 
part of CBT treatment, it has been recommended that a greater focus is placed on 
affective education (e.g., learning to define and recognise emotions and identifying the 
intensity of emotions experienced;  Green & Wood, 2013).  
Despite meta-cognitive impairments inherent in this population, clinicians 
have been encouraged to use CBT with individuals with ASD. Hare (2004) purports 
that these individuals share the thinking errors or “all or nothing thinking” (e.g., rigid, 
biased, and negative perceptions), seen in individuals who suffer anxiety and 
depression. Since CBT has proven effective in reducing anxiety in this population it 
has been suggested that those with ASD may additionally benefit from CBT-based 
meta-cognitive interventions designed for non-ASD individuals with anxiety (Hare, 
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2004). With these findings in mind, and incorporating appropriate modifications and 
individualisation, CBT programs for individuals with ASD have begun to demonstrate 
significant promise in reducing anxiety.  
Further characteristics of ASD have been proposed as impediments to the 
effectiveness of CBT. For example, it has been questioned whether the inherent 
difficulties in social interaction may interfere with the relationship between therapist 
and client, one of the central components of successful CBT (Dobson & Dobson, 
2009). In addition, the ability to be insightful and self-reflective has been identified as 
a potential barrier to treatment success, with an increased emphasis on teaching 
practical skills (e.g., social or adaptive self-help skills) suggested (Kenig & Levine, 
2010; Lang et al., 2010). Other unique challenges often inherent in youth with ASD 
that are likely to hinder therapeutic engagement and successful treatment outcomes 
include emotional dysregulation, executive dysfunction (such as poor planning, 
organisation, goal setting, flexibility and working memory deficits) and attention 
deficits, restricted interests (e.g., may become bored with content outside of specific 
interest area), communication (e.g., comprehension, literal interpretation), and a lack 
of motivation and difficulty in skill generalisation (Ozsivadjian & Knott, 2011; 
Scattone & Mong, 2013). Experiencing difficulties in one or more of these areas can 
make session engagement challenging. For example, an adolescent may not view their 
behaviour as problematic and may even deny experiencing anxious symptomology. 
As such, they are likely to lack motivation in changing the behaviour that the program 
is targeting (Scarpa & Lorenzi, 2013). Likewise, having strong interests in a particular 
area may mean that the adolescent does not engage easily in content outside of this 
area, such as learning about emotion identification. The individual cognitive profile of 
the adolescent is likely to determine session engagement levels. For example, a child 
who is affected by executive dysfunction, attention and communication difficulties 
may experience more problems in understanding and engaging in session content and 
home practice tasks than a child who is not. As a result, some flexibility, in treatment 
content and delivery, to address both individual and common needs of adolescents 
with ASD, need to be considered. 
2.3.5 Modifications to CBT Treatment for Individuals with ASD.  To 
account for the core features of ASD that may limit the effectiveness of standard CBT 
programs, such as social and communication deficits, a number of modifications have 
been suggested (Cooper, Loades, & Russell, 2018; Mcgillivray & Evert, 2014; Sze & 
Wood, 2007). These include the need to consider language and developmental levels, 
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focus on hands-on activities, use direct and flexible teaching methods, and in vivo 
practice, to aid in the generalisation of skills (Anderson & Morris, 2006; Moree & 
Davis, 2010; White et al., 2009). While evidence on CBT for youth with ASD is still 
in its infancy, clinical research asserts the following strategies to improve the 
accessibility of CBT concepts for children and adolescents with ASD.  
2.3.5.1 Affective education. Due to common limitations in communication and 
social skills, adolescents with ASD often experience difficulty in identifying how they, 
and others are feeling, and in self-reporting thoughts, affective states and physiological 
sensations (Hagopian & Jennett, 2014). As a result, identifying subjective experiences 
of fear and anxiety can be problematic and why affective education is emphasised in 
the treatment of anxiety. Affective education is used to increase the individual’s 
knowledge within her- or himself and others (Scarpa et al., 2013). In CBT programs, 
individuals with ASD are explicitly taught about the connection between thoughts, 
emotions, and behaviours (Anderson & Morris, 2006; Attwood, 1999; 2004a). First, 
basic education on emotions is given (what emotions are, why we have them, and how 
to recognise emotions in ourselves and others). Second, assistance in translating 
emotions into words is provided as well as developing ways to reason about thoughts, 
feelings and behaviours in situations. Specific strategies have been developed to assist 
in affective education including creating a feelings book (Attwood, 1999; 2004a), 
using social stories, comic strip conversations, emotion thermometers, and computer 
programs (Anderson & Morris, 2006; Silver & Oakes, 2001). In addition, an emphasis 
on teaching children with ASD about the physical symptoms of anxiety as opposed to 
relying on the subjective emotional feeling, assists the child to concretely identify 
when he or she is experiencing anxiety. 
2.3.5.2 Behavioural strategies.  Given that youth with ASD may lack 
motivation to engage in therapy sessions, an emphasis on providing multiple 
opportunities to practice skills taught within CBT programs has proven beneficial 
(Rotheram-Fuller & MacMullen, 2011). Furthermore, concrete behavioural evidence 
can be gained through practical exercises such as experiential learning and exposure, 
and can assist in explaining cognitive constructs. In addition, behavioural supports to 
increase attentiveness and engagement, such as token economies (e.g., having time to 
talk about interests, chocolates, stars on a chart when child is attentive), prompting, 
routines (e.g., visual schedule for session plan), and reinforcement plans have been 
included in CBT programs (Green & Wood, 2013; Rotheram-Fuller & MacMullen, 
  
41 
2011). These positive reinforcement strategies can assist children and adolescents to 
initially engage in the CBT program and may also be used to help to shape the required 
behaviour for sessions (e.g., paying attention). Over time reinforcements can be 
reduced once intrinsic motivation increases. This can occur, for example, as a result of 
experiencing the effectiveness of coping skills and the benefits associated with 
attending CBT sessions (e.g., making friends in session or feeling more relaxed after 
a progressive muscle relaxation exercise). 
2.3.5.3 Visual strategies.  Reducing abstract language during psychoeducation 
and cognitive restructuring sessions, and increasing visual learning aids (such as 
thought bubbles, cartoon scenarios, and emotion thermometers) assists in the 
identification of thoughts and emotions, and the implementation of cognitive strategies 
(Lang et al., 2010; Reaven, 2009; Sze & Wood, 2008). For example, Reaven and 
colleagues (2009) employed visual strategies in their CBT sessions with children (e.g., 
drawings, photography, and multiple choice lists) to teach basic CBT concepts. Wood 
et al. (2009) used a number of cartoons to assist in the identification of physiological 
signs of anxiety, and to generate thoughts to assist with anxiety management. Children 
were then encouraged to draw their experience of anxiety in the form of cartoons. 
While remission of all anxiety disorders for over half the children in this study were 
found, treatment components were not isolated. 
2.3.5.4 Graded exposure.  Graded exposure is most suited to anxiety disorders 
where there is an explicit and identifiable stimulus that is being avoided (e.g., social 
phobia, OCD, and specific phobia) (Hagopian & Jennett, 2014). It has been suggested 
to be an important part of treatment for anxiety and the preferable and ethical treatment 
choice compared to exposure through “flooding” (Green & Wood, 2013; Reaven et 
al., 2009). Gradual exposure exercises incrementally use real or imagined anxiety-
provoking situations to face fears and are usually assigned for homework as well as 
within session. Often, more time is spent on exposure for youth with ASD compared 
to typically developing children (Chalfant et al., 2007) because behavioural exercises 
are less abstract and provide concrete feedback which can help to facilitate therapeutic 
progress (Scarpa & Lorenzi, 2013). Green and Wood (2013) proposed that even if 
youth do not fully recognise or understand their own anxiety, they are likely to benefit 
from a decrease in avoidant behaviour, maintained through exposure to anxiety-
provoking but harmless stimuli. In the Coping Cat program, 12 out of 16 sessions 
included exposure therapy for children with ASD compared to 8 out of 16 sessions for 
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their typically developing peers (Wood et al., 2009). Primary outcomes for the ASD 
children in this study were found to be comparable to results from a study of typically 
developing children (Barret et al., 1996; Wood et al., 2006). 
2.3.5.5 Incorporating special interests.  As mentioned, youth with ASD often 
have circumscribed interests (American Psychiatric Association, 2000) and therefore 
may be reluctant to participate in psychosocial sessions since they fall outside their 
realm of interest. Some researchers have suggested using the strengths, interests, and 
talents of the individual child to facilitate motivation, interest, and learning during 
therapy sessions (Reaven et al., 2009). For example, based on the assumption that 
many children with Asperger’s syndrome have a special interest in science or science 
fiction, Sofronoff et al. (2005) created a metaphor to be used over treatment sessions 
whereby children were “astronauts” or “scientists” exploring a new planet as they 
explored their own emotions. Noteworthy, whilst CBT programs have used interests 
during the psychoeducation and graded exposure components, these are decreased 
over time to avoid reinforcing problematic obsessions (Moree et al., 2009). However, 
initial engagement aided by the use of special interests can assist adolescents to being 
more open to discussing their own emotional challenges (Sofronoff, Beaumont & 
Weiss, 2014). Therefore, with the issue of motivation being significant for this client 
group, drawing upon special interests can be an integral clinical tool to therapeutic 
engagement and progress.   
2.3.5.6 Disorder specific hierarchies.  In addition to utilising the strategies 
above, researchers are discovering the value of incorporating disorder specific 
hierarchies into treatment protocols (Moree et al., 2009). These may be related to 
difficulties in communication and social skills, adaptive functioning, repetitive or 
restricted interests, and/or skills associated with daily living. For example, if a child 
experiences high emotion dysregulation, their CBT program may need to be 
individualised to promote adaptive emotion regulation. Specific strategies can be 
implemented as part of the CBT program in order to foster skills in the areas identified 
as problematic while simultaneously treating comorbid anxiety symptoms (Moree & 
Davis, 2010). 
2.3.5.7 Learning profile.  Despite intellectual functioning within, or above, the 
normal range, individuals with ASD often present with very uneven cognitive profiles 
on IQ tests (Attwood, 2013). Therefore, anxiety treatment outcomes may be enhanced 
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if cognitive strengths and weaknesses are taken into consideration by clinicians when 
designing CBT programs (Scarpa et al., 2013). For example, if the adolescent has 
advanced visual reasoning abilities, program content may be learnt with the use of 
demonstration or visual imagery. However, an adolescent with strong reading 
comprehension skills may learn greatly from reading program text (Scarpa et al., 
2013).  
In addition, individuals with ASD may experience problems with 
socioemotional processing, sequential memory, and processing information in novel 
contexts (Scarpa et al., 2013). Extra time in sessions or across sessions may be required 
to cognitively process and respond to socioemotional information and this can be aided 
by supporting verbal with written instruction. 
2.3.5.8 ADHD.  With high rates of comorbid ADHD amongst the ASD 
population, session engagement may be impacted when adolescents are having 
difficulty with sustaining attention, shifting attention (more apparent in those with 
ASD), impulsivity and/ or hyperactivity (Simonoff et al., 2013). The effect of these 
behaviours within a group format is more pronounced and can be distracting for fellow 
participants. Clinicians may need to target certain behaviours with positive 
reinforcement; include short, structured activities; and break larger components into 
smaller parts to assist in the adolescent sustaining attention (Attwood & Scarpa, 2013). 
In addition, difficulties in organisation and planning, working memory and time-
management may impede in-session and home practice tasks. Both clinicians and 
parents may need to prompt and supervise the adolescent to complete activities and 
behavioural exercises (Attwood & Scarpa, 2013). Overall, an expanded CBT 
framework is suggested when working with individuals with both ASD and ADHD in 
order to target attention, hyperactivity, and executive functioning problems. 
2.3.5.9 Sensory issues.  Poor sensory-motor processing includes low tolerance 
and high aversion to certain sounds, light, textures, smells or touch and may well 
interfere with participation in a CBT program. Therapists can determine the sensory 
needs of the adolescent during assessment and attempt to minimise potentially 
arousing sensory stimuli within the therapeutic environment (Attwood & Scarpa, 
2013). 
2.3.5.10 Language profile.  Youth with ASD often demonstrate poor 
pragmatic skills, including problems attuning the rules of spoken language to the social 
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situation they are in (Scattone & Mong, 2013). It is not uncommon for these children 
and adolescents to engage in lengthy and verbose monologues, interrupt conversations, 
use formal over informal language, and demonstrate a literal interpretation of language 
(Gaus, 2007). In addition, even those with language may struggle to describe their 
internal experiences (Joshi et al., 2013; Leyfer et al., 2006) and this may interfere with 
the therapeutic process. For these reasons, CBT therapists need to ensure that 
communication is concrete and developmentally appropriate (Rotheran-Fuller & 
MacMullen, 2011). 
Overall, each adolescent with ASD has their own cognitive profile which may 
impact on their anxiety symptomology and interfere with their engagement in 
treatment and their comprehension of session material. Overall, researchers and 
clinicians need to account for the individual needs of youth with ASD, address ASD-
related barriers to treatment, and align treatment to developmental and functioning 
levels (Hagopian & Jennett, 2014; Wood et al., 2015). While significant gaps in 
research remain, there is now an early body of work to guide clinicians in 
implementing CBT programs for youth with ASD. However, further research to 
examine treatment efficacy for anxiety in these individuals is needed.  
2.3.6 Parent involvement. A number of studies have benefitted from the 
involvement of parents in treatment programs, with many researchers suggesting 
treatment outcomes show positive effects when parents are included in the delivery of 
CBT strategies (e.g., Chalfant et al., 2007; White et al., 2009). Parent involvement can 
assist with the full implementation of the program and in skill generalisation 
(Rotheram-Fuller & MacMullen, 2011). In addition, parents can provide 
encouragement and reinforcement for newly acquired behaviours learnt through the 
treatment program (Selles & Storch, 2013). Often one parent is involved in a treatment 
program and training sessions and fulfils the supportive role of consultant, 
collaborator, or “coach” (Chalfant et al., 2007; Kendall, Aschenbrand, & Hudson, 
2003). For adolescents of reasonable functioning and where little comorbidity exists, 
less parental involvement may be necessary (Velting, Setzer, & Albano, 2004). 
However, for many adolescents with ASD who are significantly compromised by their 
anxiety, and young in developmental level, then increased parental participation is 
likely to benefit treatment gains (Sofronoff, Attwood, & Hinton, 2005).  
Among a sample of 10-12- year old children, Sofronoff et al. (2005) evaluated 
the impact of parent involvement on assisting children to manage their anxiety outside 
of the clinical setting. Participants were randomly assigned to a child-based 
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intervention, child and parent intervention, or wait list condition. At post-treatment, 
children in the child and parent intervention reported fewer anxiety symptoms in 
comparison to both other groups. These results and others (e.g.,  Chalfant, et al., 2007; 
Scarpa and Reyes, 2011) suggest that for pre-teens, parent involvement can have a 
positive effect in enhancing treatment effectiveness for anxiety reduction.  
For older adolescents (15-25 year olds), Mcgillivray and Evert (2014) 
conducted a study aimed at reducing depression, stress, and anxiety. While there were 
significant reductions in depression and stress symptomology at post-treatment (as 
reported by the youth) following CBT intervention, there were no significant changes 
in anxiety related symptoms. The authors questioned whether the absence of parent 
involvement in this study attributed to this outcome. To date, a paucity of research 
aimed at determining the usefulness of parent’s involvement in CBT programs 
particularly for older adolescents with ASD exists. Head-to-head comparisons of CBT 
programs with and without parent involvement are necessary in future research. 
Furthermore, understanding what aspects of parent training and involvement 
potentially aid in successful treatment outcomes for the adolescent would be of great 
benefit (Scarpa et al., 2013). 
2.3.6.1 Parent mental health.  Recently it has been highlighted in the research 
that parental anxiety adversely impacts optimal treatment outcomes for typically 
developing children. Hudson and colleagues (2014) used the Cool Kids Anxiety 
program and found that clinically anxious children with non-anxious parents were 
more likely to experience diagnostic remission post-treatment compared to those with 
anxious parents. Furthermore, parent’s anxiety symptoms reduced following 
participation in both the family-based CBT and the parent training conditions. The 
authors proposed that reductions in the child’s anxiety may have led to changes in 
parent’s anxiety levels (Hudson et al., 2014). Similar results were found by Cobham 
et al. (1998) whereby 40% of children were free of their anxiety disorder diagnosis at 
the end of CBT treatment if they had one anxious parent, compared to 82% of children 
without anxious parents. Research demonstrates that the efficacy of CBT is 
substantially reduced when children have an anxious parent. With early evidence that 
anxious parents are more common in ASD populations, it is probable that this group 
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of children fare less well following CBT treatment. Further research in this area is 
certainly warranted.  
2.4 Review of CBT Treatment for Anxiety in Youth with ASD  
With the identification, development, and implementation of modifications to 
standard CBT programs (as outlined above), CBT for youth with ASD is emerging as 
a promising anxiety treatment (McGillivray, 2014). Evidence from the literature 
supports a combination of the above strategies to be the most effective approach in 
modifying CBT for use with children and adolescents with ASD (Moree et al., 2009). 
Manual-based modified CBT interventions have demonstrated effectiveness in both 
individual therapy and group treatment (Chalfant et al., 2007; Sze & Wood, 2007, 
2008). To date, ten pilot studies have involved the examination of the efficacy of CBT 
protocols targeting the treatment of anxiety in children and youth with ASD (Wood et 
al., 2014). Previously, researchers have modified traditional CBT due to the 
unavailability of a specific manual-based CBT program for groups of individuals with 
ASD. For example, in a manualised treatment study by Chalfant and colleagues (2007) 
a modified Cool Kids CBT program (Lyneham, Abbott, Wignall, & Rapee, 2003) was 
compared with a waitlist group, among 28 children with a high functioning ASD (8-
13 years). In this family-based group program, more time was devoted to relaxation 
and exposure techniques (both within and outside of sessions), and the 12-session 
program was implemented over six months. The researchers found that 71% of the 
participants were free of an anxiety diagnosis upon completion of the program 
(Chalfant et al., 2007). In comparison, all 19 children in the waitlist condition still met 
the criteria for an anxiety disorder upon completion of the study. Unfortunately, long-
term treatment gains are not known since follow-up data was not collected. In addition, 
the sample size was small with only the oldest participants falling within the adolescent 
range. A small number of studies have modified CBT protocols aimed at children with 
ASD for adolescents with ASD, with mixed results. For example, applying a 
combination of individual and group anxiety and social skills intervention for 12-17 
year olds, White and colleagues (2009) found no significant reduction in anxiety for 
the treatment group. 
Whether youth with ASD gain more treatment success with individual or group 
treatment has yet to be determined. Indeed, for typically developing youth, little 
difference in treatment outcomes for group and individual anxiety treatment has been 
found (Rapee, Wignall, Hudson, & Schniering, 2000). Further comparative research 
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for youth with ASD is needed (Reaven, Blakely-Smith, Culhane-Shelburne, & 
Hepburn, 2012). The efficacy of individual and group studies on anxiety reduction for 
those with ASD will now be examined. 
2.4.1 Individual CBT. There have only been approximately eight published 
studies using individual CBT to reduce anxiety in youth with ASD (e.g., Cardaciotto 
& Herbert, 2004; Reaven and Hepburn, 2003). Although some of these studies (e.g., 
Greig and MacKay, 2005; Sze & Wood, 2007) suggest the effectiveness for anxiety 
reduction using CBT, these were uncontrolled case studies. Furthermore, treatment 
fidelity, inter-observer agreement, and control for any alternative explanations for 
anxiety reduction (for example, maturation and concurrent interventions) were absent 
(Lang, Regester, Lauderdale, Ashbaugh, & Haring, 2010). In fact, to date, randomised 
controlled trials evaluating individual CBT treatment for anxiety in ASD have been 
scarce although offer promising results (e.g., Wood et al., 2009; Storch et al., 2015). 
For example, using a modified CBT program, the Behavioural interventions for 
Anxiety in Children with Autism (BIACA) protocol Wood et al., (2009) found 63.4% 
of children (7-11 years of age) no longer met any anxiety disorder criteria at post-
treatment, compared to 9% of waitlist participants. Following, Wood et al. (2014) 
adapted the BIACA protocol for thirty-three adolescents with ASD (11-15 years). 
While independent evaluator ratings demonstrated significantly lower anxiety scores 
at post-treatment for the CBT group compared to the waitlist group, no treatment effect 
was obtained on parent and adolescent questionnaire measures of anxiety, or for 
remission of primary anxiety disorder diagnosis. The authors noted that these 
adolescents demonstrated highly complex psychiatric presentations compared to the 
younger population they had previously studied. For example, adolescents in this study 
met criteria for 2-7 comorbid diagnoses in addition to their ASD. The authors 
questioned whether the ADIS-IV-C/P may have been insensitive to smaller changes in 
symptomology given the baseline severity level of the youth’s anxiety.  
However, Storch and colleagues (2015) investigated the efficacy of the BIACA 
protocol with 31 adolescents (11-16 years, mean age of 12.74) and found 11 of the 16 
adolescents in the CBT treatment group to be positive treatment responders compared 
to 4 of the 15 in the TAU group. Although, no changes in child or parent-reported child 
anxiety were found. Storch and colleagues questioned whether the challenges with a 
lack of measures specific to this population may have played a contributing role here, 
and whether parents had difficulty differentiating anxiety and ASD symptomology. In 
addition, Ehrenreich-May et al. (2014) conducted an open trial with 11-14 year olds 
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with ASD and clinical anxiety and found a significant reduction in principal anxiety 
disorder severity scores, and clinician-rated overall anxiety symptoms from baseline 
to post-treatment.  
It has been questioned whether the modular (individual therapy) approach to 
CBT for anxiety, as demonstrated in the BIACA studies, provides increased efficacy 
and effectiveness compared to fixed protocols. Some researchers have suggested that 
modular therapy may better target individualised presenting problems and 
comorbidities, and contribute to improved overall functioning (Kerns et al., 2016). 
Currently, a multi-site RCT comparing the BIACA protocol, a fixed CBT protocol (the 
Coping Cat program; Kendall & Hedtke, 2006), and treatment-as-usual control for 
children with ASD is being conducted (see Kerns et al., 2016). Results of this and 
similar studies will assist in determining the efficaciousness of these varying treatment 
models and whether treatment outcomes differ for individual and group CBT.  
2.4.2 Multimodal CBT programs for adolescents with ASD. Due to the 
proposed bi-directional relationship between social skills deficits and anxiety in 
individuals with ASD (see Chapter 1), White and colleagues (2013) conducted a 
randomised controlled trial on Multimodal Anxiety and Social Skills Interventions 
(MASSI). MASSI is a CBT program that targets concurrent anxiety and social 
disability in adolescents with ASD via individual therapy, group social skills training, 
and parent coaching. The reasoning behind this “dual focus” is that adolescents with 
high levels of anxiety may be less able to make use of the social skills training, avoid 
opportunities to practice newly learned social skills, or both. Likewise, if the social 
disability is due to a skill deficit, addressing only anxiety may lead to improved social 
skill ability (White et al., 2013). MASSI was developed specifically for adolescents 
with HFA and moderate or greater anxiety problems, and consists of both individual 
and group sessions. Therapists selected appropriate treatment modules to meet the 
individual needs of the 30 participants (aged 13-17; mean age of 15 years) and these 
were repeated where necessary. Parents attended the final 15 minutes of each 
individual session. The combined treatment was predicted to protect against attrition 
and promote rapid improvement compared to sequential treatment. Parent-report on 
the Social Responsiveness Scale (SRS; Constantino & Gruber, 2005) demonstrated 
16% improvement in ASD social impairment. Whilst there was a reduction in anxiety 
symptoms by 26% using the CASI-Anx child and adolescent symptom inventory - 4 
ASD anxiety scale (CASI-Anx; Sukhodolsky et al., 2008) this change was not 
significant. This study was limited by its small sample size, which perhaps contributed 
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to a smaller effect size (within-group effect size = 1.18) than some previous studies 
(e.g., Reaven, 2009; Wood, 2009). The authors suggested that this may be due to 
previous studies having younger participants and more parent involvement, or perhaps 
more anxiety-targeted CBT is necessary within a dual-focus treatment. It may be that 
anxiety is better targeted on its own rather than combined with social skills, especially 
considering the difficulties that some individuals have with switching focus/ tasks.  
More recently, Murphy et al. (2017) compared the MASSI protocol outlined 
above, with an active control group. This pilot RCT for 12-18 year old adolescents 
with ASD employed non-directive supportive individual and group counselling 
sessions and compared it to the MASSI intervention to assess anxiety reduction, social 
functioning and therapeutic alliance. Overall, there were no significant differences 
found between the two groups on the anxiety, social skills, and therapeutic measures. 
There was a small group of adolescents that demonstrated a significant reduction in 
separation anxiety however the authors caution the latter finding since only a small 
number of participants (n = 9) presented with this diagnosis at pre-test. In addition, 
attendance at the counselling sessions was notably higher than at the MASSI sessions. 
Further larger-scale studies are needed to determine whether counselling is more 
appealing to individuals with ASD then manualised programs.  
2.4.3 Group CBT programs for children and adolescents with ASD. Whilst 
there have been effectiveness studies demonstrating promising results, currently, there 
have only been six published randomized controlled trial (RCT) studies of group CBT 
for youth with ASD and co-occurring anxiety disorders (Chalfant et al., 2007; Murphy 
et al., 2017; Reaven et al., 2012; Sofronoff et al., 2005; Sung, 2011; and White et al., 
2013). As discussed above, two of these utilised a multi-modal approach that 
additionally targeted social skill improvement.  
Group treatment is an economical alternative to individual therapy, which is 
often expensive for parents and therefore difficult to access. Despite suggestions that 
the linear format of group therapy limits matching intervention techniques to client 
characteristics among the general paediatric population (Kerns et al., 2016; Wood et 
al., 2014), group treatment has shown to be at least as effective as individual treatment 
(Rapee, 2000). Finally, group treatments provide the opportunity for adolescents to 
share their experiences and normalise their feelings of isolation. With significant social 
difficulties the opportunity to practice important social skills in a supportive 
environment can be highly beneficial, particularly for older adolescents with ASD who 
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are often wanting social relationships but lack the necessary skills to initiate and 
maintain them (Reaven 2009).  
The majority of group CBT anxiety treatment studies have focused on children 
with ASD. For example, Sofronoff and colleagues (2005) compared child-only and 
child + parent CBT groups to a waitlist control. Seventy-one children aged 10-12 years 
with Asperger’s disorder and parent-reported anxiety (OCD, social phobia, separation 
anxiety disorder and/or GAD) attended six weekly CBT sessions. Using the 
“Exploring Feelings” (Attwood, 2004) program specific to anxiety management, these 
researchers found a significant reduction in anxiety symptoms for both treatment 
groups in comparison to the waitlist group.  
Children in the child + parent group demonstrated greater improvement than 
the child-only group and these results were mainly observed at the 6-week follow-up 
on the Spence Child Anxiety Scale—Parent version (SCAS-P; Nauta et al., 2004) and 
the Social Worries Questionnaire (SWQ-P; Spence, 1995). The vignette used as a 
measure, “James and the Math Test”, demonstrated significant improvement in the 
number of strategies children were able to give to cope with anxiety-producing 
situations. While this study used an experimental design, it lacked blinding procedures. 
In addition, parents in the child + parent condition may have been more likely to 
expose their children to, and coach them through, anxiety-provoking situations than 
parents of children in the child-only condition. 
Similar results were found in Chalfant and colleagues’ (2007) study whereby 
the authors adapted the Cool Kids Program (Lyneham, Abbott, Wignell, & Rapee, 
2003) to better suit the needs of children and early adolescents with ASD. This 
program incorporated graded exposure and emphasised relaxation techniques, visual 
strategies in the cognitive restructuring component, and included simplification of 
cognitive restructuring tasks (e.g., listing helpful and unhelpful thoughts). The 
program was also extended to six months in length (9 weekly and 3 monthly 2-hour 
sessions). Each week parents attended a concurrent session that included 
psychoeducation, anxiety coping exercises, exposure planning, parent management 
training, and relapse prevention. Similar to the protocols used by Sofronoff et al., 
(2005) and Wood et al., (2009), parents were encouraged to serve in the role of “coach” 
or “co-therapist”, to support the delivery of interventions. Together, therapists and 
parents planned exposure tasks and, consistent with best practice in CBT, these were 
implemented and rehearsed outside of sessions (Albano & Kendall, 2002).  Forty-
seven children (aged 8-13 years) with ASD and at least one clinical anxiety disorder 
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were assigned to either the CBT or waitlist condition. Compared to the waitlist group, 
the treatment group improved on the Revised Children’s Manifest Anxiety Scale 
(RMAS-P), Spence Children’s Anxiety Scale (SCAS-P), Children’s Automatic 
Thoughts Scale, and the Strengths and Difficulties Questionnaire (parent report). Upon 
completion of the program, 71% of the participants, compared to 0% of the waitlist 
group, no longer met the criteria for an anxiety disorder diagnosis (Chalfant et al., 
2007). Unfortunately, long-term treatment gains are not known since follow-up data 
was not provided. In addition, the study clinicians conducted the post-treatment 
diagnostic interview, which may have biased the results (Green & Wood, 2013). 
Instead, independent evaluators blind to the condition of the participants are likely to 
have produced more objective results. 
In 2008, Reaven and colleagues created an original CBT manual targeting 
anxiety, as opposed to modifying an existing protocol aimed at typically developing 
children. They incorporated modifications such as systematic reinforcement, visual 
aids, and predictable routines, embedding special interests into program content, role-
play, video modelling and increased parent participation. They later conducted an RCT 
implementing random assignment and using independent clinical evaluators blind to 
condition to conduct pre-and-post assessments (Reaven et al., 2012). Using the Facing 
Your Fears (FYF) protocol (Facing Your Fears: Group Therapy for Managing Anxiety 
in Children with High-Functioning ASD; Reaven, Blakely-Smith, Nichols, & 
Hepburn, 2011) they compared group CBT intervention with treatment-as-usual 
(TAU) among 50 children with ASD aged 7-14 years. Children in the intervention 
condition attended 12 group CBT sessions to reduce anxiety with clinicians 
implementing careful pacing of each session, token reinforcement, visual structure, 
and predictability of routine, along with additional adaptations (e.g., multiple choice 
worksheets, hands-on activities, video modelling). In addition, a detailed parent 
curriculum including anxiety psychoeducation, parent coaching to enhance child 
participation, and “protective” parenting styles was implemented. Children in the 
treatment group showed greater reductions in clinician severity ratings of their 
principal anxiety diagnosis at post-intervention, compared with children in the TAU 
condition. Those in the treatment condition also met diagnostic criteria for 
significantly fewer overall number of anxiety diagnoses, and as a group, children in 
the FYF condition were significantly less likely to meet the criteria for GAD than those 
in the TAU condition. This latter finding is of interest considering previous research 
has cited challenges with treatment motivation in participants with a sole diagnosis of 
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GAD (Wood et al., 2009). All participants who received FYF intervention continued 
to meet criteria for SEP, SOC and SP diagnoses at post-treatment. Although a small 
sample of respondents, treatment gains appeared to be maintained for the FYF group 
at 3- and 6-month follow-up. Differences between the two groups at post-treatment 
may have been compromised given that some control participants continued to engage 
in treatment outside of study. The study researchers suggest that future studies include 
functional measures of success such as school attendance, improved social 
relationships, and quality of life. 
The first anxiety RCT to compare CBT to another treatment type for youth 
with ASD has been conducted by Sung et al. (2011). Here, 70 children (9-16 years; 
mean age of 11 years) were randomly assigned to either a 16-week CBT or Social 
Recreational program. The SCAS-C and the CGI-S measures were taken at pre-, post-
treatment, and follow-up (3- and 6-months). Significantly lower levels of generalised 
anxiety and total anxiety symptoms were found for participants in both programs at 6-
month follow-up on the SCAS-C. An increase in the percentage of participants rated 
as ‘‘Normal’’ and ‘‘Borderline’’ for both programs were found on the clinician ratings 
on the CGI-S. Standard components in both treatments included regular sessions in a 
structured setting, consistent therapists, social exposure and the use of ASD-friendly 
strategies, and hence may be integral to anxiety reduction programs for children and 
adolescents with ASD (Sung et al., 2011). Since parent training was not included this 
may have impacted on the generalisation of skills to other settings. This study is likely 
to be the first in an Asian setting therefore providing preliminary evidence for the 
effectiveness of CBT in an Asian cultural context (Sung et al., 2011). 
Despite some methodological concerns, group CBT treatment studies have 
demonstrated success in reducing anxiety in children with ASD (e.g., Chalfant et al., 
2007). However, there is a scarcity of RCTs investigating anxiety reduction in 
adolescents, particularly older adolescents.  
2.4.4 Adolescents/adults with ASD and anxiety. Providing CBT to ASD 
adolescents before they reach adulthood has the potential to substantially improve 
adult outcomes (Gillott & Standen, 2007; Howlin, 2000). A small number of studies, 
including some described above, have included slightly older adolescents with ASD 
in their RCTs, with mixed results (e.g., McNally, Keehn, Lincoln, Brown, & Chavira, 
2013 [8-14 years]; Murphy et al., 2017 [12-18 years]; Reaven et al., 2009 [8-14 years]; 
Reaven et al., 2012 [7-14 years]; Russell et al., 2013 [14-65 years]; Storch et al., 2015 
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[11-16 years]; Sung et al., 2011 [9-16 years]). Amongst these studies, older 
adolescents have been poorly represented.  
A couple of studies using group CBT have focused on young adults. An RCT 
by Russell and colleagues (2013) investigated CBT treatment for 46 adolescents and 
adults (mean age 26.9 years). Participants were randomised to CBT for OCD or 
anxiety management (AM), the control condition. The YBOCS was used as the 
primary outcome measure and evaluations were blind to the treatment group. Results 
demonstrated a significant reduction in OCD symptomology for both groups with no 
significant differences between the two groups at post-treatment (45% were positive 
treatment responders in the CBT compared to 20% in the AM group). Notably, family 
accommodation (e.g., parent or carer providing reassurance to person with OCD or 
working around OCD behaviours) was associated with poorer outcome for participants 
in this study. While this study demonstrates promise for CBT with older adolescents 
and adults with ASD and OCD, the wide age range may have impacted findings. 
Rounsaville et al. (2001) has suggested the need for reducing therapist and participant 
heterogeneity and opting for tighter parameters when defining the place of treatment, 
participants and therapists in order to maximise the power available in a small pilot 
study.  
In addition, one study by McGillvray and Evert (2014) examined the efficacy 
of group CBT on depression, anxiety and stress for 15-25-year-olds (mean age of 20.6) 
with ASD. They compared individuals allocated to a treatment group (“Think well, 
feel well and be well” group intervention) with those in a waitlist condition. Content 
included identifying stressful situations, recognising stress in our bodies, recognising 
emotions in ourselves and others, relationship between events, thoughts and feelings 
and coping styles. Whilst no significant differences were found in anxiety 
symptomology, intervention participants did report significantly lower depression and 
stress scores on the Depression Anxiety Stress Scales (DASS; Lovibond & Lovibond, 
1995) compared to control participants. However, a marked reduction in these 
symptoms was found for the control group and could be attributed to these participants 
having contact with the group facilitator on a number of occasions and time to reflect 
on their feelings through the assessment questionnaire (Mcgillivray & Evert, 2014). 
Furthermore, the study did not specifically address fears or worries through graded-
exposure exercises, and measures were not conducted with parents which has often 
been viewed in the literature to be a more reliable method of symptomology 
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assessment. This study lacked random selection of an equal number of participants 
into the treatment and waitlist groups. 
2.5 Summary 
While still a relatively new field of study, research investigating the effective 
treatment of anxiety in youth with ASD still lacks a strong evidence base. A number 
of aspects of treatment remain unexamined and areas showing promise require more 
systematic replication. Future research in this area could focus on using stricter 
methodology and improved evidence-based outcome measures, longitudinal data, and 
treatment acceptability measures, in order to provide more convincing data.   
This chapter briefly reported on pharmacological interventions and highlighted 
the lack of appropriate medication options for individuals with ASD. A review of 
individual and group intervention studies for individuals with ASD captured promising 
and positive effects of CBT-based interventions for decreasing anxiety symptomology 
in youth with ASD (e.g., Danial & Wood, 2013; Lang et al., 2010; Moree & Davis, 
2010; Murphy et al., 2017; Nadeau et al., 2013; Rudy, Lewin, & Storch, 2013; 
Sukhodolsky, Bloch, Panza, & Reichow, 2013). Accounting for the core deficits of 
ASD, modifications to CBT treatment have been successfully implemented across 
numerous studies. However, the majority of work in this area has centred on children. 
Generally, adolescents, in particular, older adolescents have been poorly represented. 
In addition, there has been a lack of randomised controlled trials to determine best 
practice founded on evidence-based interventions. The jury is still out on whether 
individual or group CBT is more effective in reducing anxiety, the extent to whether 
parent involvement is necessary, and the isolation of mechanisms that are attributing 
to anxiety reduction. Further, common study limitations have included assessment 
measures aimed at typically developing children, small sample sizes, parent or child 
reports only, and lack of randomization, waitlist groups, follow-up measures, and 
independent clinical evaluators (Lang et al., 2010b).  
The majority of RCTs using CBT protocols to target anxiety reduction in youth 
with ASD have focused on children and early adolescents. It is likely that parent 
components of CBT programs need to be modified to suit older adolescents given the 
increased social demands, heightened anxiety, and additional issues that arise, such as 
sexual identity and dating. There exists a strong need for the development and 
assessment of protocols in varying populations, such as an older age group. 
Information deriving from such studies are likely to provide valuable information 
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towards the development of an effective, generalisable and maintainable CBT protocol 
for affected youth.  
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Chapter 3: 
Treating Anxiety in Adolescents with Autism Spectrum Disorder using Group 
Cognitive Behaviour Therapy: A Randomised Controlled Trial (Study One) 
 
This chapter addreses the gaps in current research pertaining to anxiety 
treatment for adolescents with co-occuring ASD and clinical levels of anxiety. After 
identifying existant gaps, the details of Study 1 are provided, which is an RCT 
assessing the efficacy of group cognitive behavioural therapy for this client group. The 
study rationale, significance, and aims are then given, followed by the methods used 
to conduct the investigation. Participant symptoms were measured at pre-treatment, 
post-treatment, and for the CBT intervention group only, 6-months following 
treatment. Subsequently, the results are provided. Data were analysed using 
generalised linear mixed models (GLMMs) followed by subsidiary analyses 
investigating non-inferiority, reliable and clinically significant change, and clinical 
global improvement. The chapter concludes with a discussion of the findings. 
3.1 Addressing the Gap 
In spite of evidence that anxiety may be particularly prominent during the 
adolescent years (Tse et al., 2007; White et al., 2009; Witwer & Lecavalier, 2010), 
intervention research in this area has not specifically focused on adolescents (White et 
al., 2013). In fact, to the author’s knowledge, no RCTs exist that singularly focus on 
investigating group CBT for anxiety reduction in adolescents, including older 
adolescents, with ASD. A small number of systematic reviews and a trend analysis 
involving the treatment of anxiety in individuals with ASD have been conducted in 
this important area (e.g., Danial & Wood, 2013; Ho, Stephenson, & Carter, 2018; Ho, 
Stephenson, & Carter, 2015; Lang, Regester, Lauderdale, Ashbaugh, & Haring, 
2010b). Two-thirds of the studies examined by Ho and colleagues (2015) included 
participants aged between 10 and 12 years of age. In their recent trend analysis, Ho et 
al. (2018) observed a noticeable increase in trials with younger participants (aged 
between 5-8 years). With the predominant focus on children with ASD to date, less is 
known about how adolescents will respond to treatment and how to best support them 
in managing anxiety.  
As outlined in chapter 2, numerous methodological limitations have been 
reported by researchers in this field. Further, while some positive outcomes have been 
reported, it is difficult to compare treatments across studies due to a wide variation in 
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research designs, treatment approaches, and outcome measurements (Danial & Wood, 
2013; Ho, Stephensen, & Carter, 2015). For example, the place of treatment differs 
(e.g., clinic, community, school), the number and duration of sessions vary, and 
emphasis on individual components of treatment (e.g., social skills, exposure) may 
diverge across studies. In addition, the mechanisms of change that are responsible for 
anxiety reduction in individuals with ASD following CBT treatment are still in 
question (Lang et al., 2010b). CBT behaviour-oriented components have been shown 
to be more common in the reviewed studies, with exposure purported as a component 
of high importance (Ho et al., 2018). The identification of specific components of CBT 
treatment, and the teaching methods involved that may lead to clinical improvement 
is imperative in order to create cost and time effective treatment protocols for this 
client group (Kerns et al., 2016; Lang et al., 2010). 
An additional noteworthy gap in the literature is that researchers have used an 
array of outcome measures, making comparisons across studies difficult. Clinicians 
have often conducted diagnostic interviews to assess study inclusivity and self-reports 
have frequently been employed to assess treatment success. Due to the introspective 
and expressive language difficulties inherent in the ASD population, parent reports are 
heavily relied upon (Danial & Wood, 2013). However, as discussed in chapter 2, there 
are benefits to including multiple informants such child and teacher reports. It has been 
suggested that more stringent methodology and evidence-based outcome measures are 
required, including blind independent evaluators where possible (Danial & Wood, 
2013). Conducting CBT programs over a lengthened timeframe in order for skills to 
be incorporated more fully into participants’ daily lives has additionally been proposed 
(Chalfant et al., 2007; Danial & Wood, 2013).  
 Given the high rates of anxiety in adolescents with ASD, and a scarcity of 
evidence-based manualised programs, the goal of the present randomised controlled 
trial was to determine whether an evidence-based protocol previously used with 
children on the autism spectrum, the Cool Kids ASD Anxiety program (Lyneham et 
al., 2003), would be feasible and efficacious for adolescents aged 12-18 years. It was 
hypothesised that the effects of this family-based intervention would significantly 
decrease anxiety in adolescents with ASD, improve their social skills, and have a 
positive effect on family quality of life. Being a manualised program, trained 
professionals are able to implement the program within the community, increasing its 
transportability.  
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To achieve the aims of this study, two studies were conducted. Study 1 tested 
the efficacy of the intervention using a RCT with pre and post-intervention measures 
and for the intervention group, 6-month follow-up measures. The intervention group 
participants attended 12 CBT sessions while the control group waited for treatment. 
The Consolidated Standards of Reporting Trials (CONSORT) statement for RCTs was 
referred to as a foundational guideline in reporting methodological requirements 
(Campbell, Elbourne, & Group, 2004). Considering the proposed value of multiple 
informants, both parents and children were included in the evaluation of the 
intervention. In accordance with the literature, independent blind evaluators were used 
to conduct diagnostic assessments using the Anxiety Disorders Interview Schedule for 
DSM-IV for Children–Parent Version (ADIS-IV-P; Silverman & Albano, 1996). Due 
to study budget constraints and the need to limit the number of questionnaires that the 
adolescents were required to complete, the ADIS-C (child version) was not employed 
in the current study. However, given that participants were without cognitive 
impairment and with language ability, this is a valid measure to use and to combine 
with the parent version. These evaluators also employed the Clinical Global 
Impression–Improvement Scale (CGI-IS; Guy, 1976) to evaluate anxiety 
symptomology and overall functioning. In light of some researchers questioning how 
quality of life may be impacted for families who have a child with an ASD (Ooi et al., 
2008), the Beach Center Family Quality of Life Scale (FQOL; Poston, Turnbull et al., 
2003) measure was employed to evaluate this aspect. Due to the bidirectional 
relationship of anxiety and social functioning, the Social Skills Improvement System–
Rating Scales (Parent; SSIS–RS [P]; Gresham & Elliot, 1990) was additionally used 
in order to assess whether social functioning increases when a decrease in anxiety 
occurs. In addition, treatment adherence was examined by independent clinical 
evaluators. 
Study 2 explored the social validity of the intervention using a combination of 
qualitative and quantitative methodology employing questionnaires formulated by 
Gent et al. (2014) and Roberts et al. (2010).  
3.2. Rationale, Significance, and Aims of the Current Study 
Despite the high prevalence of anxiety disorders among individuals with ASD, 
and the co-occurring problems that accompany this diagnosis, there is a dearth of 
research in this area, particularly in regard to older adolescents and appropriate and 
effective treatment methodologies. In addition, there is a gap in the literature regarding 
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the impact that a comorbid diagnosis can place upon a family’s functioning and quality 
of life. The results of a preliminary finding suggest that families are adversely affected; 
however, further exploration of this relationship is needed (Ooi et al., 2008). In 
addition, researchers have recognised the social difficulties inherent in this population 
and the association between anxiety and social deficits (e.g., Bellini, 2004; White et 
al., 2013). The manner in which one affects the other has not yet been determined 
however it has been suggested that the presence of anxiety contributes to social 
disability (e.g., Barnhill & Myles, 2001; Kleinhans et al., 2010). While the treatment 
protocol used in this study does not specifically teach social skills, it is hypothesised 
that CBT targeting anxiety may produce direct effects on social skills. With anxiety 
likely to exacerbate depressive symptomology (Tse et al., 2007), in the current study 
it was hypothesised that intervention targeting anxiety would produce direct effects on 
depressive symptomology. Therefore, the aim of the present study is to examine the 
efficacy of a group modified cognitive behavioural therapy intervention on reducing 
anxiety and internalising disorders in adolescents with high functioning autism 
spectrum disorder. In addition to a longitudinal follow-up, this study involved an 
investigation of CBT treatment on depressive symptomology, and social skill ability 
and family quality of life. 
3.3 Hypotheses 
Based on previous research, a number of hypotheses regarding the effects of 
group CBT were generated. In order to evaluate group CBT for adolescents with ASD 
and clinical anxiety, it was important to examine the effect of time (pre-, post-
treatment and follow-up) and condition (CBT and waitlist) on participant symptoms 
of anxiety. In addition, the hypotheses outlined below were designed to investigate if 
CBT targeting anxiety can assist in reducing depressive symptomology, and in 
improving social functioning and family quality of life. The final hypothesis is based 
on previous findings where CBT participants showed a greater reduction in the total 
number of psychiatric diagnoses at post-treatment compared to those in the waitlist 
group (McNally et al., 2013). The Pre-Posttreatment hypotheses are arranged 
numerically and pertain to anxiety (H1a), depression (H1b), psychosocial functioning 
(H1c), family quality of life (H1d), and overall psychopathology (H1e). 
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3.3.1 Pre-post-treatment primary hypotheses. 
H1a: Compared to adolescents in the waitlist group, adolescents in the 
intervention group will show significantly greater pre-post reductions in levels of 
anxiety (as measured by the SCAS-C, SCAS-P, and ADIS-P).  
H1b: Compared to adolescents in the waitlist group, adolescents in the 
intervention group will show significantly greater pre-post reductions in levels of 
depression (as measured by the SMFQ-C, SMFQ-P). 
H1c: Compared to adolescents in the waitlist group, adolescents in the 
intervention group will show significantly greater pre-post increases in levels of 
psychosocial functioning (as measured by the SSIS-P). 
H1d: Compared to parents in the waitlist group, parents in the intervention 
group will report significantly greater pre-post increases in family quality of life (as 
measured by the FQOL). 
H1e: Compared to adolescents in the waitlist group, adolescents in the 
intervention group will show significantly greater pre-post reductions in the overall 
number of comorbid disorder diagnoses (as measured by the ADIS-P).  
3.3.2 Six-month follow-up primary hypotheses. Hypotheses in this section 
are based on findings investigating CBT for children with ASD, which show that 
treatment gains from interventions targeting anxiety are maintained at follow-up 
(Reaven, Blakely-Smith, Leuthe, et al., 2012; Wood et al., 2009). 
H2a: The significant pre-post reductions in levels of anxiety (as measured by 
the SCAS-C, SCAS-P, and ADIS-P) observed in the intervention group will be 
maintained or enhanced at 6-month follow-up  
H2b: The significant pre-post reductions in levels of depression (as measured 
by the SMFQ-C, SMFQ-P) observed in the intervention group will be maintained or 
enhanced at 6-month follow-up.  
H2c: The significant pre-post improvements in levels of psychosocial 
functioning (as measured by the SSIS-P) observed in the intervention condition will 
be maintained or enhanced at 6-month follow-up.  
H2d: The significant pre-post improvements in levels of family quality of life 
(as measured by the FQOL) observed in the intervention condition will be maintained 
or enhanced at 6-month follow-up.  
H2e: The significant pre-post reductions in total comorbid disorder diagnoses 
(as measured by the ADIS-P) observed in the intervention condition will be maintained 
or enhanced at 6-month follow-up.  
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3.3.3 Secondary hypotheses. Secondary Hypotheses 3-5 involve predictions 
regarding the diagnostic status of primary anxiety disorders, reliable and clinically 
significant change and Clinical Global Impression-Improvement (CGI-Improvement; 
Guy, 1976). That is, the group changes that are predicted in Hypotheses 1 and 2 are 
also predicted to occur at an individual level (Jacobson & Truax, 1991). Hypothesis 3 
is based on previous findings that CBT leads to remission from anxiety symptomology 
(Wood et al., 2015). Hypothesis 4 involves the prediction that group CBT will result 
in clinically significant change in SCAS-C/P scores for youth with ASD. In addition, 
Hypothesis 5 is based on previous studies demonstrating positive treatment response 
on the CGI Improvements Ratings scale following group CBT (e.g., Reaven & 
Blakeley-smith, 2013; Wood et al., 2009, 2014; Wood et al., 2015).  
H3: Compared to adolescents in the waitlist group, a significantly higher 
proportion of individuals in the intervention group will demonstrate pre-post remission 
from their primary anxiety disorder (i.e., will no longer meet their pre-treatment 
primary diagnosis at post-treatment). 
H4: Compared to adolescents in the waitlist group, a significantly higher 
proportion of adolescents in the intervention condition will show a pre-post reliable 
reduction in measures of anxiety (SCAS-C/P). 
H5: Adolescents in the intervention group will show a significant reduction in 
anxiety severity from pre-test to 6-month follow-up (as measured by the CGI-I 
improvement ratings).  
3.4 Method 
3.4.1 Participants. 
3.4.1.1. Power analysis and sample size.  The intervention effect is shown in 
the Group (CBT, control) x Time (pre-, post-intervention) interaction. The primary 
hypotheses (Hypotheses 1-4), therefore involve predictions of Group x Time 
interactions. According to G*Power (Version 3.1; Faul, Erdfelder, Lang, & Buchner, 
2007), at a per-test alpha-level of .05, 60 participants (30 in each condition) are 
required for an 80% chance of capturing a “small” to “moderate” Group x Time 
interaction (f = .185).  A moderate interaction was found by Chalfant et al., (2007). 
When data are collected longitudinally, there is the problem of participant 
attrition (wave non-response). Wave non-response will normally reduce statistical 
power. Compared to the traditional statistical procedures for analysing behavioural 
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change (e.g., repeated measures ANOVA), the statistical model employed to test 
hypotheses in the current study (Generalised Linear Mixed Model; GLMM) is less 
sensitive to participant attrition because it does not rely on participants providing data 
at every assessment point; the GLMM maximum likelihood procedure is a full 
information estimation procedure that uses all the data present at each assessment 
point (see: Bryk, 1987; Dimitrov & Rumrill, 2003; Holden, Kelley, & Agarwal, 2008). 
This reduces sampling bias and the need to replace missing data. GLMM implies the 
use of data present at each assessment point because time (pre-, post-intervention, and 
6-month follow-up) is interpreted as a Level 1 variable that is nested within 
participants at Level 2. This method for accommodating missing data is thought to be 
superior to an intention-to-treat (ITT) analysis, and the last observation carried forward 
(LOCF) method (see Lachin, 2015; Lewis & Machin, 1993; Reaven, Blakely-Smith, 
Leuthe, et al., 2012; Verbeke, Molenberghs, & Beunckens, 2008). 
3.4.1.2. Recruitment.  Forty-nine adolescents (40 males, 9 females) between 
the ages of 12- and 18-years (M = 14.23 years, SD = 1.76), were recruited from Perth, 
Western Australia (WA). This study was therefore underpowered and the impact that 
low participant numbers have on the overall results will be discussed later in the 
chapter.  Participating parents self-referred in response to advertising flyers and letters 
circulated through Disability Services Commission (DSC), Therapy Focus, the 
Department of Education (WA), Catholic Education Office (WA), various autism and 
disability organisations including Autism West, along with a number of online ASD 
family support groups, email lists, and by word of mouth. The covering letter and 
advertisement flyer are displayed in Appendix A. Diagnostically, all youth met criteria 
for at least one anxiety disorder (see Table 2) with a clinical severity rating (CSR) 
above 4 as determined by the Anxiety Disorders Interview Schedule for the Diagnostic 
and Statistical Manual of Mental Disorders (4th ed.; DSM-IV; American Psychiatric 
Association, 1994), Child Version, Parent Form (ADIS-IV-C/P; Silverman & Albano, 
2004). These disorders included social phobia (SoP), generalised anxiety disorder 
(GAD), specific phobia (SP), separation anxiety disorder (SAD), obsessive-
compulsive disorder (OCD), agoraphobia (AGOR) and post-traumatic stress disorder 
(PTSD). The average number of these disorders per participant was 2.69 (SD = 1.01). 
Some participants additionally met the criteria for non-anxiety-related disorders (see 
Table 2). These included attention deficit hyperactivity disorder (ADHD), major 
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depressive disorder (MDD), dysthymia, oppositional defiant disorder (ODD), and 
conduct disorder (CD). 
3.4.1.3 Inclusion/ exclusion criteria.  In addition, adolescents were required 
to meet the following inclusion criteria: (a) able to demonstrate a clinical diagnosis of 
ASD, Asperger’s disorder, or pervasive developmental disorder – not otherwise 
specified (PDD-NOS) (see 3.4.2 for more information) (b) aged between 12- and 18-
years; (c) a verbal IQ above 70 (as assessed in previous testing, or, if the adolescent’s 
verbal abilities were questioned by the independent assessor at baseline, then based on 
the Wechsler Intelligence Scale for Children-IV administered by the independent 
assessor); (d) the ability to read English; and (e) not taking any psychotropic 
medication or taking a stable dose of psychiatric medication (i.e., at least one month 
at the same dosage prior to baseline assessment), and, if taking medication, agreement 
for this to be maintained throughout the study.  
Participants were excluded from the study if: (a) the adolescent participated in 
psychotherapy, social skills training, or behavioural intervention such as applied 
behaviour analysis over the course of the study, including 6-months following end of 
treatment for the intervention group; (b) the family were attending child-related health 
professional services or parenting classes; (c) the adolescent began taking psychiatric 
medication or changed his or her dosage during the intervention period and for 6 
months post-treatment for the intervention group; or (d) the family were not able to 
participate in the intervention program. At the time of study enrolment 20 (40.8%) 
participants were taking medication including stimulant, anti-depressant, antianxiety, 
antipsychotic and/ or other medication (e.g., epilepsy, sleep). The above criteria were 
applied to ensure that any treatment effects exhibited following the group CBT could 
be attributed to the intervention, rather than to the effects of external psychotherapy, 
social skills training, or medication. 
3.4.2 Design and procedure.  This study was a randomised controlled trial 
(RCT) and compares an active treatment condition (group CBT) to a waitlist condition, 
with measures taken at pre-treatment and post-treatment for both conditions, and at 6-
month follow-up for the CBT intervention condition (see Figure 2). Figure 6 displays 
the study design meeting the CONSORT guidelines (Moher et al., 2010). The families 
who were interested in participating in the study contacted the primary researcher at 
Curtin University. Those families who appeared to meet the inclusion/ exclusion 
criteria following a phone call or email exchange with the parent, were sent an 
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information package containing study information and consent forms for both parents 
and adolescents, in addition to a demographic form. The parent information letter, 
demographic form and parent consent forms along with the adolescent information 
and consent forms (including consent to video recorded sessions) are presented in 
Appendices B, C, D, E, F and G respectively.  
Parents were then contacted by telephone by one of the trained graduate 
psychology masters or clinical psychology PhD student therapists to attend an in-
person anxiety diagnostic assessment (using the ADIS-IV-P) at the Curtin University 
Child Psychology Clinic. For a small number of families, this interview was conducted 
at their home (e.g., where the parent had difficulty attending the clinic due to 
competing demands). At the diagnostic assessment session, the therapist discussed the 
study information, session structure and confidentiality with the participating parent. 
The ADIS-IV-P was then administered to the participating parent. When telephoning 
the parent to make the screening appointment, the therapist requested that the parent 
provide evidence of their adolescent’s ASD diagnosis. Confirmation of diagnosis was 
viewed and/or photocopied by the therapist at the diagnostic assessment session, with 
the original returned to the parent. Participants without an ASD diagnosis were 
excluded from the study. As the primary study aim was to examine anxiety, adolescent 
ASD diagnoses were not reassessed. In Western Australia, the protocol for an 
assessment of ASD involves a psychologist trained in ASD assessments, with the 
collaboration of a paediatrician and a speech pathologist. A cognitive assessment is 
conducted as part of this assessment and this was used to confirm that the participant 
had an intelligent quotient above 70. One potential participating parent revealed that 
their child had not received an IQ above 70 some years previous. A graduate clinical 
psychology trainee within the Curtin University Child Psychology Clinic reassessed 
this participant prior to determining their eligibility for the study. 
Seven participants did not meet the diagnostic criteria for a clinical anxiety 
disorder diagnosis and were provided with a list of recommended external treatment 
providers and excluded from the study (see Figure 6). Consenting and eligible 
participants were contacted approximately 1 to 2 weeks after completing the screening 
assessment and informed of their eligibility. Parents and adolescents were asked to 
complete additional study questionnaires (see Measures section) and to return these 
by post in the prepaid envelopes provided. In addition to the ADIS-P interview, these 
assessment materials were given at baseline, post-treatment (after the final session), 
and for the CBT condition only, at 6-month follow-up. 
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When anxiety co-morbidity was present, the disorder with the highest degree 
of interference with the adolescent’s functioning (determined by the ADIS CSR and 
clinical judgement) was chosen as the primary diagnosis.  
Once a minimum of ten families met study eligibility using the methods 
outlined above, the primary researcher randomised participants employing Saghaei's 
(2004) Random Allocation Software Version 1.0. This was repeated each time another 
10-12 families were recruited. Overall, twenty-six participants were randomised to the 
CBT group and twenty-three were randomised to the waitlist condition. 
Twelve sessions were provided to the participants in the CBT condition. 
Although the original Cool Kids program was also 12 weeks in duration, Chalfant and 
colleagues (2006) suggested that providing the same number of sessions over a longer 
period of time for individuals with ASD proved beneficial in reducing anxiety 
symptoms. These authors implemented 9 weekly sessions and 3 monthly sessions. In 
order to reduce waitlist time, the current study was assessed over 10 weekly sessions 
followed by the two final sessions one month apart. Participants were randomised to 
eight groups with between 5-7 participants in each group. Variation in group sizes 
occurred when there were odd numbers in participant waves prior to randomization. 
In addition, due to attrition (see 3.6.1), waitlist groups were generally smaller than 
CBT groups. Participants in the waitlist condition received no psychological treatment 
for five months. Approximately 2 to 4 weeks after the completion of the pre-
intervention ADIS-P, the CBT /condition participants commenced the Chilled 
Program at either Curtin University Child Psychology Clinic or at Autism West in 
Perth, Western Australia. Parents in both conditions were asked to notify the primary 
investigator of any changes to medication and dosage over the course of the 
intervention period. Attendance was recorded for both conditions and all sessions were 
video-recorded for treatment adherence and clinical supervision purposes. 
Following completion of the intervention/waitlist, which was 4.5 months in 
duration, the ADIS-IV-P was re-administered to parents in both conditions and 
additional parent and adolescent measures were completed and returned. This was 
repeated 6 months later for the CBT condition only. The ADIS-IV-P interviewers were 
blind to the condition to which the families were allocated. Families were asked not to 
divulge their assigned condition. This was an integral point for comparing the CBT 
group to the waitlist condition for intervention effects due to the absence of control 
measures at 6-month follow-up (Tabachnick & Fidell, 2013). At both times, 
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interviewers asked parents whether there had been any change of medication or 
external treatment. 
Once participants in the WL condition had completed the post-waitlist 
assessment, they were offered 12-sessions of group CBT over 4.5 months (10 weekly 
and two sessions one month apart). Post-treatment measures were not collected for the 
waitlist groups since they had already waited for treatment and it was deemed by the 
Curtin University Research Ethics Committee that this was a preferable and fairer 
practice. Participants from the CBT groups were contacted six months following their 
post-treatment assessment at which time parents and adolescents again completed the 
questionnaire package and parents were administered the ADIS-IV-P by postgraduate 
psychology trainees. See “3.4.2.4 Therapists” below for information on therapist 
recruitment and training. 
3.4.2.1 Ethical and registration procedure.  The CONSORT guidelines were 
followed in the development and implementation of this RCT (Moher et al., 2010). 
Ethics approval for this study was obtained from the Curtin University Human 
Research Ethics Committee (Approval Number: HR127/2010), the Education 
Department of WA and the Catholic Education Office (WA) and complied with the 
Helinski Declaration (World Medical Association, 2008). In addition, the study was 
registered with the Australian and New Zealand Clinical Trials Registry (2007) was 
additionally gained (Trial ID: ACTRN12610001014044). 
3.4.2.2 Treatment.  The Cool Kids program: ASD adaptation (Chalfant et al., 
2011), was used for this investigation. The program title was changed to The Chilled 
Program with linguistic modifications made to ensure appropriateness when speaking 
with adolescents compared to younger children (e.g., “teens” instead of “children”). 
In addition, as Figure 4 depicts, many of the graphics were changed to suit adolescents 
who were older than the original age group of 8-12 year olds that the program was 
designed for (e.g., Manga figures “Anxious Amy” and “Confident Calvin” replaced 
the crocodile and alligator characters in the original Cool Kids program). 
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Figure 2. The Chilled Program characters, “Confident Calvin” and “Anxious Amy.” 
 
The Cool Kids Child Anxiety Program: Autism Spectrum Disorders Adaptation 
(Chalfant et al., 2011) is a CBT-based anxiety reduction program for children and 
adolescents with ASD. The manual is an adaptation of the Macquarie University, Cool 
Kids program (Lyneham et al., 2003) and is based upon Chalfant and colleague’s 
(2007) randomised control trial which demonstrated a significant reduction in anxiety 
in ASD children at both post-treatment and at follow-up.  
 This CBT program teaches children and adolescents cognitive behavioural 
skills that are targeted to combat anxiety while additionally incorporating social skills 
and assertiveness training in order to specifically address core ASD deficits. The Cool 
Kids program (Lyneham et al., 2003) is based on knowledge and empirical evidence 
about maintaining factors of childhood anxiety including biases in information 
processing, excessive avoidance, and parental overprotection. The developers of the 
program have been extensively involved in fundamental research into the nature and 
maintenance of childhood anxiety (e.g., Hudson et al., 2009). Multiple studies 
document positive behavioural outcomes at post-test, with at least one study indicating 
positive behavioural impacts at least one year after the intervention ended (Rapee 
2000). 
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The group CBT consisted of 12 manualised intervention sessions.  Each 
session ran for 2 hours a week for 10 weeks and then once a month for 2 months. The 
structure of the therapy groups consisted of parents and adolescents attending the first 
part of the session together. Adolescents then attend a group session together whilst 
the primary caregivers had a break and time to converse amongst themselves. Parents 
then attended a session together whilst the adolescents had a supported break with 
either one or two of the co-therapists. The exception to this is Session 6 where families 
spend the entire session together, working in parent/child dyads, developing an 
exposure stepladder. The purpose of the parent session was to address anxiety 
education, relaxation strategies, cognitive restructuring exercises, graded exposure, 
parent management training and relapse prevention (Chalfant et al., 2007). Parents 
were at times required to practice the skills that their adolescent was learning in session 
as well as to take on the role of “coach” to assist their adolescent in generalising the 
skills learned across settings. Between sessions the parent and adolescent were 
required to complete home practice tasks (e.g., relaxation strategies, restructuring 
thoughts, exposure tasks).  
The main areas covered in the program are outlined in Table 1.  The program 
includes recognition of anxious feelings and physical symptoms of anxiety, modified 
cognitive restructuring exercises, coping, self-talk, and exposure to feared stimuli and 
relapse prevention. The major components of the program are relaxation and exposure. 
The material covered is more concrete in nature than the original “Cool Kids” 
program, requiring participants to be less skilled in communication. The earlier 
sessions of the program are heavily focused on training, whereby therapists introduce 
and role-play anxiety management strategies, which are then practised by the 
adolescents. The latter sessions are considered practice sessions and allow the 
adolescent to consolidate their new skills and plan their weekly exposure tasks. The 
exposure tasks serve as homework activities to be completed by the parent/adolescent 
dyad. Parents attending the concurrent sessions were provided with a parent-based 
group CBT manual (Chalfant et al., 2006). 
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Table 1 
Outline of the “Chilled Program”  
Session Session Overview 
1 Program overview: Parents and adolescents are introduced to therapist, 
each other and the program. Group rules are established. 
Feelings and worries are normalised and discussed. Adolescents learn to 
identify feelings and the three parts of anxiety. Healthy worries versus 
unhealthy worries are introduced, as are the physiological signs of 
anxiety. 
Parents learn about the nature, causes and treatments of anxiety.  
2 Learning to relax: Cool breathing and progressive muscle relaxation are 
introduced and practiced. Adolescents learn to rate their worry on the 
worry scale. 
Parents set goals for the program and learn about the “anxiety model” 
including causes and maintenance of anxiety.  Parents learn to target the 
physical aspects of anxiety and relaxation techniques. 
3 Relaxation, imaginal exposure and anxious thoughts: Adolescents 
imagine a fearful situation to rate their anxiety and to practice their 
relaxation techniques from Session 2. Activities that help the adolescent 
to feel good are the focus of the last part of the session. 
Parents are also introduced to imaginal exposure as well as to the a-b-c 
model of CBT. Thinking errors are discussed and parents are asked to 
keep a copy of their feelings, events and thoughts. 
4 Learning to think helpful thoughts: Helpful and unhelpful thoughts are 
introduced, using examples. The consequences of these (feelings) are 
highlighted. 
Parents learn about managing the cognitive aspects of anxiety (e.g., 
helpful/unhelpful thoughts, cognitive restructuring). 
5 Becoming the boss of fears and worries: Adolescents identify situations 
where their anxieties have been restricting them. 
Parents learn about managing the behavioural components of anxiety 
(i.e., avoidance). Psychoeducation on exposure is given. 
Families together: A list of fears/ worries is formulated in each 
adolescent/parent dyad. 
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6 Creating stepladders: Family dyads work together to form a stepladder of 
a fear/worry. A plan to boss back worries is created. 
7 Parenting anxiety and bossing worries: Adolescents review their first 
step and revisit unhelpful thinking. 
Parents learn about encouraging courageous vs. anxious behaviour, the 
importance of praise and of modelling, encouraging independent 
behaviour and reducing protective behaviour. Parents are also given 
information on breaking down anxious or undesirable behaviour, 
building coping strategies and managing excessive worry. 
8 Dealing with worry: Adolescents review their exposure step and revise 
relaxation strategies. 
Parents are informed of challenges that can occur during exposure 
exercises and also given information on social skills and assertiveness. 
 9 Creating stepladders and challenges to progress: Adolescents reflect on 
what they achieved and any pitfalls in their exposure exercises. In 
addition, they are encouraged to look at how they could help someone 
with anxiety. 
Parent engage in a “creating stepladder” activity. 
10 Continuing Exposure: Revisit relaxation skills.  
Parents cover challenges to exposure and plan for the break between 
sessions. 
11 Chronic problems, maintenance and setbacks: Adolescents to think of 
situations that might make their worries return and how to manage this. 
Parents review their adolescent’s progress and are given 
psychoeducation on chronic anxiety and depression, as well as how to 
manage setbacks. 
12 Reviewing goals and future plans: Adolescents identify any changes that 
have occurred for them over the program. Parents review their goals and 
contemplate future plans. Families together discuss longer term goals 
and are given an award for participation. 
3.4.2.3 Program modifications for adolescents with ASD.  
Modifications incorporated in the delivery of the program included:  
• The use of visual schedules and token reinforcers.  
• The offer for therapists to scribe for adolescents during written tasks. 
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• The weaving of special interests into the program content;  
• The use of sensory and motor items to assist in regulating behaviour 
(e.g., fidget toys, fit balls and weighted items);  
• The Chilled Program manga characters (“Anxious Amy” and 
“Confident Calvin”) and the use of these characters and accompanying 
dress-up props to role-play management of anxiety.  
• A hands-on and flexible approach to activities / sessions (e.g., a body 
drawn on a large sheet of paper to indicate physiological signs of 
anxiety).  
These modifications, while differing in empirically support, are not new to 
cognitive behavioural therapy programs for youth with ASD (see Chapter 2 for more 
information on CBT program modifications generally). Due to the unique profiles and 
varying comorbidities of the adolescent participants in this study, flexibility in 
program delivery was paramount while simultaneously ensuring protocol adherence. 
For example, if an adolescent exhibited strong ADHD symptomology, more 
movement occurred in the session (e.g., role-plays standing up, use of fit ball for the 
participant, and throwing a small bean toy to the participant when they answer a 
question). Adolescents who displayed repetitive behaviours in talking about their 
special interest were provided with time to speak about their interest once they 
completed a task (preferred reinforcement). In addition, their special interest was 
woven into the session content to assist them with attending in session. Although a 
group program, quickly understanding the individual profile of participants and being 
flexible in the delivery of the content, appeared to assist in program engagement. In 
addition, creating a safe, validating, and fun environment was essential in order for 
participants to feel encouraged to return for the next session. This was achieved by 
allowing the adolescents enough time within sessions to discuss their areas of interest, 
converse with each other and share experiences (e.g., bullying was an initiated 
discussion by the adolescents across groups and appeared to be an experience that most 
participants could identify with), with an attempt to make the sessions as “light” and 
different to school as possible so that participants could gain a sense of enjoyment at 
sessions without viewing them as more “school work.” 
Flexibility was incorporated into the parent sessions given that the client 
population were older than the original protocol was intended for. While not a formal 
part of the protocol, parents were able to introduce topics that were likely to be more 
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relevant to teens such as increased social demands, transition to high school and 
beyond high school, employment issues, sexual identity and dating. 
3.4.2.4 Therapists.  Therapists were university psychology graduate trainee 
Masters or PhD students. The primary researcher (Kidd), who trained in the Cool Kids 
program and is experienced in working with individuals with ASD, facilitated all of 
the CBT and waitlist groups, with the assistance of two postgraduate students in the 
Masters of Clinical Psychology program or the combined Masters/PhD Clinical 
Psychology program. An exception here was a student in the Masters of Counselling 
Psychology program who was a registered psychologist with extensive experience and 
training in ASD. All of the co-therapists were female, reflecting the demographics of 
the psychology postgraduate cohort.  
Prior to co-facilitating the group CBT, these students were required to attend 
one of two training sessions. The first provided training in administering the ADIS-
IV-P for those who were assessors at pre-, post-intervention and/or follow-up. As 
noted, these students were blind to the intervention condition of each family. 
Interviewer training involved attending a presentation on the administration of the 
ADIS-IV-P, observing a videotaped interview whilst following the corresponding 
completed ADIS-IV-P booklet, and conducting at least one mock interview using the 
ADIS-IV-P under the supervision of the primary researcher. In addition, all interviews 
were video recorded with segments viewed and outcome measures discussed with their 
clinical supervisor whilst on placement in the Curtin University Psychology Clinic. 
Due to the longitudinal nature of the study and the time-limited Masters program, it 
was not always possible to have the same student conduct the assessment at pre-, post-
intervention and follow-up. 
The second training session was tailored to the students who were to assist in 
the group CBT intervention program. Students were initially provided with reading 
material on the study intervention, relevant articles (e.g., Chalfant et al., 2007), and 
information and website links regarding ASD. Students then attended a half-day 
training session that included an overview of the Chilled Program and ASD, working 
therapeutically with adolescents with high functioning ASD/anxiety and their families, 
and conceptualising and constructing behavioural experiments. Students were given a 
copy of the Therapist, Parent, and Adolescent Chilled Program manuals to read prior 
to program commencement (adapted from the Cool Kids ASD Adaptation manuals; 
(Chalfant et al., 2011). 
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Clinical supervision was provided to the primary researcher in-between 
sessions by the project supervisor, Associate Professor Clare Roberts (School of 
Psychology, Curtin University). Videotaped group sessions were viewed by the project 
supervisor to ensure that the group CBT protocol was correctly delivered (see checklist 
information below) and to troubleshoot any difficulties that emerged for participants 
or therapists. In addition, the primary researcher was in contact with the group co-
therapists to discuss facilitator roles and responsibilities prior to each session, in 
addition to any feedback from the supervision session. Following each group session, 
all three therapists participated in a brief peer supervision session with any difficulties 
discussed with the project supervisor. 
3.4.2.5 Treatment adherence and session quality.  To ensure treatment 
consistency across the groups, the primary researcher facilitated all sessions with close 
adherence to the Chilled Program manual. In order to strive for adherence to the 
intervention protocol, the primary researcher and co-therapists examined a checklist 
prior to each session (see examples in Appendix H). As established measures of 
treatment adherence were not available in the existing literature, an adaptation by the 
primary researcher (Kidd) of the Roberts, Kane, Thomson, Bishop, and Hart (2003) 
intervention study served as the checklist in this study. At the end of each session 
therapists completed this program content checklist to determine whether the topics 
and activities in each module were adhered to, and to evaluate program facilitation. 
This included overall success of the session, preparation, presentation, rapport with 
the group, and level of cohesion within the group. A 10-point Likert scale was used to 
rate each item, ranging from 1 (not at all successful) to 10 (very successful). The 
primary researcher’s project supervisor (Roberts) examined the checklist to ensure that 
it demonstrated high content validity.  
The integrity of treatment adherence is of high importance (Fairburn & Cooper, 
2011) and was independently assessed by two graduate clinical psychology trainees 
(coders) and supervised by experienced clinical psychologists/ clinical placement 
supervisors at Curtin University Psychology Clinic. The coders, with knowledge of 
CBT and the treatment protocol, used the same treatment checklist as mentioned 
above, to rate the facilitator’s adherence to the session goals on 25 (24%) randomly 
selected video recorded CBT and WL group sessions. For example, goals from Session 
2 included: (a) review homework (families together), (b) Overview of group rules/ 
home tasks (c) introduce My Cool Breathing Guide (d) introduce Calvin’s Relaxation 
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Tools, (e) introduce concept of why it’s important to relax, (f) introduce The Worry 
Scale (g) assign home practice tasks. Treatment fidelity was rated at 93% and 
agreement between the two coders was excellent (k = 1.00), suggesting high adherence 
to the treatment manual.  
The independent coders additionally rated five components of each session on 
a Likert scale of 1-10 (low to high). The viewed sessions were rated on overall success 
of session (M = 8.48, SD = 0.71), session preparation (M = 8.96, SD = 0.94), 
presentation of session (M = 8.16, SD = 1.43), therapist rapport (M = 8.04, SD = 1.46), 
and group cohesion (M = 7.60, SD = 1.44).  
3.4.3 Measures. Demographic information (Appendix C) was collected from 
each participant and included age, gender, ethnicity, diagnosis, previous interventions, 
medications, and primary carer/ sibling information. Additional measures were 
administered on three occasions, pre-intervention (Time 1), post-intervention (Time 
2) for both conditions and at 6-month follow-up (Time 3) for the intervention group 
only (see Figure 3). This study incorporated multi-modal and multi-person assessment 
as recommended in the psychological literature (Kazdin, 1986). In Study 2 of this 
thesis, participant satisfaction was assessed following treatment with parents and 
adolescents in both conditions. This involved the completion of a 7-item rating scale 
that assessed perceived efficacy of the program (see Appendix I and J).  
3.4.3.1 Parent outcome measures.  
3.4.3.1.1 Anxiety Disorders Interview Schedule for Children-Parent Version 
(ADIS-P; Silverman & Albano, 1996). Diagnostic status was assessed using the parent 
interview schedule of the child version of the ADIS-P, which distinguishes between 
the DSM-IV anxiety disorders, and excludes other possible comorbid disorders. It 
involves the utilisation of an interviewer-observer format with items assessing 
cognitive, behavioural, and physiological responses across a range of potentially 
anxiety-producing situations (e.g., interacting with peers or separating from a parent). 
In addition, parents are asked to rate symptom interference on their child’s life on a 9-
point scale (0 = not at all interfering and 8= highly interfering) with diagnoses derived 
from the severity level arising from the interview. In the current study, parent-reported 
Interference Ratings ≥ 4, total number of symptoms endorsed, and the clinical 
impression for each diagnostic category, formed the independent clinical evaluators 
Clinician Severity Rating (CSR) across DSM-IV categories. Severity ratings ranged 
from 0 (absent), 2 (mild), 4 (moderate), 6 (severe), and 8 (very severe). If CSRs ≥ 4 
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then the adolescent met the criteria for that particular disorder. Research has shown 
the ADIS-C/P to have sound psychometric properties (Silverman, Saavedra & Pina, 
2001) with good reliability, concurrent validity (e.g., Wood et al., 2002), and 
acceptable to excellent (7- to 14-day) test-retest reliability (k = 0.65–1.00) across 
anxiety disorder categories (Silverman, Saavedra & Pina, 2001).  Previous studies 
(e.g., Rapee, Barrett, Dadds, & Evans, 1994) have shown moderate to high interrater-
reliabilities for the diagnoses of the separate anxiety disorders (k = 0.59 to 0.82). The 
ADIS-C/P has been successfully used in studies with ASD children and adolescents 
(e.g., Chalfant et al., 2006, McNally et al., 2013; Wood et al., 2009, Strang et al., 2012) 
and enables clinicians to determine whether or not the difficulties that the adolescent 
experiences are severe enough to warrant a diagnosis of anxiety beyond their ASD 
related difficulties.  
3.4.3.1.2 The Spence Children’s Anxiety Scale for Parents (SCAS–P; Nauta, 
Scholing et al., 2004). This measure contains 38 items relating to parent’s perception 
of situations in which their child could experience feelings of anxiety, with parents 
indicating on a 4-point scale how often each anxiety item occurs for their child. Like 
the child version of the SCAS, the parent version yields a total score (between 0-114, 
with 114 being the greatest level of anxiety) and six sub-scales: panic attack and 
agoraphobia, separation anxiety, physical injury fears, social phobia, obsessive 
compulsive, and generalised anxiety disorder/ overanxious disorder. The total scale 
has high internal consistency (Cronbach’s alpha = .92) and the six subscales have 
adequate to excellent internal consistencies with Cronbach’s alphas ranging from .61 
for physical injury fears to .81 for panic and agoraphobia ((Nauta et al., 2004). With a 
minimum acceptable value for Cronbach’s alpha being .70, the subscales in the present 
study ranged from .68 to .78 indicating good internal consistency. Based on caregivers 
of ASD youth, evidence of convergent validity between the SCAS-P, the Kiddie-
Schedule for Schizophrenia and Affective Disorders-Present (K-SADS-PL) and the 
DBC has been found (Zainal et al., 2014). The parent and child versions of the SCAS 
correlate well with each other, with parent-child agreement ranging from .41 to .66 
across the subscales (Nauta et al., 2004). The SCAS and SCAS-P have both been used 
to measure anxiety symptoms and treatment outcome with high levels of internal 
validity and reliability (Sofronoff et al., 2005) in anxious children with ASD (e.g., 
Chalfant et al., 2007; Sofronoff et al., 2005; Sung et al., 2011). 
3.4.3.1.3 The Beach Center Family Quality of Life Scale (FQOL; Poston et al., 
2003). This scale consists of 25 items assessing family ratings of importance and 
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satisfaction across five domains: Family Interaction (e.g., “My family enjoys spending 
time together”), Parenting (e.g., “Family members teach the children how to get along 
with others”), Emotional Well-being (“My family members have friends or others who 
provide support”), Physical/Material Well-being (“My family has a way to take care 
of our expenses”), and Disability-Related Support (“My family member with special 
needs has support to make progress at school or workplace”). A 5-point scale 
determines satisfaction with each of the items. Good internal consistency has been 
demonstrated for both the importance rating (Cronbach’s alpha = .94) and the 
Satisfaction rating (Cronbach’s alpha = .88). In the present study, Cronbach’s alpha 
for satisfaction across the five domains ranged from .72 to .82, indicating good internal 
consistency. Test-retest reliability correlations have been studied for both importance 
and satisfaction responses for all of the FQOL subscales with all correlations 
significant at .01 level or beyond. Convergent validity has been demonstrated with 
both the Family APGAR questionnaire (, which  (r = .68) (Smilkstein et al., 1982; 
Hoffman et al., 2006) and the Family Resource scale (r = .60; Dunst & Leet, 1987; 
Hoffman et al., 2006).  
3.4.3.1.4 The Social Skills Improvement System–Rating Scales (Parent) (SSIS 
– RS (P); Gresham & Elliott, 1990). The SSIS-RS is a rating scale for parents to 
evaluate the social behaviour of their child or adolescent aged between 3- and 18-
years-of-age. The SSIS provides information on social behaviour and measures 
whether the child or adolescent uses various social skills during interactions with 
others. The questionnaire has been standardised on a sample of 4,000 children and 
includes separate norms for males and females. Good internal consistency for the 
social skills scale has been found (Cronbach’s alpha = .83 to .94; Gresham & Elliot, 
1990). The convergent validity of the SSIS has been demonstrated against other 
measures of social competence (Flanagan, Alfonso, Primavera, Povall, & Higgins, 
1996). Good test-retest reliability have been shown for the Total Social Skills scores 
(r = .84) and the Total Problem Behaviour scores (r = .86) (Gresham & Elliott 2008). 
In addition, the SSIS-RS has shown to differentiate members of special populations 
such as autism spectrum disorder, emotional/behavioural disturbance, and 
speech/language impairment (Gresham & Elliott, 2008). 
3.4.3.1.5 The Short Mood and Feelings Questionnaire – Parent (SMFQ-P; 
Angold & Costello, 1987). This is a 13-item questionnaire completed by parents in 
order to detect depressive symptomology in their child or adolescent. This 
questionnaire contains a series of phrases that can help describe how adolescents, aged 
  
77 
13- to 18-years, have been feeling or acting recently and has been successful in 
discriminating adolescents with major depression from those with sub-threshold 
depression or no depressive disorder (Daviss et al., 2006).  The SMFQ has 
demonstrated good internal consistency (Cronbach’s alpha = .97) (Messer, Angold, & 
Costello, 1995) and reasonable test-retest reliability (r = .78) (Wood, Kroll, Moore, & 
Harrington, 1995). The MFQ-P has shown a sensitivity of .75 and specificity of .73 
for an ICD-10 diagnosis of depression and a sensitivity of .86 and specificity of .87 
for DSM-III-R depression (Thaper & McGuffin, 1998).  
3.4.3.2 Adolescent outcome measures.  
3.4.3.2.1 The Spence Children’s Anxiety Scale - Child (SCAS; Spence, 1997). 
This scale measures the overall levels of anxiety in children and adolescents. It 
contains 38 items and measures six domains (a) separation anxiety, (b) social phobia, 
(c) obsessive compulsive problems, (d) panic/agoraphobia, (e) physical injury fears 
(Items 2, 18, 23, 25, and 33), and (f) generalised anxiety. Each symptom is rated on a 
4-point scale (“never”, “sometimes”, “often”, or “always”) according to how often the 
child experiences the symptom. The SCAS has demonstrated sound psychometric 
properties, with a convergent validity of .75 with the Revised Children’s Manifest 
Anxiety Scale (RCMAS) and an internal reliability coefficient of .93, along with a 
Guttman split-half reliability of .92 (Spence et al., 2003). Cronbach’s alpha for the 
subscales in the present study ranged from .79 to .86 indicating good internal 
consistency. Factor analysis confirmed the subtypes of anxiety assessed in the scale 
have been found to be consistent with the typology of the DSM-IV (APA, 2000). To 
date, there are no validity data for children with ASD; however, the SCAS has been 
usefully used in research with children with ASD (e.g., Gillott & Standen, 2007). 
3.4.3.2.2 The Short Mood and Feelings Questionnaire, Child version (SMFQ-
short- C; Angold & Costello, 1987). This questionnaire is a 13-item questionnaire 
completed by children in order to detect depressive symptomology. This questionnaire 
contains a series of phrases that can help describe how adolescents, ages 13- to 18-
years, have been feeling or acting recently and has been successful in discriminating 
adolescents with major depression from those with sub-threshold depression or no 
depressive disorder (Daviss et al., 2006). The SMFQ has demonstrated good internal 
consistency (Cronbach’s alpha = .97) (Messer et al., 1995) and reasonable test-retest 
reliability (r = .78) (A. Wood et al., 1995). The MFQ-C at the selected cut-off point 
showed a sensitivity of .6 and specificity of .61 for ICD-10 depression, and a 
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sensitivity of .75 and specificity of .74 for DSM-III--R depression (Thaper & 
McGuffin, 1998). 
3.4.3.3 Therapist measures. 
3.4.3.3.1 The Clinical Global Impression (CGI) – Improvement Scale (CGI-IS; 
(Guy, 1976). The CGI-IS is a global rating of improvement in anxiety and overall 
psychiatric symptoms ranging from 1 “completely recovered” to 5 “no change” to 7 
”very much worse” (see Table 2). The independent clinical evaluator who administer 
the ADIS-C/P will use this scale to rate each adolescent’s improvement or decline at 
post-treatment/post-waitlist assessment. A rating will be produced based upon the 
independent evaluators’ follow-up interview in comparison to baseline ADIS-P 
interviews in regard to anxiety and related global impairment. The adolescents who 
receive a rating of 1, or 2 (very much better and much better) will be considered 
treatment responders while all other cases considered non-responders, following 
research precedent (e.g., Storch, Lewin, De Nadai, & Murphy, 2010; Walkup et al., 
2008; Wood et al., 2014). These ratings were derived in a similar manner to the 
methods described in previous studies (Walkup et al., 2008; Wood et al., 2009).  
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Table 2 
Guidelines for the CGI-IR ratings  
CGI-I guidelines 
 
1 = Very much improved—nearly all better; good level of functioning; minimal 
symptoms; represents a very substantial change 
 
2 = Much improved—notably better with significant reduction of symptoms; 
increase in the level of functioning but some symptoms remain 
 
3 = Minimally improved—slightly better with little or no clinically meaningful 
reduction of symptoms. Represents very little change in basic clinical status, level 
of care, or functional capacity 
 
4 = No change—symptoms remain essentially unchanged 
 
5 = Minimally worse—slightly worse but may not be clinically meaningful; may 
represent very little change in basic clinical status or functional capacity 
 
6 = Much worse—clinically significant increase in symptoms and diminished 
functioning 
 
7 = Very much worse—severe exacerbation of symptoms and loss of functioning 
 
Note. Busner and Targum, 2007. Adapted from Spearing, M.K., Post, R.M., 
Leverich, G.S., et al. Modification of the Clinical Global Impressions (CGI) Scale 
for use in bipolar illness (BP): the CGI-BP. Psychiatry Research 1997; 73(3):159–
71. 
3.5 Data Analysis 
A series of generalised linear mixed models (GLMMs) – one for each of the 
outcome measures - was tested in order to determine whether the intervention group 
reported pre-post changes on the outcome measures relative to the control group. The 
GLMMs were implemented through SPSS’s (Version 22) GENLINMIXED 
procedure. The GLMM represents a special class of regression model.  The GLMM is 
“generalised” in the sense that it can accommodate outcome variables with markedly 
non-normal distributions; the GLMM is “mixed” in the sense that it includes both 
random and fixed effects. Each of the present GLMMs included two nominal random 
effects (participant, therapy group), one nominal fixed effect (group: CBT, control), 
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one ordinal fixed effect (time: pre, post), and one 2-way interactions (Group x Time). 
Additional GLMMs were tested to determine whether significant pre-post changes in 
the CBT group were maintained at the 6-month follow-up. These GLMMs included 
two nominal random effects (participant, therapy group), and one ordinal fixed effect 
(time: pre, post, follow-up). Significant interactions were followed-up by conducting 
least significant difference (LSD) contrasts across the simple main effects for time 
(pre, post). For the GLMMs that tested for maintenance effects within the intervention 
group, significant time effects were followed-up by conducting LSD contrasts across 
the main effect of time (pre-, post-intervention, follow-up). 
The traditional ANOVA repeated measures model requires the following 
assumptions to be satisfied: Normality, homogeneity of variance, sphericity, and 
independence of observations. The GLMM “robust statistics” option was invoked to 
accommodate violations of normality and homogeneity of variance. Violations of 
sphericity were accommodated by changing the covariance matrix from the default of 
compound symmetry to autoregressive. Finally, by specifying the multilevel nature of 
the current data (participant nested within therapy group) in the GLMM syntax, 
GLMM was able to accommodate intra-group dependencies in the outcome measures.  
In order to optimise the likelihood of convergence, a separate GLMM analysis was run 
for each of the outcome measures. Analysing each outcome independently of the 
others will inflate the familywise error rate. The per-test alpha was therefore corrected 
to control the inflation. Changes in the binary outcomes (H3-H6) were analysed using 
Fisher’s Exact 1-sided tests (Bryk, 1987; Holden et al., 2008).  
 A number of correlations will be conducted in order to investigate possible 
mediation and moderation effects.   
3.5.1 Effect size.  The magnitude of the Group x Time interaction was 
estimated with partial-eta squared. The magnitude of the main effects were estimated 
with Cohen’s d. SPSS’s GLMM does not output effect sizes so both partial-eta squared 
and Cohen’s d were derived by converting F-values and the LSD t-values into partial-
eta squared and Cohen’s d respectively.  For partial-eta squared, values of .01, .06, and 
.14 represent small, medium and large effect sizes respectively (Richardson, 2011). 
For Cohen’s d, values of .2, .5, and .8 represent small, medium and large effect sizes 
respectively (Cohen, 1988). 
3.5.2 The Reliable Change Index.  The reliable change (RC; Jacobson & 
Truax, 1991) score was employed to determine whether time-related change on the 
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outcome measures was statistically reliable and demonstrative of a genuine 
behavioural change, as opposed to measurement error (Jacobson & Truax, 1991). The 
RC score can be interpreted as the degree to which the person changes on the outcome 
variable divided by the standard error of difference between Time 1 and Time 2 scores. 
Due to anxiety reduction being the primary focus in the current study, for each 
adolescent, reliable change indices (RCIs) were calculated on the SCAS-P and SCAS-
C. The following formulae was used to calculate reliable change:  
 
Table 3 
Formulae used to Calculate Reliable Change 
 
 Reliable change SDiff SE 
Formulae 
 
!" − !$%&'((  )2(%,)" %$)1 − /00 
 
An RCI equal to or greater than 1.96 in the direction of healthy range indicates 
improvement, whereas an RCI of 1.96 or greater in the direction of clinical range 
indicates deterioration (Jacobson & Truax, 1991). Scores less than 1.96 are classified 
as unchanged. After the intervention group had received group CBT, the total number 
of individuals considered recovered, improved, unchanged and deteriorated in anxiety 
between pre-treatment and post-treatment and pre-treatment and 6-month follow-up 
were calculated. To determine whether the CBT group had a significantly higher 
proportion of participants demonstrating change, compared to the WL participants, 
Fisher’s 1-sided tests were conducted. Nonclinical normative data was taken from a 
large community sample of Australian school children (n = 4916) including boys (n = 
2,386) and girls (n = 2,530) between 9-15 years who completed the SCAS-C. The 
norms provided for the older age range (12-15 years) were employed for the purposes 
of the current study. Nonclinical normative data for the parent report (SCAS-P) was 
based on a study of 484 parents of anxiety-disordered children and 261 parents in a 
normal control group (Nauta et al., 2004)  
3.6 Results 
3.6.1 Participant flow.  Figure 6 displays the CONSORT diagram, which 
outlines the participant flow through the study. During the recruitment phase of this 
study, 78 potential families expressed an interest in participating in the study via 
  
82 
contact with the primary researcher. Nine of these families had an adolescent who did 
not have an official autism spectrum disorder diagnosis and therefore were not eligible 
for the study, and the remaining 13 families declined (e.g., too busy/ unable to make 
the session time) or did not return the completed demographic and consent forms. 
Therefore, fifty-six adolescents and their participating parents were recruited for the 
study. Seven of these adolescents did not meet the criteria for an anxiety disorder 
diagnosis and therefore were not included in the study. Three families withdrew from 
the waitlist condition before completing post-test assessment due to seeking external 
psychotherapy and one family withdrew from this condition due to relocating 
overseas. One adolescent withdrew from the treatment group after attending one 
session due to anxiety interfering with his ability to participate in a group environment 
(see discussion). Therefore, while 49 families remained at pre-test (26 CBT 
intervention and 23 WL control), only 44 families (25 CBT, 19 WL) completed post-
intervention/waitlist outcome measures. Twenty-four treatment families from the CBT 
intervention condition completed the primary measure at the 6-month follow-up, 
although nine of these families did not return completed secondary measures. None of 
the waitlist participants completed measures after they had received treatment (see 
Figure 6 below).  
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Figure 3. CONSORT diagram of participants’ progress through the phases of the 
study. 
3.6.2 Compliance with treatment. 
3.6.2.1. Attrition.  Four (8.2%) WL control families withdrew from the study 
prior to post-treatment/intervention measures being taken (one family moved overseas 
and the remaining wanted to seek psychological treatment immediately). One (2.0%) 
family withdrew from the CBT intervention condition after attending one therapy 
session. This participant met criteria for five anxiety disorder diagnosis, in addition to 
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(n = 9)
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Allocated to waitlist 
control group (WL) 
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 (n = 26)
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Completed post-test
(n = 19)
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(n = 25) 
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 Completed follow-up 
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dysthymia and ASD. He was having difficulty attending school at the time, managing 
a maximum of 2 days a week. His mother reported that the group environment was too 
overwhelming for him. Therefore, five out of 49 families (10.2%) did not complete 
the treatment trial. In addition, another family from the CBT group did not complete 
follow-up measures. 
3.6.2.2. Session attendance.  No significant difference was found between the 
treatment and treated waitlist groups in the number of group therapy sessions attended 
(CBT Intervention condition: M = 11.16, SD = 1.02; treated WL control condition: M 
= 11.22, SD = 1.48; t(47) = 0.17, p = .87). Overall, 93.3 % of sessions were attended 
across conditions with 52.3% of participants attending all 12 sessions, 31.8% attending 
11 sessions, 9.1% attending 10 sessions, and 2.3% attending 6, 8 and 9 sessions. 
Homework compliance and parent reading compliance was not recorded in this study.  
3.6.2.3. Adherence to restrictions of external treatment and medication 
change.  At the time of study enrolment, 20 participants (40.8%) were taking 
prescribed medication, including antidepressant, antipsychotic and stimulant 
medication. Over the course of the 5-month study, no medications targeting anxiety or 
mood were reported as having been commenced or terminated in either group; 
however, there was a reported dosage increase for one participant in the waitlist group.  
3.6.3 Data screening and missing data. SPSS Version 22 was used for 
statistical analysis. Data were entered and re-checked in order to minimise errors in 
data entry. Data cleaning was then conducted using the SPSS Descriptive and 
Frequency procedures to determine whether missing or out-of-range values existed 
(Tabachnick & Fidell, 2007). SPSS Missing Value Analysis was conducted to screen 
for missing data for unit non-response which is when participants fail to complete a 
certain assessment or data collection point and therefore not completing any 
questionnaires. Table 2 displays unit non-response across all three data collection 
points for both conditions. From the possible 861 data points for the seven outcomes 
collected across three assessment points, unit non-response was approximately 17%. 
Given that data were collected over several months, missing data derived from the five 
participants that dropped out of the study which is referred to as wave non-response, 
along with those families who failed to return their questionnaire packages. This 
occurred more frequently for participants in the intervention groups at the 6-month 
follow-up collection point (36.5% of participants at follow-up had missing 
questionnaires). Fortunately, as previously stated, all of the primary outcome measures 
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were completed at each time collection point aside from the five families that dropped 
out and did not complete their post-measures or follow-up measure. 
Compared to the traditional statistical procedures for analysing behavioural 
change (e.g., repeated measures ANOVA), GLMM is less sensitive to participant 
attrition because it does not rely on participants providing data at every assessment 
point; the GLMM maximum likelihood procedure is a full information estimation 
procedure that uses all the data present at each assessment point. No participant is 
dropped from the analysis because all available data are used to obtain parameter 
estimates. This reduces sampling bias and the need to replace missing data. GLMM is 
able to use the data present at each assessment point because time (pre, post, 6-month 
follow-up) is interpreted as a Level 1 variable that is nested within participant at Level 
2 (which is itself nested within therapy group at Level 3). 
 
Table 2 
Unit Non-response across Time (pre, post and follow-up) and Condition in Outcome 
Measures 
Measure n  Missing  n (%) 
ADIS-P 123 6 (4.8) 
FQOL 103 21 (17) 
SCAS-C 104 20 (16) 
SCAS-P 101 23 (18) 
SMFQ-C 97 27 (22) 
SMFQ-P 102 22 (17) 
SSIS-RS 103 21 (17) 
Note. Sample sizes varies across variables due to missing data. ADIS-C/P Anxiety 
Disorder Interview Schedule – Parent, SCAS-C Spence children’s anxiety scale – 
child, SCAS-P Spence children’s anxiety scale – parent, SMFQ-C short mood and 
feelings questionnaire – child, SMFQ-P short mood and feelings questionnaire – 
parent, FQOL Beach family quality of life scale, SSIS-RS Social Skills Improvement 
System – Rating Scales. 
 
 
3.6.4 Comparison of participant demographic and clinical characteristics. 
Baseline demographic and clinical characteristics were analysed to determine group 
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equivalence as defined by statistically non-significant differences between groups (p 
> .05). Table 4 illustrates the baseline demographic and clinical characteristics for 
participants in the intervention and control condition. The sample comprised of more 
males (n = 40) than females (n = 9) with the mean age of participants in the CBT 
condition being 14.73 years, (SD = 1.79), similar to that in the WL condition where 
the mean age was 13.65 (SD = 1.61). Employing independent samples t-tests revealed 
no significant differences between the two conditions for participant’s age, school 
grade, and age of ASD diagnosis, nor for age of parents. Fisher’s exact tests (2-sided) 
determined that adolescents did not significantly differ across the two groups in terms 
of male/female ratio, whether they had sibling/s, their ethnicity, whether English was 
their first language, their autism spectrum disorder diagnosis, and medication status. 
In addition, parents did not differ on their marital or employment status across the two 
conditions. The majority of parents that participated in the program were mothers 
(88%) and the remaining were fathers (12%). Occasionally parent couples attended 
sessions together although the participating parent was recorded as the person 
completing the outcome measures.  
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Table 4 
Pre-treatment Comparability of Participant Characteristics in the CBT Intervention 
and WL Control Conditions 
 Intervention 
(n = 26) 
M      SD    Range    
Control 
(n = 23) 
   M      SD    Range      
Two-sided t-test Entire sample 
(n = 49) 
 M      SD    Range      
 
Age (years) 
 
14.73   1.82    12-18 
 
13.65    1.61   12-17 
 
t(47) = 1.96, p = .055a 
 
14.22   1.79  12-18 
School Grade 9.77   1.81       7-13 9.06    1.39      7-12 t(47) = .168, p = .136a 9.48   1.68     7-13 
Age of ASD Diagnosis 9.22   4.07       2-14 8.50    3.50      2-14 t(47) = .655, p = .516 a 8.88   3.79     2-14 
Mother’s age (years) 45.08   6.05     34-56 43.57    6.97    29-55 t(43) = .779, p = .440a 44.38   6.46   29-56 
Father’s age (years) 48.45   6.87     34-61 46.00    8.56    29-60 t(37) = .988, p = .330a 47.26   7.74   29-61 
     
 n (%) n (%) Fisher’s exact test 
 
n (%) 
 
Gender  
   
p = .376 
 
    Male 20 (77) 20 (87)  40 (82) 
    Female   6 (23)   3 (13)    9 (18) 
Sibling   p = .982  
    Yes 24 (92) 20 (87)  44 (90) 
    No   2 (8)   3 (13)    5 (10) 
Adolescents’ ethnic 
background  
  p = .586  
    Caucasian 24 (92) 21 (90)  45 (90) 
    Asian   2 (8)   1 (5)    3 (7) 
    Pacific Islander    0 (0)   1 (5)    1 (3) 
English as a first language 26 (100) 23 (100)  49 (100) 
ASD Diagnosis    p = .630  
     Autism          20 (77) 15 (65)  35 (71) 
     Asperger’s        4 (15)   7 (30)  11 (22) 
     PDD-NOS        2 (8)    1 (4)    3 (6) 
Prior Treatment* 23 (89) 15 (65) p = .769 38 (78) 
Medication** 10 (39) 10 (44) p = .445 20 (41) 
Parents Marital Status   p = .255  
   Single   9 (35)   5 (19)  14 (29) 
   De-facto   1 (4)   0 (0)    1 (2) 
   Married 15 (58) 15 (65)  30 (61) 
   Remarried   1 (4)   2 (9)    3 (6) 
Mothers Occupation   p = .091  
   Professional 14 (56)   8 (35)  22 (45) 
   Unprofessional   6 (23)   5 (22)   11(22) 
   Unemployed   1 (20)   4 (80)    5 (10) 
Fathers Occupation   p = .286  
   Professional 12 (46) 11 (48)  23 (47) 
   Unprofessional   4 (15)   5 (22)    9 (18) 
   Unemployed   1 (4)   0 (0)    1 (2) 
Participating Parent   p = .400  
   Mother 24 (92) 19 (83)  43 (88) 
   Father                              2 (8)   4 (17)    6 (12) 
Note. a t-test rather than Fisher’s exact-sided tests were used to test for group differences in scale outcome variables. 
*Prior treatment included Occupational Therapy, Psychology, Speech Pathology, Applied Behaviour Analysis and/or 
a combination of these. 
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**Medication included stimulant (n = 9), anti-depressant (n = 2), antianxiety (n = 5), antipsychotic and other (e.g., 
epilepsy, sleep) (n = 4). 
 ***Sample size varies across variables due to missing data 
 
Table 5 displays baseline outcome measures for participants in the intervention 
and control conditions. An independent samples t-test found that participants in the 
CBT and WL conditions did not differ significantly on the outcome variable (ADIS-
P) for the number of anxiety disorder diagnoses for which they met criteria. Likewise, 
Fisher’s exact tests (2-sided) revealed no significant differences between participants 
in the CBT and WL groups for the type of primary anxiety disorder diagnosis, or for 
the type of behavioural and mood disorders comorbid to ASD. Therefore, baseline 
characteristics were excluded as covariates in the subsequent analyses. While not 
significant, the largest difference between the two conditions was observed in the 
number of participants that met the criteria for specific phobia, 16 in CBT condition 
compared to 8 in the WL condition, p = .088.  
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Table 5 
Baseline Psychological Disorders of Entire Sample Randomised to the CBT and WL 
Conditions based on Parent Response to ADIS-IV-C/P 
 Intervention 
(n = 26) 
 M      SD    Range    
Control 
(n = 23) 
M      SD    Range      
  
Two-sided t-test 
Entire sample 
(n = 49) 
M      SD    Range      
     
Mean Number of Anxiety 
Disorder Diagnoses  
2.73    1.1     1-5    2.48   1.3   1-5   p = .374  2.61   1.16   1-5   
   Fisher’s exact 
test 
 
 
 n (%)   n (%)  n (%) 
 
Primary Anxiety Disorder  
   
p = .449 
 
   SOCP   8 (32)   9 (39)  17 (35) 
   GAD   9 (36)   6 (32)  15 (31) 
   SP   8 (30)   4  (5)  12 (25) 
   OCD   1  (4)   3 (13)    4  (8) 
   PTSD   0 (0)   1 (5)    1 (2) 
Anxiety Disorders 
Comorbid to ASD 
    
      SOCP 23 (88) 17 (74) p = .273 40 (82) 
      GAD 18 (69) 15 (65) p = .502 33 (67) 
      SP 16 (62)   8 (35) p = .088 24 (50) 
      SAD   5 (19)   7 (30) p = .508 12 (25) 
      OCD   5 (19)   4 (17) p = 1.00   9 (18) 
      PD   1  (4)   0  (0) p = 1.00   1  (2) 
      AGOR   2  (7)   5 (22) p = .230   7 (14) 
      PTSD   1  (4)   1  (4) p = 1.00    2 (4) 
      SM   2  (8)   1  (4) p = 1.00    3 (6) 
      ENU   1  (4)   0  (0) p = 1.00    1 (2) 
      ST   1  (4)   0  (0) p = 1.00    1 (2) 
Behavioural; Disorders *     
   ADHD     
      Inattentive  8 (31) 10 (43) p = .390 18 (36) 
      Combined  7 (28)   2  (9) p = .145   9 (18) 
   CD  2  (8)   1  (4) p = 1.00   3  (6) 
   ODD  6 (23)   4 (17) p = .731 10 (20) 
Mood Disorders     
   MDD  4 (16)   0  (0) p = .112   4  (9) 
   Dysthymia  2  (8)   3 (13) p = .655   5 (10) 
Note.  
*SOCP social phobia, GAD generalized anxiety disorder, SP specific phobia, SAD separation anxiety disorder, OCD 
obsessive-compulsive disorder, OCD Obsessive Compulsive Disorder, PD panic disorder without agoraphobia, 
AGOR agoraphobia, PTSD post-traumatic stress disorder, SM selective mutism, ENU enuresis, ST sleep terror, 
ADHD attention deficit hyperactivity Disorder, CD Conduct Disorder, ODD oppositional defiant disorder, MDD major 
depressive disorder. 
All disorders are based on ADIS-C/P CSR of 4 or higher; no participants met criteria for ADHD hyperactive disorder. 
Percentages do not always add up to 100 percent due to some participants meeting the criteria for more than one 
disorder or not all participants having a particular disorder. 
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3.6.5 Concurrent psychiatric symptomology. Analysis of baseline 
psychological disorders did reveal the psychologically complex presentation of the 
participants, a notable characteristic found in previous studies targeting anxiety 
reduction in this population (e.g., Reaven, Blakely-Smith, Leuthe, et al., 2012; Wood 
et al., 2014). Across the entire sample, participants in this study met the criteria of a 
mean 2.61 anxiety disorder diagnoses co-occurring with their ASD (see Table 4). 
However, the number of overall comorbid psychiatric diagnoses (e.g., anxiety and 
other psychiatric conditions based on ADIS-P Clinical Severity Ratings) ranged from 
2 to 6 over and above their ASD diagnosis (M = 3.71, SD = 1.21). While there was an 
apparent difference between the number of comorbid psychiatric disorder diagnoses 
at pre-intervention, CBT (M = 4.00, SD = 1.17) and WL (M = 3.39, SD = 1.97) this 
difference between the two conditions was not significant, t(47) = 1.80, p =.078, partial 
η2 = 0.12.  
3.6.6 Descriptive Statistics. The descriptive statistics for the scale measures 
in the CBT and WL condition are displayed in Table 6. There was a significant 
difference between conditions for SCAS-P PD/AGOR subscale, t(44) = 2.30, p = .026,  
and the FQOL subscale emotional well-being, t(45) = 2.11, p = .040. There were no 
significant differences in pre-treatment scores between conditions for the remainder of 
the scale measures. 
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Table 6 
Means and (Standard Deviations) of Outcome Variables for the CBT Intervention 
Condition, Control Condition, and Entire Sample at Baseline 
Measure Intervention Control t(df) p Entire Sample 
 (n = 26) (n = 23)  
  
            
SCAS-C Total 29.36 (16.33) 29.00 (10.23) t(45) = 0.15 p = .883 29.68 (15.65) 
SCAS-C SAD   3.16 (3.25)   3.64 (3.17) t(45) = 0.72 p = .614   3.38 (3.29) 
SCAS-C SOCP   5.88 (3.36)   7.23 (4.52) t(45) = 1.16  p = .249   6.51 (3.96) 
SCAS-C OC   6.44 (3.61)   5.00 (3.40) t(45) = 1.40 p = .167   5.77 (3.55) 
SCAS-C PD/AGOR   4.68 (4.09)   4.14 (3.20) t(45) = 0.50 p = .618   4.43 (3.67) 
SCAS-C PIF   3.00 (3.09)   3.64 (2.06) t(45) = 0.82  p = .418   3.30 (2.65) 
SCAS-C GAD   6.20 (3.72)   6.14 (3.18) t(45) = 0.06  p = .950   6.17 (3.44) 
 
   
  
SCAS-P Total 34.92 (14.63) 29.00 (10.23) t(44) = 1.56  p = .126 32.22 (13.03) 
SCAS-P SAD   4.40 (3.07)   3.76 (2.41) t(44) = 0.77 p = .443   3.11 (2.77) 
SCAS-P SOCP   8.56 (5.25)   8.33 (4.02) t(44) = 0.16 p = .872   8.46 (4.68) 
SCAS-P OC   5.40 (3.34)   4.05 (3.37) t(44) = 1.36 p = .180   4.78 (3.39) 
SCAS-P PD/AGOR    5.72 (3.14)   3.62 (3.03) t(44) = 2.30  p =.026*   4.76 (3.23) 
SCAS-P PIF   4.92 (3.11)   4.52 (2.29) t(44) = 0.48  p = .631   4.74 (2.74) 
SCAS-P GAD   5.88 (2.44)   5.71 (2.33) t(44) = 0.23  p = .816   5.80 (2.36) 
 
   
  
SMFQ-C Total   5.65 (4.32)   8.00 (4.55)  t(42) = 1.75  p = .087   6.77 (4.54) 
SMFQ-P Total   7.96 (4.13)   8.55 (5.35) t(46) = 0.43  p = .672   7.56 (4.87) 
 
   
  
FQOL Total 88.69 (15.01) 95.57 (13.67) t(45) = 1.63 p = .111 91.77 (14.69) 
FQOL Family 21.42 (4.89) 23.19 (4.39) t(45) = 1.25  p = .216 22.19 (4.70) 
FQOL Parenting  21.12 (4.64) 22.57 (4.46) t(45) = 1.08 p = .282 21.77 (4.57) 
FQOL Emotional  11.27 (3.03) 13.33 (3.68) t(45) = 2.11  p = .040*   12.19 (3.46) 
FQOL Physical 20.88 (2.69) 21.48 (3.34) t(45) = 0.67 p = .504 21.15 (2.98) 
FQOL Disability  14.00 (3.46) 14.86 (2.22) t(45) = 0.98  p = .332 14.38 (2.98) 
 
   
  
SSIS-RS SS 77.96 (15.99) 76.36 (8.75) t(46) = 0.43  p = .678 77.23 (13.08) 
SSIS-RS CPB 127.54 (23.80) 120.55 (28.40) t(46) = 0.93  p = .358 124.33 (25.96) 
SSIS-RS Autism 22.73 (4.55) 22.73 (5.31) t(46) = 0.00  p = .998 22.73 (4.86) 
            
Note. Sample sizes varies across variables due to missing data. 
SCAS-C Total Spence children’s anxiety scale – child (total score), SCAS-C SAD Spence children’s anxiety scale (separation 
anxiety), SCAS-C SOCP Spence children’s anxiety scale (social phobia), SCAS-C OC Spence children’s anxiety scale (obsessive 
compulsive), SCAS-C PD/AGOR Spence children’s anxiety scale (panic/ agoraphobia, SCAS-C PIF Spence children’s anxiety 
scale (physical injury fears), SCAS-C GAD Spence children’s anxiety scale (generalised anxiety), SCAS-P Total Spence 
children’s anxiety scale – Parent (total score), SCAS-P SAD Spence children’s anxiety scale (Separation anxiety) SCAS-P SOCP 
Spence children’s anxiety scale (social phobia), SCAS-P OC Spence children’s anxiety scale (obsessive compulsive), SCAS-P 
PD/AGOR Spence children’s anxiety scale (panic/ agoraphobia, SCAS-P PIF Spence children’s anxiety scale (physical injury 
fears), SCAS-P GAD Spence children’s anxiety scale (generalised anxiety), SMFQ-C short mood and feelings questionnaire – 
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child, SMFQ-P short mood and feelings questionnaire – parent, FQOL Total Beach family quality of life scale (total score), FQOL 
Family Beach family quality of life scale (family interaction), FQOL Parenting Beach family quality of life scale (parenting) 
FQOL Emotional Beach family quality of life scale (emotional well-being), FQOL Physical Beach family quality of life scale 
(Physical/ Material Well-being), FQOL Disability Beach family quality of life scale (Disability-Related Support), SSIS SS The 
Social Skills Improvement System – Rating Scales (Parent) (Social Skills Standard Score), SSIS CPB The Social Skills 
Improvement System – Rating Scales (Parent) Competing Problem Behaviour Standard Score, SSIS Autism The Social Skills 
Improvement System – Rating Scales (Parent) Autism Raw Score. 
*p < .05. **p < .01. ***p < .001.  
 
3.6.7 Hypothesis testing. The tested hypotheses for study one are detailed 
below. Comparisons on the outcome variables between pre-intervention and post-
intervention for the CBT and WL groups are also presented below in Table 6. Initial 
findings pertain to the anxiety outcome measures (ADIS-P and SCAS-C/P). The total 
number of anxiety disorders is additionally examined. The hypotheses are arranged 
numerically and pertain to anxiety (H1a), depression (H1b), psychosocial functioning 
(H1c), family quality of life (H1d), and overall psychopathology (H1e). Whether post-
intervention observed changes are maintained at 6-month follow-up is then examined 
from H2a-e (CBT group only) with follow-up data for the CBT group displayed in 
Table 8. Secondary Hypotheses 3-5 make predictions regarding diagnostic status of 
primary anxiety disorders, reliable and clinically significant change and Clinical 
Global Impression-Improvement (CGI-Improvement; Guy, 1976). This is followed by 
the exploration of whether anxiety reduction intervention can assist in reducing 
depression and improving social functioning and family quality of life.
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3.6.8 Primary hypothesis testing. 
3.6.8.1 Hypothesis 1a: Anxiety. 
Table 7 
Adjusted Means and Standard Errors of Anxiety and ADIS-P Outcome Variables at Baseline and Post-test for the Intervention and Control 
Conditions 
  Condition Time  Condition*Time Partial Intervention Condition Control Condition 
 
Effect Effect Effect η2 Baseline Post- Simple main effects of time Cohen's Baseline Post-Waitlist Simple main effects of time Cohen's 
     M(SE) Treatment p-value d M(SE) M(SE) p-value d 
            M(SE)             
NOAD F(1,89) = 15.17 F(1,89) = 19.07 F(1,89) = 25.04 0.38 2.73 (0.06)
a 1.46 (0.17)b 7.32 2.93 2.52 (0.13)
a 2.54 (0.13)a 0.16 0.05 
 p < .001*** p < .001*** p < .001***    <.001****    0.907  
Anx CSRs F(1,89) = 0.25 F(1,89) = 35.81 F(1,89) = 25.42 0.22 16.92 (0.84)a 
8.18 
(1.49)b 9.39 3.76 
13.56 
(0.75)a 
13.13 
(1.26)a 0.34 0.14 
 p = .619 p = .001*** p = .001***    <.001***    0.738  
SOCP F(1, 89) = 0.20 F(1,89)  = 0.15 F(1,89) = 2.88 0.03 5.41 (0.33)a 4.26 (0.76)a 1.66 0.66 4.10 (0.67)
a 4.91 (0.49)a 0.75 0.32 
 p = .605 p= .696 p = .093    0.101    0.29  
GAD F(1,89) = 0.19 F(1,89) = 26.96 F(1,89) = 8.64 0.09 4.54 (0.70)a 1.28 (0.28)b 4.67 1.87 3.67 (0.42)
a 2.65 (0.48)b 2.69 1.15 
 p = .666 p < .001*** p < .004**    <.001***    .008**  
SP F(1,89) = 0.07 F(1,89) = 2.94 F(1,89) = 10.04 0.1 3.08 (0.25)a 1.42 (0.52)b 7.98 3.19 2.04 (0.54)
a 2.80 (0.89)a 0.82 0.35 
 p = .789 p = .090 p < .002**    <.001***    0.416  
SAD F(1,89) = 0.40 F(1,89) = 1.19 F(1,89) = 0.06 0 1.16 (0.43)a 0.63 (0.33)a 1.01 0.4 1.47 (0.47)
a 0.86 (0.60)a 0.69 0.29 
 p = .530 p = .280 p = .940    0.315    0.495  
OCD F(1,89) = 1.83 F(1,89) = 2.74 F(1,89) = 1.80 0.01 1.03 (0.51)a 0.05 (0.03)b 1.99 0.8 0.97 (0.31)
a 0.89 (0.19)a 0.2 0.08 
 p = .179 p = 2.74 p = .183    .049*    0.843  
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PD F(1,89) =1.40 F(1,89) = 1.40 F(1,89) = 1.40 0.01 0.19 (0.16)a 0.00 (0.00)a 1.18 0.47 0.00 (0.00)
a 0.00 (0.00)a 0 0 
 p = .239 p = .239 p = .239    0.239    0  
AGOR F(1,89) = 0.70 F(1,89) = 0.48 F(1,89) = 0.63 0.01 0.63 (0.56)a 1.17 (0.20)a 0.12 0.05 0.53 (0.46)
a 0.66 (0.35)b 2.36 1.01 
 p = .404 p = .492 p = .629    0.902    .021*  
PTSD F(1,89) = 2.08 F(1,89) = 0.07 F(1,89) = 0.27 0 0.20 (0.16)a 0.00 (0.00)a 1.18 0.47 0.30 (0.26)
a 0.37 (0.29)a 0.14 0.06 
 p = .150 p = .791 p = .604    0.239    0.89  
SM F(1,89) = .025 F(1,89) = 3.35 F(1,89) = 4.76 0.05 0.31 (0.15)a 0.01 (0.01)b 2.03 0.81 0.17 (0.15)
a 0.19 (.17)b 0.88 0.16 
 p = .875 p = .067 p  .032*    .045*    0.38  
ENU F(1,89) = .3.72 F(1,89) = 0.03 F(1,89) = .050 0 0.15 (0.13)a 0.20 (0.17)a 0.2 0.08 0.00 (.000)
a 0.01 (.007)a 1.167 0.49 
 p = .057 p = .866 p = .823    0.84    0.246  
ST F(1,89) = 1.39 F(1,89) = 1.40 F(1,89) = 1.40 0.02 0.19 (0.16)a 0.00 (0.00)a 1.18 0.47 0.00 (0.00)
a 0.00 (0.00)a 0.84 0.35 
 p = .240 p = .239 p = .239    0.239    0.402  
DYS F(1,89) = 0.58 F(1,89) = 15.79 F(1,89) = 0.58 0.01 0.50 (0.23)a 0.00 (0.00)b 2.15 0.86 0.74 (0.21)
a 0.00 (0.00)b 3.55 1.51 
 p = .445 p < .001* p = .445    .034*    <.001***  
MDD F(1,89) =0 .00 F(1,89) = 0.47 F(1,89) = 6.31 0.07 0.94 (0.53)a 0.23 (0.15)b 1.73 0.33 0.02 (0.02)
a 1.22 (0.64)b 1.9 0.81 
 p = .979 p = .493 p = .014*    0.088    0.061  
ADHD 
COM  F(1,89) = 0.86 F(1,89) = 0.05 F(1,89) = 0.07 0 1.89 (0.97)
a 1.41 (0.56)a 0.96 0.38 0.46 (0.29)
a 1.10 (0.65)a 1.7 0.41 
 p = .356 p = .826 p = 0.74    0.342    0.092  
ADHD F(1,89 )= 0.51 F(1,89) = 7.47 F(1,89) = 0.71 0.01 1.92(0.36)a 1.27 (0.68)a 1.66 0.66 2.71 (0.37)
a 1.45 (0.65)b 2.15 0.92 
INN p = .476 p = .008** p=.400    0.101    .035*  
ODD F(1,89) = 0.60 F(1,89) = 15.82 F(1,89) = 0.12 0.01 1.46 (0.54)a 0.62 (0.37)a 1.98 0.79 1.21 (.076)
a 0.21 (0.18)b 5.5 2.35 
 p = .44 p < .001*** p = .734    0.05    <.001***  
CD F(1,89)= 0.01 F(1,89)= 0.01 F(1,89)= 0.41 0 0.34 (0.29)
 
a 
0.16 
(0.14) a 0.5 0.2 
0.17 (0.15) 
a 0.31 (0.24)
a 0.4 0.29 
 p =.933 p = .923 p = .523    0.616    0.689  
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Note. Change in subscript denotes a significant change between baseline and post-treatment/post-waitlist. Partial η2 = partial eta squared; Sample sizes varies across variables due to missing data. ADIS-P Anxiety 
Disorder Interview Schedule – Parent Number of Anxiety Disorders (NOAD), ADIS-P Total Dx Anxiety Disorder Interview Schedule – Parent total psychiatric diagnoses, SOCP social phobia, GAD generalized 
anxiety disorder, SAD separation anxiety disorder, OCD obsessive-compulsive disorder, SP specific phobia, PD panic disorder with agoraphobia, AGOR agoraphobia, PTSD post-traumatic stress disorder, ADHD COM 
attention deficit hyperactivity disorder (combined), ADHD INN attention deficit hyperactivity disorder (inattentive), MDD major depressive disorder, ODD oppositional defiant disorder, SCAS-C Spence children’s 
anxiety scale – child (Total). 
Baseline and Posttest anxiety disorder is based on ADIS-C/P CSR of 4 or higher. 
*p < .05. **p < .01. ***p < .001. 
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The purpose of Hypothesis H1a was to determine if adolescents in the 
intervention group would show significantly greater pre-post reductions in levels of 
anxiety (as measured by the SCAS-C, SCAS-P, and ADIS-P) compared to the WL 
group. Independent t-tests revealed no significant difference between the CBT and WL 
groups in their number of pre-treatment anxiety diagnoses. However, a large 
significant Condition x Time interaction was found in the overall number of post-
treatment anxiety disorder diagnoses (see NOAD in Table 7 and Figure 6). Post-hoc 
least significant difference (LSD) contrasts conducted across the simple main effects 
for time indicated a large significant pre-post decrease for the intervention group, but 
no significant pre-post change for the control group.  
 
Figure 4. The change in the number of anxiety disorder clinical severity ratings  
across time and condition. 
 
Further analyses were conducted to ascertain whether significant decreases in 
severity occurred for overall anxiety and particular anxiety disorders using the Clinical 
Severity Ratings (CSR) values from pre-intervention to post-intervention on the 
ADIS-P. Table 7 shows that there was a significant Condition x Time interaction for 
CSR ratings across all anxiety disorders. LSD contrasts conducted across the simple 
main effects for time indicated a significant decrease from pre-post for the CBT 
condition, but not for the WL condition. Upon further examination, significant 
Condition x Time interactions for both specific phobia and generalised anxiety 
disorder CSRs were found. LSD contrasts conducted across the simple main effects 
for time indicated a significant pre-post decrease in CSRs for specific phobia in the 
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CBT group, but no significant pre-post change for the control group (see Table 7 and 
Figure 7). 
 
Figure 5. The change in Specific Phobia CSRs across time and condition 
 
In addition, LSD contrasts conducted across the simple main effects for time 
indicated that CSRs for GAD significantly decreased from pre-intervention to post-
intervention for both groups. However, the significant Condition x Time interaction 
for GAD indicates that the intervention group showed a greater pre-post reduction in 
CSRs compared to the control group (see Figure 9). 
 
 
Figure 6. The change in generalised anxiety disorder clinical severity ratings across 
time and condition. 
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Table 8 
Adjusted Means and Standard Errors of SCAS-C/P at Baseline and Post-test for the Intervention and Control Conditions 
  Condition Time  Condition*Time Partial Intervention Condition Control Condition 
 
Effect Effect Effect η2 Baseline Post- Simple main effects of time Cohen's Baseline Post-Waitlist Simple main effects of time Cohen's 
     M(SE) Treatment p-value d M(SE) M(SE) p-value d 
            M(SE)             
SCAS-
C 
F(1,84) = 
0.10 F(1,84) = 0.90 F(1,84) = 0.98 0.01 
29.63 (4.86) 
a 
27.20 (3.80) 
a 1.05 0.58 29.78 (1.44)
 a 29.85 (0.74) a 0.08 0.45 
 p = .753 p = .346 p = .324    0.296    0.076  
SCAS-
P 
F(1,81) = 
0.04 
F(1,81) = 
24.62 F(1,81) = 46.98 0.36 
34.95 (2.44) 
a 
24.64 (1.54) 
b 11.27 4.51 28.58 (1.66)
 a 29.92 (2.06) a 0.89 0.38 
 p = .840 p < .001*** p < .001***    <.001***    0.375  
                          
Note. Change in subscript denotes a significant change between baseline and post-treatment/post-waitlist. Partial η2 = partial eta squared; Sample sizes varies across variables due to missing data.  
SCAS-P = Spence children’s anxiety scale – parent, SCAS-C = Spence children’s anxiety scale – child. *p < .05. **p < .01. ***p < .001. 
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Any changes in adolescent anxiety were additionally measured with the SCAS-
C/P Total Scores (see Table 8 and Figure 9). There was a large significant Condition 
x Time interaction on the parent-reported anxiety symptomology at post-treatment (see 
Figure 8). Post-hoc LSD contrasts indicated that parents in the CBT group reported a 
significant pre-post decrease in anxiety symptomology however, no significant change 
was reported by parents in the WL group. In addition, for adolescent-rated 
symptomology (SCAS-C Total Score), there was no significant Condition x Time 
interaction, no significant main effect for condition, and no significant main effect for 
time.  
 
Figure 7. The change in parent reported anxiety (SCAS-P) across time and condition 
 
Given the significant findings in the SCAS-P, the subscales of this measure 
were investigated with Table 9 demonstrating medium and large significant Condition 
x Time interactions for all of the SCAS-P subscales except for the Obsessive- 
Compulsive subscale (there was however a small significant main effect for time on 
this subscale). Post-hoc LSD contrasts demonstrated significant reductions in anxiety 
on each of the subscales for the CBT group. The only significant change across time 
for the WL group was on the social phobia subscale where anxiety showed an increase 
between pre-and post-test. 
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Table 9 
Adjusted Means and Standard Errors of SCAS-Parent Subscale Outcomes at Baseline and Post-treatment/Post-waitlist for the Intervention and 
Control Conditions 
 Condition Time  Condition*Time Partial Intervention Condition Control Condition 
 
Effect Effect Effect η2 Baseline Post- t/ Cohen's Baseline Post-Waitlist t/ Cohen's 
     
M(SE) Treatment p-value d M(SE) M(SE) 
p-
value 
d 
            M(SE)             
SEPANX F(1,81) = 1.11 F(1,81) = 7.58 F(1,81) = 7.58 0.09 4.39 (0.64)a 3.69  (064)b 10.30 4.12 
3.67 
(0.64)a 
2.94 (0.32)a 1.42 .61 
 p < .296 p < .296 p < .007**    <.001***    .161  
SOCP F(1,81) = 1.82 F(1,81) = 9.63 F(1,81) = 63.42 0.44 6.68 (0.28)a 6.33 (0.52)b 5.89 3.76 
7.99 
(0.61)a 
8.60 (0.55)b 2.28 .97 
 p = .181 p < .003** p < .001***    <.001***    <.025*  
OC F(1,81)= 0.41 
F(1,81) = 
9.17 
F(1,81) = 3.52 0.04 5.44 (0.39)a 3.36 (0.35)b 8.43 3.37 
4.22 
(0.74)a 
3.73 (0.64)a 0.60 .26 
 p = .525 p < .003** p = .064    <.001***    .548  
PD/AGOR 
F(1, 81) = 
0.49 
F(1,81)  = 
3.64 
F(1,81) = 14.78 0.15 5.74 (0.84)a 3.29 (0.53)b 5.68 2.27 
3.52 
(0.58)a 
4.35 (0.60)a 1.14 .48 
 p = .487 p= .060 p < .001***    <.001***    .260  
PIF 
F(1, 81) = 
0.02 
F(1,81)  = 
20.22 
F(1,81) = 8.86 0.10 4.87 (0.74)a 3.83 (0.54)b 4.46 1.78 
4.56 
(0.57)a 
4.37 (0.43)a 1.28 .55 
 p = .882 p < .00*** p < .004**    <.001***    .203  
GAD 
F(1, 81) = 
0.49 
F(1,81)  = 
3.64 
F(1,81) = 14.78 0.15 5.74 (0.84)a 3.29 (0.53)b 5.68 2.27 
3.52 
(0.58)a 
4.35 (0.60)a 1.14 .48 
 p = .487 p= .060 p < .001***    <.001***    .260  
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Note. Change in subscript denotes a significant change between baseline and post-treatment/post-waitlist. Partial η2 = partial eta squared; Sample 
sizes varies across variables due to missing data. SEPANX = Spence Children’s Anxiety Scale (Separation Anxiety), SOCP = Spence Children’s 
Anxiety Scale (social phobia), OC = Spence Children’s Anxiety Scale (obsessive compulsive), PD/AGOR = Spence Children’s Anxiety Scale 
(panic/ agoraphobia, PIF = Spence Children’s Anxiety Scale (physical injury fears), GAD = Spence Children’s Anxiety Scale (Generalised 
Anxiety).  
*p < .05. **p < .01. *** p< .001
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3.6.8.2 Remission of primary anxiety disorder. Hypothesis 3 predicted that a 
significantly higher proportion of individuals in the intervention group would 
demonstrate pre-post remission from their primary anxiety disorder (i.e., would no 
longer meet their pre-treatment primary diagnosis at post-treatment) compared to 
adolescents in the waitlist group. 
As displayed in Table 10, at post-treatment, there was a significant between-
group difference in the number of adolescents who no longer met DSM-IV criteria for 
a current primary anxiety disorder, χ2 (1, N = 44) = 5.44, p = .020.  Using ADIS-P 
primary anxiety diagnoses CSRs at post-treatment as the recovery criterion, 72% (18 
of 25) of adolescents in the CBT condition no longer met criteria for their primary 
anxiety diagnosis at post-treatment compared to 31.6% (6 of 19) of those in the WL 
condition. 
 
Table 10 
Number (%) of Participants with a Primary Anxiety Disorder at Pre-treatment/ Post-
Intervention Who Demonstrated Remission from the Disorder at Post-Treatment/ 
Post-Intervention 
      Condition Type   
      Treatment Waitlist Total 
Remission No remission Count 7 13 20 
  % within Remission 35.0% 65.0% 100.0% 
  % within Condition type 28.0% 68.4% 45.5% 
  % of Total 15.9% 29.5% 45.5% 
 Remission Count 18 6 24 
  % within Remission 75.0% 25.0% 100.0% 
  % within Condition type 72.0% 31.6% 54.5% 
  % of Total 40.9% 13.6% 54.5% 
Total   Count 25 19 44 
  % within Remission 56.8% 43.2% 100.0% 
  % within Condition type 100.0% 100.0% 100.0% 
    % of Total 56.8% 43.2% 100.0% 
Note. Only participants with completed ADIS-P post-test outcome measures were 
included in this analysis. 
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3.6.8.3 Hypothesis 1b: Depression 
Table 11 
Adjusted Means and Standard Errors of Outcome Variables at Baseline and Post-test for the Intervention and Control Conditions 
  Condition Time  Condition*Time Partial Intervention Condition Control Condition 
 
Effect Effect Effect η2 Baseline Post- Simple main effects of time Cohen's Baseline Post-Waitlist Simple main effects of time Cohen's 
     M(SE) Treatment p-value d M(SE) M(SE) p-value d 
            M(SE)             
SMFQ 
C 
F(1,79) = 
0.12 F(1,79) = 0.20 F(1,79) = 4.90 0.06 
5.83 
(0.64) a 
8.10 
(1.26) a 1.39 0.56 
7.94 
(0.49) a 
6.48 (0.61) 
b 2.28 0.97 
 p = .729 p = .655 p = .030*    0.167    .025*  
SMFQ 
P 
F(1,83) = 
2.67 
F(1,83) = 
47.55 F(1,83) = 4.34 0.05 
7.96 
(0.80) a 
5.14 
(0.39) b 6.66 2.66 
8.36 
(0.67) a 
6.94 (0.48) 
b 2.92 1.25 
  p = .106 p = .001*** p = .040*                   
Note. Change in subscript denotes a significant change between baseline and post-treatment/post-waitlist. Partial η2 = partial eta squared; Sample 
sizes varies across variables due to missing data. SMFQ-P = short mood and feelings questionnaire – parent (Total).  
*p < .05. **p < .01. ***p < .001. 
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Hypothesis 1b involved the prediction that adolescents in the intervention 
group would show significantly greater pre-post reductions in levels of depression (as 
measured by the SMFQ-C, SMFQ-P) compared to the control group. There was a 
moderate significant Condition x Time interaction for adolescent-reported depression 
symptomology as assessed by the SMFQ-C (see Table 11). Post-hoc LSD contrasts 
revealed that while there was no significant pre-post difference for the adolescent self-
reports in the CBT group, there was a significant pre-post decrease in depression 
scores for the waitlist group adolescents (see Figure 10) 
 
Figure 8. The change in self-reported depression symptomology across time and 
condition. 
 
In addition, the parent-reported adolescent depression symptomology assessed 
by the SMFQ-P showed a small significant Condition x Time interaction. As shown 
in Figure 11, post-hoc LSD contrasts conducted across the simple main effects for time 
indicated that there was a significant pre-post decrease in parent-reported adolescent 
depression symptomology for both the CBT and the WL groups.  
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Figure 9. The change in parent-reported Depression symptomology across time and 
condition
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3.6.8.4 Hypothesis 1c: Psychosocial functioning. 
Table 12 
Adjusted Means and Standard Errors of Psychosocial Functioning at Baseline and Post-treatment for the Intervention and Control Conditions 
  Condition Time  Condition*Time Partial Intervention Condition Control Condition 
 
Effect Effect Effect η2 Baseline Post- Simple main effects of time Cohen's Baseline Post-Waitlist Simple main effects of time Cohen's 
     M(SE) Treatment p-value d M(SE) M(SE) p-value d 
            M(SE)             
SSIS SS F(1,84) = 0.13 
F(1,84) = 
3.58 F(1,84) = 0.09 0 77.96 (1.33)
 a 83.59 (1.74) b 2.69 1.08 75.39 (2.82) a 82.63 (7.93) b 1.27 0.54 
 p = .724 p = .062 p = .758    .009**    0.206  
SSIS 
CPB 
F(1,84) = 
0.00 
F(1,84) = 
0.47 F(1,84) = 1.96 0.02 
127.76 (1.91) 
a 
117.04 (5.48) 
a 1.66 0.66 
120.09 (5.48) 
a 
123.99 (2.81) 
a 0.5 0.21 
 p = .953 p = .493 p = .165    0.101    0.622  
SSIS 
Aut 
F(1,84) = 
1.74 
F(1,84) = 
5.43 F(1,84) = 2.66 0.03 22.73 (0.65)
 a 20.09 (1.08) b 2.35 0.94 23.09 (1.08) a 22.58 (0.71) a 0.78 0.33 
 p = .191 p = .022* p = .106    .021*    0.439  
                          
Note. Change in subscript denotes a significant change between baseline and post-treatment/post-waitlist. Partial η2 = partial eta squared; Sample sizes varies across variables due to missing data. SSIS Autism Raw 
Score, SSIS SS = The Social Skills Improvement System – Rating Scales (Parent) (Social Skills Standard Score), SSIS CPB = The Social Skills Improvement System – Rating Scales (Parent) Competing Problem 
Behaviour Standard Score, SSIS Aut The Social Skills Improvement System – Rating Scales (Parent) Autism Raw Score, SMFQ-C = Short Mood and Feelings Questionnaire – child (Total).  
*p < .05. **p < .01. ***p < .001. 
 
Hypothesis 1c involved the prediction that adolescents in the intervention group will show significantly greater pre-post increases in levels 
of psychosocial functioning (as measured by the SSIS-P), compared to adolescents in the waitlist group. As reported in Table 12, there was no 
significant Condition x Time interaction for parent-reported social skills as assessed by the SSIS-RS. There was also no significant main effect for 
condition or for time.  There was no significant Condition x Time interaction for the subscale, SSIS-RS Competing Problem behaviours, no 
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significant main effect for condition, and no significant main effect for time. While there was no significant Condition x Time interaction for the 
SSIS-RS Autism Behaviour raw score and no significant main effect for condition, there was a significant main effect for time, indicating that both 
groups showed a significant pre-post decrease in autism behaviours.  
3.6.8.5 Hypothesis 1d: Family quality of life.  
Table 13 
Adjusted Means and Standard Errors of Family Quality of Life at Baseline and Post-test for the Intervention and Control Conditions 
  Condition Time  Condition*Time Partial Intervention Condition Control Condition 
 
Effect Effect Effect η2 Baseline Post- Simple main effects of time Cohen's Baseline Post-Waitlist Simple main effects of time Cohen's 
     M(SE) Treatment p-value d M(SE) M(SE) p-value d 
            M(SE)             
FQOL F(1,83) = 0.55 
F(1,83) = 
0.22 F(1,83) = 7.11 0.08 
88.69 (1.43) 
a 
93.87 (2.49) 
b 2.37 0.95 
95.69 
(2.00) a 
92.07 
(4.13) a 1.44 0.61 
 p = .461 p = .644 p = .009**    .020*    0.153  
                          
Note. Change in subscript denotes a significant change between baseline and post-treatment/post-waitlist. Partial η2 = partial eta squared; Sample sizes varies across variables due to missing data.  
FQOL Beach family quality of life scale (Total).  
*p < .05. **p < .01. ***p < .001. 
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Hypothesis 1d predicts that parents in the intervention group will report 
significantly greater pre-post increases in family quality of life (as measured by the 
FQOL) compared to parents in the waitlist group. Table 13 shows a moderate 
significant Condition x Time interaction was found for parent-reported family quality 
of life. Post-hoc LSD contrasts indicated that treatment group parents reported a 
significant pre-post increase in family quality of life. The waitlist parents did not report 
a significant pre-post change in family quality of life (see Figure 12 below).  
 
Figure 10. The change in Family Quality of Life across time and condition  
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3.6.8.6 Hypothesis 1e: Total comorbid diagnoses. 
Table 14 
Adjusted Means and Standard Errors for the total number of comorbid diagnoses (All ADIS) at Baseline and Post-test for the Intervention and 
Control Conditions 
  Condition Time  Condition*Time Partial Intervention Condition Control Condition 
 
Effect Effect Effect η2 Baseline Post- Simple main effects of time Cohen's Baseline Post-Waitlist Simple main effects of time Cohen's 
     M(SE) Treatment p-value d M(SE) M(SE) p-value d 
            M(SE)             
All 
ADIS 
F(1,89 )= 0 
.01 F(1,89) = 12.15 F(1,89) = 3.18 0.12 
3.99 
(0.26)a 
2.37 
(0.45)b 3.43 1.37 
3.29 
(0.15)a 2.98 (0.46)
a 0.72 0.31 
 p = .922 p = .001*** p = .078    <.001***    0.476  
                          
Note. Change in subscript denotes a significant change between baseline and post-treatment/post-waitlist. Partial η2 = partial eta squared; Sample 
sizes varies across variables due to missing data. *p < .05. **p < .01. ***p < .001. 
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Hypothesis 1e involved the prediction that adolescents in the intervention 
group would show significantly greater pre-post reductions in the overall number of 
comorbid disorder diagnoses (as measured by the ADIS-P) compared to adolescents 
in the waitlist group. Changes in the total number of comorbid diagnoses (e.g., anxiety 
and other psychiatric conditions based on ADIS-P CSRs), was assessed with no 
significant Condition x Time interaction occurring (see Table 14). The main effect for 
condition was non-significant. However, the main effect for time was significant 
indicating that both groups showed a similar decrease in terms of their total number of 
comorbid diagnoses from pre-post.  
3.6.8.7 Potential predictors of the intervention effect. Age and Gender were 
tested as potential predictors of the effect of the intervention on the Number of Anxiety 
Disorders (NOAD). The 3-way Age x Time x Condition interaction was not 
significant, F (1, 85) = 2.71, p = .103, indicating that age did not  predict the 
intervention effect. Similarly, the 3-way Gender x Time x Condition was not 
significant, F (1, 85) = 3.82, p = .054, indicating that gender did not  predict the 
intervention effect.  
Age and Gender were tested as predictors of the effect of the intervention on 
the SCAS-P. The 3-way Age x Time x Condition interaction was not significant, F (1, 
74) = 1.44, p = .235, indicating that age did not predict the intervention effect. 
Similarly, the 3-way Gender x Time x Condition was not significant, F (1, 73) = 0.00, 
p = .997, indicating that gender did not  predict the intervention effect.  
3.6.8.8 Possible mediators of the intervention effect. A number of correlations 
were conducted to determine whether a decrease in anxiety results in a reduction of 
depressive symptomology (SMFQ-C/P), an improvement in social ability (SSIS-SS) 
and/or an increase in family quality of life (FQOL). Mediator links did not exist 
between Number of Anxiety Disorders (NOAD) and Primary Anxiety and these 
measures from pre-post-test and therefore a Path Analysis was not conducted (see 
Table 15 below).  
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Table 15 
Correlations between anxiety reduction and depressive symptomology, social ability, and family quality of life 
  SMFQ_Child_Total SMFQ_Parent_Total SSIS_SS FQOL_Total 
NOAD Pearson Correlation -.165 .130 -.006 .059 
Sig. (2-tailed) .316 .432 .969 .716 
N 39 39 40 40 
PrimaryAnxiety Pearson Correlation -.390 -.101 -.014 -.023 
Sig. (2-tailed) .110 .689 .956 .928 
N 18 18 18 18 
Note: NOAD - Number of Anxiety Disorders (ADIS-P), Primary Anxiety - Primary Anxiety Disorder,  
SMFQ – Short Mood and Feelings (Child/ Parent), 
SSIS -SS – The Social Skills Improvement System – Rating Scales (Parent) (Social Skills Standard Score),  
FQOL Beach family quality of life scale (Total).  
*p < .05. **p < .01. ***p < .001.  
Baseline and Post-test anxiety disorder is based on ADIS-C/P CSR of 4 or higher. 
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3.6.9 Maintenance of changes at six-month follow-up. 
Table 16 
Size and Significance of Change between Pre-treatment, Post-Treatment and Follow-Up for the Intervention Condition 
  Time 1 Time 2 Time 3 Time 1 - Time 2   
Time 1 - Time 
3   
Time 2- Time 
3   Main   
 
M(SE) M(SE) M(SE) t(df) Cohen's d t(df) 
Cohen's 
d t(df) 
Cohen's 
d effect of time Eta
2 
NOAD 2.73(0.06) 1.45(0.19) 1.17(0.25) 6.98(72)*** 1.95 6.60(72)*** 1.68 0.93(72) 0.26 F(2,72)=47.34*** 0.4 
AnxCSRs 2.12 (0.17) 1.02 (0.22) 0.83 (0.18) 5.03 (72)*** 1.41 7.40 (72)*** 2.07 0.90 (72) 0.25 F(2,72)=30.08*** 0.46 
GAD 4.55(0.69) 1.29(0.28) 0.73(0.37) 4.73(72)*** 1.33 5.66(72)*** 1.59 1.04(72) 0.29 F(2,72)=16.67*** 0.19 
SP 3.83(0.25) 1.37(0.48) 2.73 (0.76) 9.69(72)*** 2.71 2.13(72)* 0.60 3.88(72)*** 1.09 F(2,72)=88.86*** 0.55 
SCAS-P 34.96(2.44) 24.71(1.48) 27.73(3.91) 10.44(63)*** 2.92 4.60(63)*** 1.28 1.20(63) 0.34 F(2,63)=11.12*** 0.13 
SMFQ P 7.97(0.80) 5.19(0.42) 5.97(0.87) 6.87(62)*** 1.92 0.29(62)*** 0.08 1.40(62) 0.39 F(2,62)=68.45*** 0.52 
FQOL 88.7(2.99) 94.05(3.01) 94.28(3.34) 0.02(640* 0.01 0.04(64)* 0.01 0.93(64) 0.26 F(2,64)=3.47* 0.05 
                        
Note. NOAD = Number of Anxiety Disorders, AnxCSRs = Anxiety Disorder Interview Schedule – Parent (CSRs for all anxiety diagnoses), All 
CSRs = Anxiety Disorder Interview Schedule – Parent (all psychiatric diagnoses CSRs), GAD = generalized anxiety disorder, SP = specific phobia, 
SCAS-P = Spence children’s anxiety scale – parent (Total Score), SSIS = SSIS Autism Raw Score, SSIS Social Skills Standard Score, SMFQ-P 
short mood and feelings questionnaire – parent (Total Score), FQOL Beach family quality of life scale  
• NOAD, AnxCSRs, All CSRs, GAD and SP are based on ADIS-C/P CSR of 4 or above 
• *p<.05. **p<.01. ***p<.001. 
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3.6.9.1 Hypothesis 2a: Anxiety. Hypothesis 2a involved the prediction that the 
significant pre-post reduction in levels of anxiety (as measured by the SCAS-C, SCAS-
P, and ADIS-P) observed in the intervention group would be maintained or enhanced 
at the 6-month follow-up. Table 16 displays the within-group changes on the primary 
and secondary outcome measures that showed significant pre-post change for the 
intervention group. The aim of the first follow-up analyses was to determine whether 
maintenance of treatment gains, for the CBT group only, occurred at 6-months follow-
up. For the Number of Anxiety Disorders, a significant main effect of time was found 
and a significant pre-treatment to 6-month follow-up reduction was found but no 
significant post-intervention to 6-month follow-up change (see Figure 13). 
 
Figure 11. Changes in the number of anxiety disorder diagnoses from pre-post-
follow-up for the Intervention group. 
 
Using ADIS-P primary anxiety diagnoses CSRs at post-treatment as the 
recovery criterion, treatment gains were maintained at follow-up (see Table 15). At 6-
month follow-up, 79.2% of CBT adolescents demonstrated remission of their baseline 
primary anxiety disorder diagnosis. That is, at 6-month follow-up, 19 adolescents in 
the CBT group no longer met criteria for their primary anxiety disorder.  
 
 
Table 17 
Percentage of Participants without a Current Primary Anxiety Disorders at Pre-
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treatment (n = 26) Post-treatment (n = 25) and Follow-up ( n= 24) for the CBT 
Condition 
    Time 
  Pre-  Post- 6 Month 
    Treatment Treatment Follow-up 
Primary SOCP 8 (0%) 6 (24%) 2 (8.3%) 
Anxiety GAD 9 (0%) 1 (4%) 1 (4.2%) 
 SP 8 (0%) 0 (0%) 2 (8.3%) 
 OCD 1 (0%) 0 (0%) 0 (0%) 
Total   26 (0%) 7 (28%) 5 (20.8%) 
Count % within remission 0 (0%) 18 (72%) 19 (79.2%) 
Note. ADIS-P Anxiety Disorder Interview Schedule – SOCP social anxiety disorder, 
GAD, generalised anxiety disorder, SP specific phobia, OCD obsessive compulsive 
disorder. Baseline, Posttest and Follow-up anxiety disorders are based on ADIS-C/P 
CSR of 4 or higher. 
 
The significant decreases in severity using the Clinical Severity Ratings (CSR) 
values from baseline to follow-up across all ADIS-P anxiety disorders, were 
maintained at follow-up as shown in Table 16 (AnxCSRs). There was no significant 
post- to 6-month change indicating maintenance of the post-test effect.  
In regard to CSR values for individual anxiety disorders, there was a significant 
main effect of time for GAD in the CBT intervention group, with post-hoc LSD 
contrasts revealing a significant pre- to 6-month decrease in generalised anxiety 
disorder symptomology (see Table 16 and Figure 14). There was no significant post-
to 6-month change. 
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Figure 12. The change in symptoms of GAD across time for the intervention group. 
 
For Specific Phobia (as seen in Table 16 and Figure 15), there was a significant 
main effect of time. Post-hoc LSD contrasts indicated that, for the CBT intervention 
group, there was a significant pre- to 6-month follow-up decrease. There was also a 
significant post- to 6-month follow-up increase. This suggests that while participants 
significantly reduced in specific phobia from pre- to posttreatment and from pre- to 
follow-up, specific phobia symptomology had significantly increased by follow-up. 
 
Figure 13. The change in symptoms of specific phobia across time for the 
intervention group. 
As observed in Table 16 there was a significant main effect of time for the 
SCAS-Parent (Total Score). There was no significant post-treatment to 6-month 
change in anxiety as assessed by the SCAS-P. That is, parent-rated treatment gains for 
anxiety reduction were maintained at 6-month follow-up (see Figure 16 below).  
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Figure 14. The change in parent-reported symptoms of adolescent anxiety across 
time for the intervention group. 
3.6.9.2 Hypothesis 2b: Depression. Hypothesis 2b involved the prediction that  
the significant pre- to post- reduction in levels of depression (as measured by the 
SMFQ-P) that were observed in the intervention group would be  maintained or 
enhanced at the 6-month follow-up.  
For the SMFQ Parent measure, there was a significant main effect of time 
(see Table 16 above and Figure 17 below). There was a significant pre-to-6-month 
decrease in symptoms of depression. That is, parents reported significantly less 
depression symptomology for the adolescents in the CBT group. There was no 
significant post-6-month change. 
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Figure 15. The change in symptoms of depression across time for the intervention 
group. 
3.6.9.3 Hypothesis 2d: Family quality of life. Hypothesis 2d involved the 
prediction that the significant pre-post improvement in levels of family quality of life 
(as measured by the FQOL) that was observed in the intervention condition was 
maintained or enhanced at the 6-month follow-up.  
In assessing Family Quality of Life (Beach Center Family Quality of Life 
Scale), there was a significant main effect of time for the CBT intervention group (see 
Table 16 and Figure 18). There was a significant pre- to 6-month increase in parent-
reported family quality of life over time. Once again, there was no significant post- to 
6-month change. 
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Figure 16. The change in Family Quality of Life (FQOL) across time for the 
intervention group
 
3.6.9.4 Hypothesis 4: Reliable change. Hypothesis 4 involved the prediction that a 
significantly higher proportion of adolescents in the intervention condition would show a pre- 
to post reliable reduction in anxiety. Reliable change scores were computed for both the SCAS 
Child and Parent measures to ascertain both reliable change and clinically significant change 
in anxiety symptomology. Using these indexes as a basis, adolescents were grouped into those 
whose symptoms had worsened (Deterioration), those who had failed to evidence change (No 
Change), those whose symptoms had improved (Improvement) and those that had 
demonstrated recovery from anxiety symptomology (Clinically Significant Change and 
Reliable Change). If the latter, a participant’s pre-intervention score sat above the clinical cut-
off and a post-intervention score sat below the cut-off. Table 10 displays the number and 
percentage of individuals from the CBT and WL condition who experienced reliable change 
on outcome variables. Due to missing data only participants who had completed pre- and post- 
measures were included. Criterion C (see Data Analysis section) was used as the cut off score. 
Fisher’s exact 1-sided tests indicated that a significantly greater proportion of participants in 
the CBT group demonstrated reliable change in the total scores on the SCAS-P compared to 
WL control participants, (p = .041).  There were no significant differences in the proportion of 
cases demonstrating pre- to post- reliable change across the CBT and WL groups for the SCAS-
C (p = .584). Table 18 additionally includes change for CBT participants from pre-follow-up. 
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Table 18 
Proportions of Reliably and Clinically Improved Families for each Outcome Measure for the 
Intervention and Waitlist Groups 
    T1 - T2 T2 - T3 T1 - T3 
    Intervention Waitlist Intervention Intervention 
SCAS-P 
Total Score Deterioration 1 (4%) 3 (19%) 1 (5.5%) 0 (0) 
 
 
No Change 10 (38%) 8 (50%) 12 (71%) 12 (64%) 
 
 
Improvement 12 (46%) 4 (25%) 3 (18%) 4 (21%) 
 
 
Clinically 
Significant 
Change 3 (12%) 1 (6%) 1 (5.5%) 3 (15%) 
    
    
 
SCAS-C 
Total Score Deterioration 4 (15%) 2 (11%) 0 (0) 0 (0) 
 
 
No Change 15 (58%) 15 (83%) 11 (57%) 10 (56%) 
 
 
Improvement 
 
6 (23%) 1 (6%) 5 (26%) 5 (27%) 
 
Clinically 
Significant 
Change 1 (4%) 0 (0) 3 (17%) 3 (17%) 
  
 
  
   
Note. Sample sizes varies across variables due to missing data 
SCAS-P = Spence Children’s Anxiety Scale – Parent, SCAS-C Spence Children’s Anxiety 
Scale – Child 
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3.6.9.5 Hypothesis 5:  CGI-I improvement ratings. Hypothesis 5 involved the 
prediction that adolescents in the intervention group would show a significant 
reduction in anxiety severity from pre-intervention to 6-month follow-up (as measured 
by CGI-I Improvement Scores). 
Independent clinical evaluators compared each participant’s overall condition 
at post-intervention to their pre-intervention assessment. The query they responded to 
was:  
“Compared to the patient's condition at admission to the project… this 
patient's condition (since pre-test) is: 1 = very much improved; 2 = much 
improved; 3 = minimally improved; 4 = no change from baseline; 5 = 
minimally worse; 6 = much worse; 7 = very much worse since the initiation 
of treatment” (Busner & Targum, 2007, p. 30-31). 
A clinical improvement in anxiety severity was reflected in scores of 1 and 2 
based on the independent clinical evaluator assessment at post-test (see figure 4 in 
Measures Section). These were derived from the presence and frequency of relevant 
symptoms over the study period, how severe or intense the symptoms were, and the 
manner in which the symptoms are impacting on daily functioning in the main areas 
of the adolescent’s life, such as relationships, school, home, and work (Busner & 
Targum, 2007). 
Due to participant attrition only participants that had completed pre- and post-
intervention measures were included and given CGI-I ratings. It was preferable for the 
same independent clinical evaluator completed the pre- and post-intervention ADIS-P 
interview in order to glean an overall clinical picture of the participant. For the CBT 
group, 20 of 25 adolescents (60%) were rated as positive treatment responders 
compared to 3 of 19 (11%) adolescents in the WL group (χ2 [1, N = 44] = 17.84, p < 
.001). At follow-up, 21 of the 24 CBT group adolescents reflected scores of 1, 2 or 3, 
indicating that 75% of participants had very much improved (recovered), much 
improved, or minimally improved in their overall psychiatric well-being over time (see 
Table 19).    
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Table 19 
Treatment Response Demonstrating Clinical Improvement in Anxiety Across Time 
 
    
Very 
Much  Much Minimally No Minimally Much 
Very 
much 
worse   
Condition   Improved Improved Improved Change Worse Worse  Total 
Post-test CBT 8 (32%) 7 (28%) 5 (20%) 5 (20%) 0 (0) 0 (0) 0 (0) 25 
 
WL 0 (0) 2 (11%) 1 (5%) 9 (47%) 6 (32%) 1 (5%) 0 (0) 19 
Follow-
up CBT 10 (42%) 8 (33%) 3 (12.5%) 3 (12.5%) 0 (0%) 0 (0%) 
 
0 (0) 24 
Note. CBT – Cognitive behavioural therapy treatment group, WL – Waitlist group. Based on parent-reported  
assessments at Baseline, Posttest and Follow-up on ADIS-C/P CSR of 4 or higher. 
*one lost at follow-up. 
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3.6.9.6 Parent-child reports. Due to low agreement between parent and child 
reports in previous ASD studies (e.g., Blakely-Smith et al., 2012; Mazefsky et al., 
2011), intra-class correlation between child and parent reports were conducted. The 
SCAS at pre-intervention was .70 (p < .001) indicating a moderate to strong 
relationship between the two reports (Portney & Watkins, 2008). The intra-class 
correlation between child and parent reports on the SMFQ at pre-test was .57 (p < 
.001) which indicates a moderate relationship between the two reports. 
3.6.9.7 Results summary. In summary, there were four main findings. First, 
the results indicate that adolescent anxiety reduced significantly across time for the 
CBT condition but not for the WL condition. This was determined by parent and 
adolescent reports, diagnostic status and clinical independent evaluators. Second, 
parent-reported depression symptomology reduced for both groups over time, however 
there was only a decrease in adolescent self-reports of depression symptomology for 
the WL group. Third, there were no changes in competing problem behaviours, social 
skills, or autism behaviours for adolescents, as assessed by the SSIS-RS parent-reports. 
Fourth, there was a significant increase in parent-reported family quality of life for the 
CBT group over time but not for the WL group. In addition, for the CBT group, 
treatment gains were maintained at the 6-month follow-up. 
3.7 Discussion 
3.7.1 The effect of group CBT on anxiety. Similar to previous research with 
an ASD population (i.e., McConachie et al., 2014), the most frequently occurring 
anxiety disorder diagnoses at baseline in the current study were social phobia (40, 82% 
of entire sample), generalised anxiety disorder (33, 67%) and specific phobia (24, 
50%). These findings are not dissimilar to research involving typically developing 
youth which suggests that social phobia shows an abrupt incline in adolescence 
(Beesdo-Baum & Knappe, 2012) and GAD a high onset period during later 
adolescence and early adulthood. In the current study, social phobia, GAD, and 
specific phobia were also the most frequent primary anxiety disorders. This fits with 
researchers finding that adolescents with ASD tend to engage in more avoidant 
behaviours and demonstrate increased social anxiety with age compared to typically 
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developing peers where avoidant behaviours are seen to decrease (Kuusikko and 
colleagues, 2008). 
In addition to previous research demonstrating that CBT can reduce anxiety in 
children with ASD (e.g., Chalfant et al., 2007; Reaven, Blakely-Smith, Culhane-
Shelburne, et al., 2012; Sofronoff et al., 2005; Sung et al., 2011; Wood et al., 2009), it 
was anticipated that participants randomised to receive group CBT in the current study 
would demonstrate significantly greater reductions in measures of anxiety compared 
to participants in the waitlist condition. A number of areas were studied to assess the 
efficacy of the Chilled Program intervention: (a) change in anxiety severity and 
interference of primary anxiety diagnoses (b) change in diagnostic status of primary 
anxiety diagnoses; (c) change in the number of anxiety diagnoses, (d) change in Total 
SCAS-C/P scores (e) global rating of improvement in anxiety (CGIS), and (f) evidence 
of reliable and clinically significant change in anxiety symptomology. Examination of 
the hypotheses (H1a, H2a and H3, H4 and H5) revealed support for the efficacy of the 
Chilled Program and anxiety symptomology reduction. Group CBT produced a large 
reduction in the total number of anxiety disorder diagnoses, anxiety symptomology on 
the SCAS-Parent measure, and remission of primary anxiety disorder diagnoses. 
Moderate effect sizes were found for the Clinical Severity Ratings for generalised 
anxiety disorder and specific phobia. There was no significant Condition x Time effect 
at post-treatment/ waitlist on the adolescent self-reports (SCAS-C) however, there was 
a significant reduction in anxiety on this measure from pre-treatment to follow-up for 
the CBT group. However, without a comparison group, this finding cannot be 
attributed to the intervention. In addition, post-treatment decreases in all anxiety 
measures were maintained at 6-month follow-up. These findings support group CBT 
producing lasting decreases in clinical anxiety and related measures of anxiety 
symptomology. Lengthening follow-up assessments to one or two years post-
intervention would provide useful information as to whether treatment gains are 
maintained beyond this point, and whether booster sessions are useful or necessary in 
fully maintaining skills learned in the primary intervention phase.  
The finding of group CBT producing significantly greater changes in anxiety 
scores when compared to a waitlist group is in accordance with findings from Chalfant 
et al's. (2007) RCT using the Cool Kids ASD anxiety program with 8- to 13-year-olds 
with ASD. In their study, 71.4% of children no longer met criteria for a current primary 
anxiety disorder at post-treatment, similar to the 72% of CBT participants in the 
present study. However, 30% of the waitlist participants in the present study also lost 
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their primary anxiety disorder diagnosis whereas none of the participants waiting for 
treatment in Chalfant’s et al. (2007) study did. In similar studies remission rates have 
included: 32% in treatment and 21% in waitlist; Wood et al. (2014); 58% treatment, 
0% waitlist; McNally et al. (2013); and 17.65% in treatment completers; Ehrenreich-
May et al. (2014). In a systematic review of CBT studies for anxiety disorders in 
typically developing adolescents, Cartwright-Hatton, Roberts, Chitsabesan, Fothergill, 
and Harrington (2004) found the remission rates were 56.5% in the CBT groups and, 
similar to the present study, 34.8% in the control groups, proposing that CBT has a 
significant effect. In both the present study and the Chalfant et al. (2007) original study 
of the Cool Kids ASD program, the number of anxiety disorder diagnoses significantly 
reduced for the intervention groups but not for the waitlist groups from pre- to post-
treatment. This implies that CBT is an effective treatment for anxiety in ASD youth.  
There was a statistically significant reduction in GAD diagnoses and specific 
phobia diagnoses in the treatment group in the present study. Reaven  and colleagues 
(2012) reported similar findings for GAD in their study but not for the remaining 
principal diagnoses. Contrasting results were found by Wood et al. (2014) who 
suggested that there may exist challenges with treatment motivation in participants 
with a sole diagnosis of GAD. These researchers questioned whether highly complex 
psychiatric presentations of their adolescent participants (between 2 to 7 psychiatric 
diagnoses in addition to ASD) may have interfered with successful anxiety reduction 
treatment gains. However, the participants in the current study demonstrated similar 
presentations on the ADIS-P (2 to 6 psychiatric diagnoses in addition to ASD). 
Interestingly, there was no significant change in the second most frequently occurring 
primary diagnosis disorder for the CBT group, social phobia disorder (8 CBT 
participants at pre-intervention, 6 at post-intervention, and 2 at follow-up had a 
primary diagnosis of social phobia). This may fit with the conclusion of Hudson and 
colleagues (2015) that children and adolescents of typical development showed a 
slower rate of change and poorer outcomes in diagnostic status if they had a primary 
anxiety diagnosis of social anxiety disorder. This finding may also contribute to 
explaining why there was no significant changes in social functioning for the 
participants in the current study. Future studies, using long term follow-up for both 
conditions, could investigate whether individuals with ASD who have a primary 
diagnosis of social phobia do take longer to respond to CBT treatment. 
While both the CBT and WL conditions were equivalent in their SCAS anxiety 
levels at baseline, the mean levels of parent-reported adolescent anxiety on SCAS-P 
  
126 
126 
were higher for the CBT group than for typically developing children with an anxiety 
disorder (M= 32, SD = 14; Nauta et al., 2004), but not for the WL group. The SCAS-
C means of adolescent-reports in this study were noticeably lower than the children in 
Chalfant and colleague’s (2007) study. Whether adolescent reporting of anxiety occurs 
differently than that of children could be an area for further study. In contrast to parent-
rated symptomology, there were no significant changes in adolescent-rated anxiety 
using the SCAS. This may fit with current research that has found discrepancies 
between ASD parent and youth SCAS reports to be higher than in typically developing 
populations (May et al., 2015). However, no significant discrepancy between 
adolescent and parent reports was found in the present study. There was a significant 
difference between the CBT and WL groups on all of the SCAS-P subscales, except 
for social phobia subscale whereby the WL group increased in symptoms at post-
waitlist. There was a large effect size for reduction in anxiety symptomology for the 
CBT group on all SCAS subscales which indicates that the program was effective in 
treating anxiety in adolescents with ASD. 
Considering the overall complex psychiatric presentation of adolescents in this 
study, the demonstrated treatment gains on the anxiety outcome measures which were 
all maintained at 6-month follow-up are worth highlighting. These findings support 
the literature whereby similar results have been established for group CBT in children 
with ASD, and for individual or multimodal CBT with adolescents with ASD. Since 
children and early adolescents have received more attention, these findings add to the 
literature base given that 43% of adolescents in the current study were aged between 
15-18 years. With only minor changes made to the original Cool Kids ASD anxiety 
program, these findings demonstrate that group CBT with a complete focus on anxiety 
reduction can lead to positive treatment outcomes in older adolescents. 
3.7.2 The effect of group CBT on depression.  With the suggestion that 
adolescents and young adults with ASD are at risk for severe depression (Boyd, 
Woodbury-Smith, & Szatmari, 2011), this study also investigated whether a reduction 
in depression symptomology using the SMFQ would occur following CBT. It was 
predicted that these symptoms would reduce in the CBT group however, this 
hypothesis was only partially supported. This is not surprising given that anxiety was 
the treatment focus. The WL adolescent participants reported a large reduction in 
depression symptoms whereas parents in both conditions reported significant 
reductions in adolescent depression symptoms. The absence of significant reductions 
for adolescents who received CBT cannot be attributed to the commonly reported 
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discrepancies between parent and child reports (Sukhodolsky et al., 2013) since 
previous studies have found that both intervention and control condition participants 
have reported reduced symptoms in studies (McConachie et al., 2014; Wood et al., 
2009). Researchers continue to question the accuracy of youth reporting. For example, 
Sofronoff et al. (2005) and colleagues (2005) made the decision to discontinue child 
self-report after baseline, questioning its validity with this client group. Likewise, in a 
meta-analysis, Weston, Hodgekins, and Langdon (2016) found that in contrast to 
informant and clinician-reported measures, self-report measures failed to be reliably 
associated with significant change in affective symptomology. However, similar to the 
current study, McConachie et al., (2014) found a high correlation between child and 
parent reports, on the SCAS measure in their study which tends to suggest that youth 
with ASD do have the capacity to report independently about their feelings.  
In the current study, WL group participants reported a decrease in depression 
symptoms, as did their parents. A possible reason for this may be associated with 
participants knowing that they would be receiving treatment and therefore a reduction 
in feelings of hopelessness and an increase in expectations for change may have 
resulted. Certainly there has been reports of improvements in symptomology during 
waiting periods in previous studies (e.g., Lowry-Webster, Barrett, & Dadds, 2001;  
Roberts et al., 2010; Smith,  Yule,  Perrin, Tranah, Dalgleish, Clark, 2007). For 
example, due to the small sample size in their study, Mcgillivray & Evert, (2014) 
suggested that a sizeable improvement in one of their participants in the WL condition 
could have influenced a significant reduction in depression symptomology at post-test 
for their WL condition. In addition, in a non-ASD study by Smith and colleagues 
(2007), 50% of the WL control condition participants lost their PTSD diagnostic status 
by the end of the waiting list period. Likewise, a study by Jordans et al. (2010) found 
that children in both a psychosocial intervention condition and a WL control condition 
reported significant pre-post improvements in SDQ, PTSD and anxiety scores. These 
studies provide evidence for waitlist improvements however, given that similar 
findings were not observed on the other adolescent measure in the current study 
(SCAS-C), it is difficult to understand why this occurred for the depression measure 
only. Further research is needed to ascertain the relationship between depression, 
anxiety and ASD.  
For the CBT group participants, focusing on anxiety and attending group 
sessions could have increased such feelings or helped the adolescent to recognise and 
identify internalising feelings, and therefore more likely to report them. Although there 
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were not any significant differences between their pre-and-post scores. While not 
significantly different, the CBT group did present with lower SMFQ-C scores at pre-
test (M = 5.65) compared to the WL group adolescents (M = 8.00) and as such perhaps 
having less symptomology meant they had less symptoms related to depression to lose 
over time. However, while only a small number, more adolescents in the CBT group 
(n = 6) were found to have a comorbid mood disorder on the ADIS-P then adolescents 
in the CBT group (n = 3) at pre-test. Since this was a fairly inadequate sample size in 
terms of depression comorbidity, further research is needed to ascertain the 
relationship between depression, anxiety and ASD. For example, did the intervention 
participants gain greater insight to how they were feeling and consequently reported 
higher depressive symptomology? Does CBT have an adverse effect on depression 
symptoms? It may be that a longer follow-up period could better track depression 
onset. With CBT parents reporting significant reductions in symptoms of depression 
it would be useful to identify whether specific CBT components lead to reductions in 
depression symptoms in youth with ASD and comorbid clinical depression. In 
addition, whether the SMFQ is an appropriate measure for individuals with ASD is 
still in question although it has been used successfully in a number of ASD studies 
(Andersen et al., 2015; Mazefsky et al., 2014).  
3.7.3 The effect of group CBT on social skills. In the current study, using the 
SSIS-RS to measure social functioning, no significant increase in adolescent’s social 
skills was found. It has been suggested that there is a bidirectional relationship between 
anxiety and social functioning (White et al., 2013) and as such it was anticipated that 
a decrease in anxiety would result in improvements in social functioning; however, no 
correlation was found for this hypothesis. Therefore, as previously mentioned, anxiety 
reduction and social skills may need to be targeted in separate programs. With mixed 
results deriving from prior evaluations targeting both social skills and anxiety (Binnie 
& Blainey, 2013; White  et al., 2013), further research is needed to determine whether 
focusing on either anxiety or social skills is more time and cost effective. There was 
no significant difference between the two groups for the Competing Problem 
Behaviours standard score or in Autism Behaviours. These findings do not reflect 
those of Wood and colleagues (2014) who suggest that core ASD deficits may be 
ameliorated by CBT intervention for some young people with ASD. Identifying the 
components that may contribute to such findings, and whether there are types of 
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individuals with ASD/ presentations that respond more successfully to CBT treatment 
remains to be explored.  
3.7.4 The effect of group CBT on family quality of life. Based upon 
arguments that the comorbid presentation of ASD and clinical anxiety is likely to 
negatively impact parent mental health and the quality of life within families (e.g., Ooi 
et al., 2008), it was anticipated that a decrease in adolescent anxiety would increase 
family quality life. Support for the hypothesis that families attending the CBT 
intervention would report significant increases in parent-reported family quality of life 
from pre- to post-intervention compared to the WL families, was found. This is the 
first anxiety-targeted RCT for children and/ or adolescents with ASD to investigate 
family quality of life, and to demonstrate some longevity in this outcome at 6-month 
follow-up. Previous RCTs using group CBT for this client group have not investigated 
the effect of CBT treatment on family quality of life (Chalfant et al., 2007; White et 
al., 2013; Wood et al., 2014). This finding therefore makes a novel contribution to the 
existing body of literature and has clinical implications for practitioners who may 
adopt a similar approach. In addition, it has the potential to enhance everyday life for 
both adolescents and their families, in addition to strengthening the relationships they 
have with each other. The current study did not measure parent mental health although 
this is recommended for future studies. 
3.7.5 Reliable and clinically significant change.  It is important for clinical 
practitioners to ascertain the extent to which an individual has improved following 
treatment. Reliable and clinically significant change has proven an effective method 
for deriving this information in the typically developing population. In the present 
study, it was predicted that changes in anxiety would not only occur at a group level 
but also at an individual level (Jacobson & Truax, 1991). In accordance with this 
prediction, significantly more adolescent participants in the CBT group exhibited 
reliable change in anxiety SCAS-C/P (Total Scores) than participants in the WL group. 
Such results suggest meaningful changes in individual adolescents, including older 
adolescents with ASD, following CBT. The proportion of participants in the CBT 
group that achieved reliable and clinically significant change based on the SCAS-P (n 
= 12, 48%) was more than double the number of participants in the WL group 
demonstrating such change (n = 4, 21%). These gains were maintained at 6-month 
follow-up with half of the CBT group participants making reliable improvement. 
Based on the SCAS-C a larger proportion of participants met reliable change (n = 6, 
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24%) in the CBT group compared to the waitlist group (n = 1, 7.1%), with similar 
deterioration rates. Sung and colleagues (2011) measured anxiety reduction using this 
measure and found a similar number of adolescent participants in their study reached 
reliable change after receiving CBT. However, many more of their CBT participants 
achieved clinically significant change by follow-up (n =13, 44.83%) in comparison to 
those in the current study (n = 3, 12%).  
To date, very few studies have used the reliable and clinically significant 
change measure with the ASD population. McGillivray & Evert (2014) suggest that 
clinicians should refrain from using Jacobson and Traux’s (1991) calculations with 
measures that haven’t been widely used in research with people with ASD.  A 
knowledge of distribution of scores and return to normal function for this population, 
as well as normative data, is required to calculate the statistic for reliable and clinically 
significant change (Mcgillivray & Evert, 2014). Therefore, while results from this 
calculation should be viewed with caution, it may be useful for future researchers to 
use the reliable and clinically significant change measure when studying anxiety 
reduction in youth with ASD in order to gain comparative data. The majority of 
researchers in this area have tended to report overall psychiatric Clinical Global 
Improvement rather than measuring change of a specific clinical problem at an 
individual level.   
3.7.6 Clinical Global Impression Scale – Improvement. The CGI-I is a 
useful and established clinical rating tool that allows clinicians to track participant 
progress and treatment response (Busner & Targum, 2007; Kelly et al., 2010). In the 
present study, improvements in overall psychiatric severity were assessed based on the 
CGI-I with a significant difference found between conditions. Sixty percent of 
participants in the CBT condition showed improvements on the CGIS-I compared to 
11% of participants in the WL group. A number of waitlist participants (n = 7, 37%) 
demonstrated worsening of symptomology whereas none of the CBT group did. Some 
researchers have observed a reduction in treatment response from post-treatment to 
follow-up (e.g., Selles et al., 2014) but in the present study, 75% of CBT adolescents 
demonstrated improvement in overall symptomology at 6-month follow-up. These 
findings are consistent with previous studies involving adolescents with ASD. For 
example, Wood et al. (2014), in their individual CBT study of 11- to 15-year-olds, 
found 79% of their CBT group met positive treatment response compared to 28.6% in 
their waitlist group, despite no significant differences between conditions in diagnostic 
remission. Following an open trial, Ehrenreich-May et al. (2014), found 76.5% of 
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participants (11- to 14-years-of-age) achieved responder status following CBT 
treatment. Likewise, in a modular individual CBT intervention of 11- to 16-year-olds, 
68.8% of adolescents in the CBT group were treatment responders, compared to 26.7% 
of those in a “Treatment as Usual” group (Storch et al., 2015). 
In their open trial, Ehrenreich-May and colleagues (2014) found a discrepancy 
between diagnostic remission of primary anxiety for participants (11- to 14-years) at 
post-treatment and follow-up, and treatment responder status on the CGI-I. A higher 
percentage of adolescents were determined treatment responders on the CGI-I at these 
assessment points. Similar findings have been observed in studies on typically 
developing youth following CBT (for example, Ginsburg et al., 2011). Following 
intervention in the present study, less participants achieved diagnostic remission of 
their primary anxiety disorder than treatment responder status on the CGI-I however 
this discrepancy was minimal. Given that the CGI-I evaluates overall psychiatric 
improvement, it could be suggested that with a reduction in anxiety, other psychiatric 
symptomology is more likely to reduce and overall functioning is more likely to 
improve. For example, the reduction in depressive symptomology as reported by 
parents, and an increase in family quality of life that was observed following anxiety 
treatment could have assisted with increasing overall functional behaviour for 
participants in the CBT group.  
Ehrenreich-May et al. (2014) proposed that the discrepancy between the 
number of treatment responders and those that achieve a remission of their primary 
anxiety disorder could derive from (a) differences between the specific distress and 
severity of anxiety symptomology as reported by parents on the ADIS-P CSRs, and 
(b) the perception of overall improvement from baseline to post-treatment/ follow-up 
on the CGI-I as viewed by both parents and independent clinical evaluators. These 
authors suggested the possibility that early adolescents with ASD may be less likely 
to lose their anxiety diagnosis following CBT, than children with ASD, however the 
current study indicates that this may not be the case, with 72% of CBT participants 
demonstrating diagnostic remission (79.2 % by follow-up). These findings, along with 
the current study results, strongly suggest that CBT for some adolescents with high 
functioning ASD can increase psychiatric well-being. More specifically, taking into 
considerations the study limitations below, it can be suggested that the Chilled 
Program was highly effective, and likely to be as efficacious as individual CBT in 
reducing psychiatric symptomology for adolescents, including older adolescents with 
ASD.  
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In contrast, results from the waitlist participants suggest that non-treatment is 
not a viable option with 37% of this group worsening in symptoms.  
3.7.7 Mediators and moderators.  Despite being powered to detect clinical 
main effects, the current study was not powered to determine any treatment mediators 
and moderators (Storch et al. 2015). Future, large-scale, multi-site intervention studies, 
with multiple assessment points are needed to assist with revealing mediators and 
moderators of anxiety treatment for this population.  
3.7.8 Strengths of this study. The current study included a number of 
strengths. First, extending CBT intervention targeting anxiety to older adolescents 
with ASD, who have been underrepresented in RCTs. Second, this study attempted to 
include some of the components suggested as future research inclusions in Chalfant 
and colleagues (2007) study. For example, this therapists video recorded all therapy 
sessions to enable coders to evaluate treatment integrity. In addition, independent and 
blinded clinical evaluators conducted the pre-, post-intervention, and follow-up 
measures. As suggested by Chalfant (2007) and Ooi et al., (2011), family quality of 
life was assessed, as were measures of social skills (Chalfant et al., 2007). In addition, 
the current study conducted follow-up measures which were not reported on in the 
original Cool Kids ASD adaptation study (Chalfant et al., 2007). Finally, drop-out 
study participation rates were low (CBT, n = 1; WL, n = 4). 
3.7.9 Limitations of this study. Despite the significant and positive findings, 
the sample size was small, contributing to reduced power. This has been a common 
problem across all CBT studies in this area (Weston et al., 2016). In a meta-analysis 
of studies using CBT with people on the autism spectrum, Freitagand colleagues 
(2016) were found to include the largest participant group (CBT = 101; Control = 108) 
however their study focus was social responsiveness as opposed to anxiety. There is a 
critical need for large scale RCTs employing CBT to target anxiety across the lifespan. 
The participants in this study represented a rather ethnically homogenous group, which 
may limit generalisability of findings and could mean that the participants in this study 
do not accurately reflect the wider population of anxious adolescents with ASD 
(Chalfant et al., 2007). In addition, some methodological limitations in the current 
study include the absence of homework compliance and participant involvement data, 
and stringent recording of medication dosages. Some researchers have recorded the 
failure or extent to which participants have completed treatment home practice tasks 
between sessions (White et al., 2010), participant’s engagement within sessions 
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(White et al., 2013), as well as requiring participants to record medication status on a 
weekly basis during therapy sessions (Reaven et al., 2014). It is possible in the current 
study that the independent clinical evaluators did not elicit medication information 
from parents at every assessment time point. In addition, parents may not have 
volunteered or recalled changes to medication status and dosages over a five or six-
month period. It is therefore likely that more than the one recorded participant in this 
study changed medication dose over the study period. For example, in the White et al. 
(2013) study over half of the participants changed medication doses over the course of 
the intervention/waitlist period even though they had been asked to remain on a stable 
dose prior to study commencement. Future studies can provide parents with a measure 
to frequently assess adherence to medication change and engagement in external 
psychotherapy. 
A further limitation of the present study is the absence of follow-up measures 
by the waitlist group at 6-months. More recently it has been suggested that “treatment 
as usual” or active control groups are preferable over waitlist groups. Active control 
groups can discern whether treatment gains are attributed to contact time with the 
therapist or session structure rather than the treatment itself (Sung et al., 2011). Using 
this method, significant and positive treatment gains were found in Sung and 
colleague’s study for participants employed in either a social recreational program or 
a CBT intervention. These authors suggest that regular, structured sessions with 
consistent therapists and social exposure were all contributing factors to anxiety 
reduction in adolescents with ASD, rather than CBT itself. 
Similar to Chalfant et al's. (2007) study, the adolescents in the current study 
were not formally assessed for ASD by the study therapists and therefore the validity 
of their diagnostic status could be queried. However, all participants did show 
documentation of their diagnosis and any potential participants were excluded from 
the study if this was absent. Furthermore, study participants fell within the average or 
above average autism behavioural level subscale on the SSIS-RS (90% falling within 
the above average range at pre-test). In addition, session therapists, including the 
primary researcher, were able to observe participant behaviour over the 5-month 
intervention period for both groups and verified that participants did present as 
meeting the criteria for an autism spectrum disorder. 
Furthermore, group treatment will not suit all adolescents with ASD. As noted, 
one of the CBT participants found the group environment to be anxiety provoking and 
needed to withdraw from the intervention program. It may be that individuals with 
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highly complex psychiatric profiles may be better suited to individual treatment or 
multi-modal therapy where they begin with individual treatment and then engage in 
group treatment at a later stage. Research into successful group treatment engagement 
is needed. 
Since there can be an overlap of symptoms between ASD characteristics and 
anxiety symptoms, the measures employed need to be considered in addition to the 
treatment outcomes (McConachie et al., 2014). Similar to previous studies the ADIS-
P was deemed appropriate in differentiating between ASD behaviours and anxiety 
symptoms. There continues however to be uncertainty regarding how to best measure 
self-reports given that adolescents may lack insight and self-reflection (Hurtig et al., 
2009; Mazefsky et al., 2011; McConachie et al., 2014). There is considerable work to 
be done in ascertaining which measures are appropriate and meaningful for this 
population.   
In addition, knowledge of group assignment may have impacted responses. 
However, since the WL group stayed fairly constant in their anxiety levels from pre-
to post- measures it does not appear that waiting for treatment attenuated anxiety levels 
(Chalfant et al., 2007). Conversely, the treatment group responses may have been 
impacted by their knowledge of receiving treatment which could have led to a 
reduction in symptomology reporting.  
3.7.10 Future research. Future research could involve the investigation of the 
role that parents play in determining positive treatment outcomes for an older 
adolescent population. For example, Sung et al. (2011) showed positive treatment 
outcomes for adolescents with ASD without parent participation. Likewise, Ung, 
Selles, Small, and Storch (2014) found that parent involvement was not a moderator 
of treatment response, in their meta-analysis of CBT for youth with ASD. In addition, 
isolating the specific CBT components that lead to reduced anxiety and explicating the 
mediators and moderators of treatment response would prove highly beneficial for 
clinicians. This has been achieved in non-ASD youth anxiety studies (e.g., Kendall et 
al., 2016). Qualitative reports from parents in this study suggest both exposure and 
parent training were related to successful treatment outcome (see Study 2). Finally, as 
(Chalfant et al., 2007) declared following their study, it is questionable whether an 
ASD adaptation of the Cool Kids program is necessary in producing successful 
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treatment outcomes. It may be that the original Cool Kids program without adaptation 
(Lyneham et al., 2003) could have produced similar results.  
3.8 Chapter Summary 
This study is the first randomised controlled trial of the Cool Kids ASD 
Adaptation program targeting anxiety in older adolescents (aged 12-18 years) with 
ASD. Results demonstrated significant reductions in anxiety as indicated by diagnostic 
status, clinical severity scores, therapist ratings of overall clinical severity, parent and 
adolescent reports. In addition, decreases in parent-reported depression symptomology 
and increases in family quality of life were observed. Treatment gains were maintained 
at 6-month follow-up. Given that there were no significant pre-treatment differences, 
these findings provide support for the efficacy and social validity of a group, 
manualised, family-based cognitive-behavioural-therapy treatment for anxiety 
reduction in adolescents with high functioning ASD.  
Results from this study are consistent with findings from previous RCTs that 
have mainly focused on younger children and early adolescents (e.g., Chalfant et al., 
2007; Wood et al., 2009). This trial is the first known RCT to assess group CBT 
singularly targeting anxiety in adolescents, including older adolescents, with ASD. 
With social and emotional demands often increasing during adolescence, exacerbating 
the unique and often complex challenges inherent to ASD, elevated anxiety levels are 
common and the need for effective treatment paramount.  
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Chapter 4: The Social Validity of a Manualised Family-Based 
Anxiety-Reduction CBT program for Adolescents with High Functioning 
Autism Spectrum Disorder (Study Two) 
4.1 Introduction 
The purpose of Study Two was to assess the social validity of the Chilled 
Program for adolescents with high functioning ASD and clinical levels of anxiety. 
Wolf (1978) introduced the term “social validity” to the field of behavioural research 
to address concerns regarding consumers’ adherence to and acceptance of behavioural 
programs. Within this framework, Wolf (1978) suggested there are at least three levels. 
First, do the specific behaviour goals of behaviour match what it is that society wants? 
Second, do the carers / participants / consumers find the procedures to be appropriate?  
Last, are the consumers satisfied with the results, including unexpected findings?  In 
the past, concerns that this concept would lead to the de-objectification of scientific 
research have been raised (e.g., Barrett, 1987). However, the current study aligns with 
researchers who assert that social validity adds another dimension to evidence-based 
practice by not only highlighting issues regarding its applied value, but assessing 
whether the targeted population believe the intervention has been of assistance, and 
whether it has had a positive effect on their daily life (Kazdin, 2005; Ollendick, 2014b; 
Ooi, 2013).  
Assessment can occur on a global level whereby consumers rate their 
satisfaction with the whole intervention, or it can occur on a component level, where 
they rate individual segments of the intervention on satisfaction (Foster & Mash, 1999; 
Ooi, 2013). To date, the subjective experience of adolescents with high functioning 
autism spectrum disorders has only been explored in a small number of CBT anxiety 
reduction studies (e.g., McConachie et al., 2014; Reaven, Blakely-Smith, Leuthe, et 
al., 2012; White et al., 2013). For example, White and colleagues (2013) examined the 
feasibility of a pilot CBT program targeting anxiety and social skills. These authors 
found that parents rated their satisfaction with the program slightly higher (mean score 
of 8.21 out of 10) than the adolescents did (mean score of 7.47). Similarly, Reaven and 
colleagues (2012) administered satisfaction questionnaires post-intervention to both 
parents and children with 72% finding the overall activities to be “very helpful”. 
Neither of these studies reported use of qualitative feedback from participants. 
Fleishmann (2005) asserts qualitative research methodology to be effective in 
disclosing the personal perspectives of parents of children with ASD. In addition, a 
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phenomenological approach can capture the richness of experience of both parent and 
child (Marshall & Rossman, 2006; Miles & Huberman, 1994).  
While there has been a surge in ASD intervention research over recent years, 
missing greatly from the literature has been the subjective experience or the voice of 
people with ASD (Charlton, 1998). In more recent years, individuals on the autism 
spectrum have adopted the phrase ‘Nothing about us without us’ (for example, the 
Autistic Self Advocacy Network http://www.asan-au.org/2013/08/nothing-about-us-
without-us-a-research-agenda/) to reflect that their views are commonly 
misrepresented or misused by neurotypical (non-autistic) autism researchers, and the 
community at large, and that the voice of the autistic person needs to be heard in autism 
research. It has been suggested that a reluctance to involve the voices of young people 
with ASD could be due to the communication difficulties inherent with this condition 
(Beresford, Tozer, Rabiee, & Sloper, 2004; Lewis, 2009) and focusing on the deficits 
of ASD rather than recognising the strengths, abilities and personalities of these 
individuals (Allred, 2009; Baron-Cohen, 1989; Harrington, Foster, Rodger, & 
Ashburner, 2013).  
The aim of this study is to explore the social validity of the Chilled Program 
(see Study 1 for more information on the intervention) by gathering both qualitative 
and quantitative data from the adolescent participants and their parents. 
4.2 Method 
4.2.1 Design. A mixed methods design was employed in order to assess the 
social validity of the Chilled Program. Here, both quantitative and qualitative data was 
collected and interpreted (Creswell & Plano Clark, 2011). This process involved the 
integration of participants’ subjective experience of the intervention and their 
quantitative feedback regarding the intervention. In this manner, multiple sources of 
data enrich the results. 
4.2.2 Participants. The participants consisted of 33 of the adolescents and 36 
of the parents from Study One who completed at least 90% of the Chilled Program. 
Participants were from both the CBT intervention group and the Waitlist group. Since 
the adolescent sample was non-identifiable in this study, a breakdown of male / female 
participants and specific ages cannot be given. Adolescents were in the age range of 
12-18 years. Parent participants consisted of 32 mothers (M = 44.78) and 4 fathers (M 
= 47.89). Most participants were Caucasian with five or fewer families being of Asian 
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or Pacific Islander descent. Given that adolescent details were absent from the 
questionnaire (in light of assuming they would feel more comfortable in providing 
honest feedback), the baseline characteristics of adolescents and parents are taken from 
Study One and are displayed in Table 1. 
4.2.3 Measures.  At the final group session, the Program Satisfaction 
Questionnaire measured the extent to which participants enjoyed activities and which 
activities they found most helpful. The adolescent questionnaire was adapted from the 
Student Evaluation Form by Gent et al. (2014) and Roberts et al. (2010). The author 
of the current study developed the Program Satisfaction Questionnaire – Parent 
Version. These questionnaires are not standardised measures and therefore lack 
psychometric properties. 
4.2.3.1 The Program Satisfaction Questionnaire—Parent Version 
(Appendix I). This questionnaire requested information on parents’ observation of 
their adolescent’s behaviour over the course of the program. The primary researcher 
developed 12 items that were specifically designed to align with program content. It 
included three qualitative items: “Please describe any changes in your adolescent’s 
skills or behaviour that you believe are directly due to their involvement in the Chilled 
Program”, “Since the beginning of the program, what changes have occurred in how 
you support your adolescent (if any)?” and “We would particularly welcome any other 
comments you have about the program. Please write any other comments in the space 
below”. In addition, nine quantitative items were examined using a Likert scale 
ranging from 1 (not at all) to 5 (very much). These included items related to parent’s 
confidence in supporting their adolescent after the program, the extent to which they 
believed their adolescent enjoyed the program, satisfaction with program content, and 
noticeable changes in their adolescent since attending the program.  
4.2.3.2 The Program Satisfaction Questionnaire—Adolescent Version 
(Appendix J). This questionnaire included 15 items on program satisfaction, seven 
items on usefulness of the skills taught, and five open-ended items on general 
feedback. Participants responded to quantitative items on a Likert scale ranging from 
1 (not at all) to 5 (very much). Open-ended items examined the activities adolescents 
enjoyed and used the most, as well as how they might want to improve the program 
(“The activities I enjoyed the most were…,” “The activities I did not enjoy were…,” 
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“The skills I use most from the program are…,” “How would you make the program 
better?” and “Is there anything else you would like to say about the program?”).  
4.2.4 Procedure.  Ethical approval was obtained from the Curtin University 
Human Research Ethics Committee, the Western Australia Department of Education, 
and the Catholic Education Office (WA) in 2011. This study was conducted as part of 
Study One therefore participants were recruited as outlined in Study One.  
 At the final Chilled Program treatment session, adolescents and parents were 
asked to rate their overall satisfaction with the program. This took approximately 10 
minutes to complete. All ratings were completed in private without the primary 
therapist in the room. Some adolescents did require some assistance in comprehending 
the items on the measure and in these cases the co-therapists provided this. Parents 
provided their name and their adolescent’s name on the parent questionnaire and 
adolescents were encouraged to remain anonymous in their response.  Participants 
placed the completed sheets into one large envelope. For families who did not attend 
the final session, or if they expressed that they felt more comfortable completing the 
questionnaire at home, they were provided with a pre-paid envelope in order to easily 
return the completed form. 
4.2.5 Statistical analysis. Descriptive statistics were employed to analyse the 
quantitative responses. Qualitative responses were transcribed, collated, and subjected 
to content analysis. In contrast to the objective statistical figures derived from 
quantitative analysis, qualitative methodology provides rich and meaningful 
information about an individual’s experience or opinions (Patton, 2002). There exists 
a wide range of qualitative approaches underpinned by numerous theoretical 
frameworks with varying methods for analysing qualitative data. Given that there was 
no prior theory about participants’ experience of this intervention, a deductive 
approach to data analysis was employed, allowing for an understanding of how the 
participants perceived the intervention (Ooi, 2013). Content analysis is an approach 
that groups similar words and themes together and allows for a true reflection of what 
was expressed by the participant without making inferences (Ooi, 2013; Wilkinson, 
2008). This method involves “coding [of] participants’ open-ended data into closed 
categories, which summarise and systematize the data” (Wilkinson, 2008, p.198). An 
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advantage of content analysis is that the product of analysis can be presented as 
quantitative data for comparison purposes.  
In this study, utilising content analysis and safeguarding accuracy of 
interpretation, the researcher collated responses and these were crosschecked for 
interpretation by one of the researcher’s supervisors, Associate Professor Clare 
Roberts. Responses to the questionnaire items were operationalised as words or 
phrases (Milward, 2007). Due to clarity and simplicity of the procedure, Berg's (2007) 
procedure for standard content analysis was employed. First, the written responses to 
the five open-ended questions were read. These were then typed according to the order 
of the items and notes were made along the margins. For example, responses (from all 
participants) to the first question were read and followed by the second question and 
so forth. The notes were then turned into codes and codes were grouped to form 
categorical labels or themes. Parent participants were de-identified in the analysis and 
the quotations were coded by a number that was designated to each participant 
questionnaire. 
4.3 Results and Discussion 
The results and discussion section is comprised of four parts, namely: (a) 
adolescent quantitative feedback which consists of the overall ratings of the 
intervention, (b) adolescent qualitative feedback which is comprised of responses to 
five open-ended questions, (c) parent quantitative feedback consisting of overall 
feedback about the program and any changes in their adolescent since completing the 
intervention, and (d) qualitative feedback from parents comprising of three responses 
to open-ended questions.  
4.3.1 Adolescent quantitative feedback. A total of 33 adolescents completed 
the Program Satisfaction Questionnaire upon completion of the intervention. The 
overall program satisfaction including relevance / usefulness of the program content, 
and the extent in which the intervention was helpful to participants can be viewed in 
Table 20. Adolescents reported that the program was easy to understand (M = 4.00, 
SD = 1.03), and that the skills they learnt were useful. Overall, learning how to 
recognise anxious thoughts (M = 4.00, SD = 1.00), using helpful thoughts (M = 3.93, 
SD = 1.17), and learning to relax (M = 3.97, SD = 1.04), were rated most useful. The 
program additionally helped participants to understand their feelings (M = 3.82, SD = 
1.18) and cope with stress (M = 3.82, SD = 1.18). Lower ratings were associated with 
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external components such as “I talked about the program to my friends,” (M = 2.06, 
SD = 1.30), and “My friends have commented on the changes in me as a result of the 
program,” (M = 1.79, SD = 1.34).  
 
Table 20 
Descriptive Statistics of the Program Intervention Evaluation for Adolescents 
derived from The Program Satisfaction Questionnaire—Adolescent Version  
Item              Range   M SD   Mode 
I looked forward to the group each week   2-5 3.57  0.97 3 
The information was easy to understand   2-5 4.00 1.03 5 
The student guide was useful and easy to read  1-5 3.60 1.12 4 
The program was useful in my everyday life   2-5 3.55  0.97 3 
The program was helpful for getting along with friends 1-5 3.73 1.23 5 
The program was useful for helping get along with family 1-5 3.33 1.31 4 
The program helped me have confidence in myself  1-5 3.76 1.06 4 
The program helped me to understand my feelings  1-5 3.82 1.04 4 
The program helped me cope with stress   1-5 3.82 1.18 4 
The program helped me to feel more positive about life 1-5 3.58 0.97 4 
I talked about the program to my friends   1-5 2.06 1.30 1 
My friends have commented on changes in me  1-5 1.79 1.34 1 
I talked about the program with my family   1-5 3.30 1.33 3 
My family have commented on changes in me  1-5 3.24 1.30 3 
I would recommend the program to my friends  1-5 2.88 1.45 1 
Learning about feelings was useful    1-5 3.76 1.20 5 
Learning to relax and cope in difficult situations was useful 2-5 3.97 1.05 4 
Learning how to recognise my anxious thoughts was useful 1-5 4.00 1.00 5 
Learning how to use helpful thoughts was useful  1-5 3.94 1.17 5 
Learning how to create stepladders was useful  1-5 3.42 1.20 3 
Learning how to be assertive was useful   1-5 3.61 1.17 4 
Learning how to improve my relationships was useful 1-5 3.70 1.18 4 
Note. 1 = did not like/ find helpful at all to 5 = very much liked or found helpful. 
 
4.3.2 Adolescent qualitative feedback. Content analysis of the adolescent’s 
responses to the five open-ended questions were categorised into four main themes, 
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namely: (a) friendship / normalising experience, (b) Chilled skills I use, (c) reduced 
anxiety, and (d) program improvement.  
4.3.2.1 Friendship and a normalising experience.  More than half of the 
adolescents reported that the Chilled Program provided them with an opportunity to 
interact with others who experience similar difficulties. It appeared that the program 
offered a normalising experience, a well-documented benefit of group therapeutic 
work generally (Rapee, 2000). The group setting may have been an opportunity to 
share in a safe space with others that have experienced common hardships.  
Personally I found one of the most helpful aspects of the program was 
getting to meet others like myself and seeing that I am not the only one who 
suffers from anxiety. 
Meeting and conversing with other people my own age that I could relate 
to well; gaining help and support from (helpful) people to assist in my outside 
life and private hardships at home and school. 
Congruent with parent reports in Sofronoff’s (2005) study, many adolescents 
commented on making friends during the program. During the group sessions 
adolescents frequently spoke of bullying experiences and the loneliness they feel in 
the school environment. With significant social difficulties, the opportunity to practice 
important social skills in a supportive environment is highly beneficial, particularly 
for older adolescents with ASD who are often wanting social relationships but lack the 
necessary skills to initiate and maintain them (Reaven et al., 2009). 
It was good meeting new people and socialising.  
I have made a new friend and that’s all I need.  
I had a good laugh. I wish I had everyone’s phone numbers so I could 
keep seeing them.  
When asked what activities they enjoyed the most, eleven participants 
specifically mentioned the “break time” (approximately 30 minutes each session while 
the parent session was conducted) as one of, or their most enjoyable activities in the 
program. This may reflect the common difficulties that are reported in ASD research 
in regards to loneliness and bullying, including the challenges that this population 
commonly face in the school environment (e.g., Hammond & Hoffman, 2014; Koegel, 
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Kim, Koegel, & Schwartzman, 2013; Settipani et al., 2012). The group may have been 
an opportunity to share in a safe space with others that have experienced similar 
hardships. 
The activities I enjoyed the most were during the break time. We would 
usually play hangman but on the first week we played Jenga and Boggle. 
Playing with the boys outside running around.  
Not all responses were positive in terms of interacting with group members:  
Putting up with other teens, especially H since he’s really intense.  
(The) boys (were) restless in break. 
4.3.2.2 Chilled skills I use.  In response to the skills that adolescents use most 
from the program, “Deep/Cool breathing” was reported by 16 of the participants; 
“helpful thoughts” were reported by 15 of the participants; “relaxation tools” by 4 
participants, and learning to control my feelings by 2. Some participants reported a 
combination of these and other skills.  
I do my cool breathing when I am at TAFE with TN my worst teacher. 
Identifying effectively when I am feeling worried and distress[ed] as well 
as skills I can use to comfort and eliminate these.  
Learning to control my feelings.  
4.3.2.3 Reduced anxiety.  Not surprisingly, given the nature of the Chilled 
Program, a number of participants reported the anxiety-reduction benefits that they 
have gained from the program. 
It improved my stress and anxiety levels.  
I was very sceptical about the program and I remember saying, “I wanted 
out” but over time I slowly adapted to being in the program and this proved 
to be very effective.  
The program helped me with my stress.  
Three participants didn’t find the techniques as helpful: 
I think the speech therapy did more for me than the Chilled Program.  
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I have my own methods that work really well.  
Some of the topics I had already been through with a therapist so they 
were a bit boring.  
4.3.2.4 Program improvement.  In response to the items, “How would you 
make the program better?” and “Is there anything else you would like to say about the 
program?” a high level of positive feedback was provided (e.g., “it was fun”, “it was 
good”).  
It was fun and overall fantastic. 
I would recommend the content of this course to anybody dealing with 
anxiety – derived issues as I have found them very effective in their 
delivering, application, and results (short or long-term).  
Some adolescents would have liked the program to be longer. This could derive 
from their enjoyment of the program or it could mean that they haven’t benefitted 
enough from the program and needed more time to learn the techniques. Chalfant and 
colleagues (2007) emphasised the need to have a lengthened program for children with 
ASD compared to typically developing children. In order to reduce the program 
waiting time for the control condition this program was reduced in length by 
approximately 1 month in comparison to Chalfant’s original study.   
I found the program extremely valuable and much enjoyed coming each 
week. Maybe the program could be longer? The long breaks over the 
holidays were a bit unfortunate. Maybe an AS support group or something 
similar would be really cool! Yay, Chilled!!! J  
Maybe more time? Otherwise I think it was pretty good.  
The most disliked activity centred on the workbook and writing. Eleven 
participants commented on this. Many individuals with ASD have difficulty with 
handwriting, which may reflect these responses (Kushki, Chau, & Anagnostou, 2011). 
With this in mind, participants were consistently given the option of having one of the 
co-therapists scribe for them and this offer was taken up on a number of occasions. In 
addition, the worksheet style may remind students of school and as such may be 
viewed in a negative light. Notably, Attwood and Scarpa, (2013) recommend keeping 
handwriting to a minimum when using workbooks within CBT programs due to poor 
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handwriting skills often demonstrated by those with ASD. These authors suggest 
incorporating activities involving listening, watching and doing in favour of writing. 
An example of responses when asked about the activities they did not enjoy, included: 
The practical (like writing and reading).  
The written exercises in which I was required to express my own feelings 
and experiences of late  
The activity that I did not enjoy was all the writing. I find it easier to learn 
verbally  
Nine participants responded that they would not make any changes to the 
program. 
I would not change the program…I loved every moment. 
… they were all useful in each and every day of my life… It couldn’t be 
improved. 
I wouldn’t; I believe that the program is effective in its missions and 
performs/ conveys its contents and aims in an easy and calming way.  
Some individuals did offer ideas for program improvement: 
Talking more about emotions themselves. I don’t really understand them 
so it’s difficult to identify and deal with my own let alone others. It would be 
nice to go through and learn not to worry that your emotions are different to 
others and learn and be able to identify how they are different. It can be very 
hard and horribly disappointing when you don’t feel what you are ‘supposed’ 
to feel. 
Make it more adolescent friendly from 12-18. It’s brilliant for 9-14 years 
right now.  
Not talk about anxiety so much  
More relaxation.  
Overall, adolescents commented favourably on the intervention and recalled 
the skills that they have learned during the program. A highlight was the interaction 
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that they gained with their fellow participants. They indicated that the intervention 
could be improved by having less writing and bookwork.  
4.3.3 Parent quantitative feedback. Thirty-six parents completed the 
program satisfaction questionnaire upon completion of the Chilled Program.  The 
overall program satisfaction including relevance / usefulness of the program content, 
and the extent in which the intervention impacted participants can be viewed in Table 
21.  Overall, parents were highly satisfied with the content covered in the program (M 
= 4.67, SD = 0.48), the facilitator (M = 4.72, SD = 0.51) and rated the overall program 
highly (M = 4.56, SD = 0.50). They observed positive changes in their child since 
participating in the program (M = 3.94, SD = 0.79), felt the program was effective in 
helping their child (M = 3.97, SD = 0.91) and reported feeling confident in their ability 
to support their child’s social and emotional development after the program (M = 3.92, 
SD = 0.55). Lower ratings were attached to the items regarding how much their child 
talked with their parent about the program (M = 3.08, SD = 1.02) and negative changes 
that parents had observed in their children since commencing the program (M = 1.44, 
SD = 0.94). 
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Table 21 
Descriptive Statistics of the Program Intervention Evaluation for Adolescents 
derived from The Program Satisfaction Questionnaire—Adolescent Version  
 
Item         Range   M     SD    Mode 
Please rate how confident you are in your ability to   3-5 3.92 0.55 4 
support your adolescent’s future social and  
emotional development 
To what extent did your child enjoy participating in   1-5 4.00 1.17 5 
the Chilled Program?  
How satisfied were you with the content covered in   4-5 4.67 0.48 5 
the program? 
To what extent has your adolescent talked with you   1-5 3.08 1.03 4 
about the program? 
From your own observations, as well as comments   2-5 3.97 0.91 4 
you may have received from others, how effective  
do you feel the program was in helping your  
adolescent?  
To what extent have you noticed positive changes in  1-5 3.94 0.79 4 
your adolescent since participating in the program? 
To what extent have you noticed negative changes   1-5 1.44 0.94 1 
in your adolescent since participating in the program? 
How satisfied were you with your parent group   3-5 4.72 0.51 5 
facilitator? 
Overall, how would you rate the program?   4-5 4.56 0.50 5 
Note. 1 = did not like/ find helpful at all to 5 = very much liked or found helpful. 
 
4.3.4 Parent qualitative feedback. Parent’s qualitative feedback was 
classified into four themes: (a) upskilling parents, (b) anxiety reduction, (c) exposure, 
and (d) positive family experience. A brief discussion of these follows. 
4.3.4.1 Upskilling parents.  When parents were asked what changes in how 
they support their adolescent, have occurred since the beginning of the program, 
twenty-one parents reported they are now able to guide or “coach” their adolescent in 
identifying their emotions and managing their anxiety. Since parents are provided with 
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psychoeducation on anxiety and taught skills introduced to adolescents over the course 
of the Chilled Program they reported having an understanding of when their child is 
anxious and of being equipped with strategies to assist their child. Certainly, research 
in this area has asserted that parent involvement may play an important role in 
successful treatment outcomes (Barmish & Kendall, 2005; Cobham et al., 1998; 
Reaven, 2009; Sofronoff et al., 2005). In addition, it is likely that many of these parents 
continually play a coaching or supporting role in their adolescent’s life compared to 
parents with typically developing teens (Reaven, 2009). Therefore, when provided 
with the skills, they adapted well to the role of a Chilled Program coach. In order to 
protect the identification of the adolescents, different initials have been given in place 
of their names in the following quotes. 
I remind him of strategies and sometimes demonstrate how I need to use 
them myself to stay calm.  
We coach [D] and role-play possible situations to prepare her for things 
that might happen. We remind her of things that might happen. We remind 
her to use relaxation techniques and have helpful thoughts when worrying 
about a situation / event.  
I prompt [L] to use cool breathing and I help him to use helpful thoughts 
when he is anxious. I demonstrate mistakes are okay and model how I make 
mistakes too. 
In addition, parents reported becoming more aware of their own emotions and 
how these may impact on their child. Parents were asked to practice the home CBT 
tasks themselves (e.g., helpful thoughts, relaxation strategies) in order to gain mastery 
of the strategies so that they could then guide their adolescent. This may have increased 
parents’ awareness of their own anxiety levels. 
I continue to be mindful of how I support P when my own stressors get in 
the way.  
I try to help him to relax – sometimes I need to “Chill” myself. 
We are more calm in our approach to C and use relaxation techniques 
ourselves and cool breathing.  We are trying to be consistent in our approach.  
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Forty-one responses across the three items indicated that parents have noticed 
a difference in their child’s ability to identify their emotions, regulate their emotions, 
and an overall reduction in their child’s anxiety. For example: 
H doesn’t scream straight away when stressed.  
Has tried some new things, more strategies to cope with anxiety, more 
talkative about how she is feeling.  
A has started to be a lot calmer in his behaviour and seems to not to lose 
his temper as much. He uses his deep breathing exercises as well as muscle 
relaxation prior to bed and this is assisting in his sleeping.  
Related to anxiety reduction, seventeen parents specifically reported the 
stepladder exposure exercise had been helpful in assisting their child to face and 
manage specific fears/phobias. Some parents commented generally, for example, “the 
ladders are a great strategy to use” and others more specifically reported the benefits 
of using structured exposure with their adolescent: 
Our first challenge was about cockroaches and [S] seems to be a lot calmer 
around them now.  
V has tried many new foods (and liked them) he has submitted to 
vaccinations. His whole attitude has ‘changed’ dramatically – for the better.  
O certainly has come out of his “shell” more. I have noticed he initiates 
conversations, approaches people to chat and can have a continuing 
conversation.  
Overall, satisfaction and positive feedback regarding the Chilled Program was 
reported by sixteen parents.  
The (therapists) were fantastic in their approach. The program has helped 
my son understand anxiety and ways to deal with it when it is happening.  
I’s confidence improved greatly through this program she has gained 
excellent skills to use in stressful situations and despite some setbacks from 
time to time, she’s managing her anxiety so much better than she ever has! 
Thank you!  
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Training and involvement in treatment may assist parents in feeling more 
confident about helping their child (Sofronoff et al., 2005). Families in this study 
reported that they felt a sense of empowerment and efficacy in their ability to assist 
their child in managing anxiety. In addition, relationships in parent/child dyads were 
reportedly strengthened. Research has demonstrated that comorbid anxiety can place 
considerable stress on families who have a child or adolescent with ASD (Ooi et al., 
2008). The finding that reducing anxiety in young people with ASD results in a 
reduction in parental stress may be supported in this study (Ooi et al., 2008). In 
addition, relationships between parent and child and overall family quality of life were 
reported to improve. 
X has enjoyed participating in the Chilled Program and he was looking 
forward to it each week. It has made us empowered to deal with his anxiety 
with tools that can be applied to any situation.  
The program has been absolutely wonderful for both B and myself. It has 
been a pleasure to have been part of it. I would recommend any child/parent 
that has anxiety issues to participate in such a program. It truly has made a 
difference. Thank you (facilitator).  
“Tools” have become the new “time-out.”  
Another positive impact of the Chilled Program was that some parents reported 
their adolescent’s difficulties were normalised. As mentioned, group treatments often 
provide the opportunity for adolescents to share their experiences and normalise their 
feelings of isolation (Rapee, 2000).  It has been documented that due to the difficulties 
in social interaction, the opportunity to practice important social skills can be 
beneficial, particularly for older adolescents with ASD who may desire social 
relationships but are not skilled in initiating and maintaining them (Reaven et al., 
2009).  
It was very helpful for [L] to be able to recognise that she was anxious and 
to know that there are others just like her.  
D’s realization that he is not the ‘only one!’ Others his age have similar 
worries and fears.  
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4.3.4.2 Parent support.  Often for parents, having a child with ASD can 
contribute to feelings of isolation. Gaining support from other parents who have a 
shared lived experience of raising a child with ASD was gleaned from the comments: 
The size of the group was just right. Being able to talk to other parents was 
beneficial.  
Wonderful to meet other parents who also put in long hours and hard 
‘yards’  
Whilst parents reported few negative aspects of the program, two parents 
commented on the difficulty in setting aside time for both the sessions and the home 
practice tasks between sessions.   
This program is great for the parents and the child, the only problem I 
found was the time factor in doing a bit everyday BUT in doing this through 
the stepladder the results were good. I am looking forward to school holidays 
to commit to doing some more goals. Thank you so much!  
4.4 Chapter Summary 
The purpose of this study was to explore the experience of adolescents and 
parents who participated in the Chilled Program. Overall, the results of the findings 
suggest that both adolescents and parents perceived the program favourably, evidenced 
by the following observations. First, the quantitative responses from the adolescent’s 
global evaluation of the program demonstrated a positive attitude toward the program 
(mean satisfaction score of 3.47 out of 5), with parent’s global responses rating slightly 
higher (mean satisfaction score of 3.81 out of 5). These results reflect the findings of 
White et al., (2013) and Reaven, Blakeley-Smith, Culhane-Shelburne, and Hepburn, 
(2012) whereby parents rated the program slightly higher than did adolescents.  
Adolescents found the program easy to understand and actually rated this item 
highest. This could be interpreted in two ways. First, the program information is 
presented in a manner that aligns with the common complex cognitive profiles of this 
population. Alternatively, since the original program was aimed at 8-12 year olds, 
perhaps participants are reflecting that the program content was too “young” or “easy” 
for them and could be adapted for a higher developmental level. While some small 
adaptations were made to the original Cool Kids program (see Study One), the 
program content largely remained the same. 
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Parents rated their satisfaction with the facilitator, and then the program, above 
all other items. In this study the primary author delivered all of the treatment with the 
assistance of two co-therapists assigned to each group.  Due to the numerous 
challenges in working with the unique and complex needs of this population, it may 
be that the author’s clinical experience working with this population limits the 
generalisability of the study results. Rounsaville, Carroll, and Onken, (2006) 
recommend reducing therapist heterogeneity in order to maximise the power available 
in a small sample. To date, the clinical factors and parameters of flexibility required 
to successfully work with this client group have not been isolated (McNally et al., 
2013).  
The majority of adolescents and parents reported a reduction in adolescent 
anxiety symptomology, the main goal of treatment. For the adolescents, the 
accumulation of specific anxiety management skills was prominently reported, for 
example, 16 adolescents commented that “Cool Breathing” was a skill that they now 
used, and 15 adolescents reported using “Helpful Thoughts”. Seventeen parents 
specifically commented on the benefits of their child using exposure techniques to 
assist with their anxiety. Whilst research supports the efficacy of exposure for anxiety 
reduction, the mechanism that brings about this change remains under-researched and 
has not yet been established (Hogendoorn et al., 2014).  Future studies could employ 
a dismantling design for the purpose of isolating certain treatment components in order 
to examine the effect of individual components on anxiety reduction (Hogendoorn et 
al., 2014). Whilst head-to-head studies are still required to investigate the efficacy of 
individual versus group CBT treatment in this population, the qualitative feedback 
from the adolescents and parents emphasised the benefits gained through participating 
in group-based therapeutic work. The sessions appeared to provide a safe environment 
for adolescents to work on reducing their anxiety, with others who may be like-
minded, or have experienced similar difficulties. Given that a high proportion of this 
population experience social difficulties, the group environment may in fact be a 
preferable treatment, providing an unmet social and normalising need. Evidence to 
this, in the general paediatric literature, a reduction in loneliness has also been found 
to mediate change in children diagnosed with social phobia (Alfano et al., 2009). 
For parents, being provided with information and skills on understanding and 
managing anxiety was expressed as being helpful. In the Chilled Program, where the 
duration of sessions was over approximately four and a half months, parents may have 
felt supported and empowered, to assist their child in managing their anxiety. 
  
153 
153 
Prominently, parents are often encouraged to participate in interventions when they 
have younger children with ASD, with little participation from parents in adolescent 
clinical treatment. In light of this, Reaven (2009) purports a dearth in documentation 
of the parent's evolving role in anxiety intervention for adolescents with anxiety. In 
the Chilled Program, parents remained at the clinic for each 2-hour session and when 
they were not participating in parent or family components (e.g., when the adolescent 
session was operating), they were provided with a space to have refreshments with 
each other. The discussions that took place among parents during this time, and within 
parent sessions, may have additionally provided support and/or a normalisation 
experience for parents. This supports findings of previous studies whereby parent 
involvement has positively contributed to treatment success (e.g., Chalfant et al., 2007; 
White et al., 2009). 
Interestingly, a number of parents revealed that they had gained insight into 
recognising their own anxiety levels, and had begun to use the skills learnt in the 
program for themselves as well as their child. With the literature reporting high levels 
of parental stress, this finding supports that of Hudson and colleagues (2014) who 
reported that parent anxiety symptoms reduced following participation in the Cool 
Kids program. However, it may be that reductions in their child’s anxiety may have 
led to changes in parent’s anxiety levels (Hudson et al., 2014). It would have been 
useful for the present study to assess parent anxiety levels at pre-and-post intervention.  
Both adolescents and parents reported satisfaction with the program, an 
acquisition of skills aligned with the program goals, and as outlined in Study One, they 
demonstrated high session attendance. This evidence of feasibility means that further 
refinement and development of Cool Kids Child Anxiety Program: ASD Adaptation 
(Lyneham et al., 2003) for adolescents is warranted.  
4.4.1 Limitations and future research. There are several limitations in the 
current study. First, the sample size for the quantitative component was relatively 
small and participants were, for the most part, Caucasian. Second, adolescent 
participant demographics are not exact due to adolescent anonymity and missing data. 
For adolescent participants, this study has therefore used demographic data derived 
from Study One. Third, it could be problematic for other studies to directly compare 
results, given the use of non-standardised measures for assessing social validity. The 
questionnaires used however, were administered with ease and have been successfully 
used in other evaluation studies (e.g., Roberts et al., 2010). Fourth, with global 
questionnaires completed at post-treatment, participants were not asked to provide 
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weekly ratings of sessions, or any form of measurement across time. Such information 
may have been useful in identifying specific tasks or components within sessions that 
were deemed to be helpful or unhelpful. In addition, parents provided feedback 
without anonymity and this may have impacted their responses. For example, 
responses may be affected by a social desirability bias or demand characteristics. 
Given the high number of adolescent participants that provided negative feedback on 
the handwriting component, it may be useful for future studies to trial the use of 
electronic devices to record session work, or replace some of the written components 
with increased practical exercises, audio or visual material, or discussions within 
sessions. While attendance rates were high (see Study One), engagement during 
program sessions was not recorded for individual participants. This information could 
have been useful as it may have correlated with program session satisfaction (Schwartz 
& Baer, 1991). 
Finally, and most importantly, although this study sought to hear the voices of 
young people with ASD and their parents, in order to determine how they feel in 
response to the program, they were not consulted in regards to the design, 
methodology, or on terms of reference used in this study. The need for participatory 
research in the field of autism is paramount. It is critical that individuals with ASD are 
able to bring their perspective and ideas to autism research to enhance the quality of 
the research process, as well as conveying an in-depth understanding to their 
experiences. In gaining the perspectives of individuals with ASD, future RCTs could 
focus on including youth with ASD and their families in the research design process 
through focus groups or online surveys. In addition, program satisfaction 
questionnaires could be administered electronically which would likely be more 
appealing to youth with ASD since they would not need to handwrite responses, and 
lengthier, more in-depth responses may be generated through typing. Whether typed/ 
electronic responses elicit more engagement and deeper responses compared to written 
feedback could be investigated in future studies for this population. Furthermore, the 
use of well-planned semi-structured interviews employing strategies similar to those 
shared by Harrington and colleagues (2013) are likely to gain greater qualitative 
information regarding the intervention than a written questionnaire.  
In summary, the voices of young people with ASD are often omitted in autism 
research for a variety of reasons. Some researchers have trialled particular strategies 
and carefully planned their research methodology in order to capture an in-depth 
understanding of the experiences of these youth. To date however, the social validity 
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studies of anxiety interventions for youth with ASD are limited and for the most part, 
lack qualitative feedback. This study provides evidence for the acceptability and future 
development of the Cool Kids Child Anxiety Program: ASD Adaptation for 
adolescents (the Chilled Program). Future research examining the social validity of 
this intervention, and others similar to it, is warranted. Findings from such studies will 
enhance our understanding of how the client with ASD (and their family) perceives 
CBT treatment. Based upon the results of this study, the Chilled Program showed good 
acceptability and relevance to both parents and adolescents and appeared to meet the 
participant’s needs for anxiety reduction.  Perhaps most importantly, a number of 
parents and adolescents reported evidence of daily life enrichment as a result of 
participation. Recommendations for future intervention research take account of 
including youth with ASD, and their families, in the research process. In addition, 
developing and implementing creative strategies to enable adolescents with ASD to 
express their views and experiences of the intervention is of high importance. Through 
this process, despite certain social and communication challenges, the voices of 
individuals with ASD are more likely to be heard, which is imperative if they are 
expected to fully participate in research.  
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Chapter 5: General Discussion and Conclusions 
5.1 Overview 
Co-occurring anxiety disorders are common in youth with an autism spectrum 
disorder and are associated with increased aggressive and oppositional behaviours, 
limited social engagement, and the potential to adversely affect academic 
performance, employability, and relationships (Gadow et al., 2008; Howlin & Moss, 
2012). With a surge of autism and anxiety research in recent years, this thesis began 
with a review of the literature on the history, prevalence, cognitive deficits and risk 
factors associated with autism spectrum disorders and co-occurring anxiety disorders. 
This was followed by an in-depth literature review on interventions for youth with 
ASD and clinical anxiety, with a particular focus on group cognitive behavioural 
therapy. Two linked studies were provided in the following chapters with the aim to 
increase the knowledge of cognitive behavioural therapy treatment for anxiety 
reduction in adolescents with ASD. The present chapter provides a summary of the 
major findings of each study, the integration of the two studies and how they uniquely 
contribute to the literature, along with the clinical and theoretical implications of these 
findings. Strengths and limitations of this research and directions for future research 
are outlined prior to the thesis conclusion.  
5.2 Key Findings 
5.2.1 Re-statement of the key findings of study one. The purpose of study 
one was to conduct a randomised controlled trial (RCT) to compare the efficacy of 
group CBT to a waitlist control. The major finding in this study was that the Cool Kids 
Child Anxiety Program: ASD Adaptation, a group, family-based anxiety reduction 
treatment, was effective in reducing anxiety symptomology in adolescents, including 
older adolescents, with ASD, with treatment gains maintained at 6-months follow-up. 
This finding suggests that adolescents (aged 12- to 18-years), with both ASD and 
clinical anxiety, can benefit from this intervention even though the original ASD 
protocol was aimed at children aged 8- to 12-years-of-age. This result is also congruent 
with previous research, including the Chalfant et al. (2007) investigation of the Cool 
Kids Child Anxiety Program: ASD Adaptation with children.  
Secondary findings indicated that for adolescents, depression symptoms may 
become elevated with anxiety CBT treatment, however parent reports demonstrated a 
decrease in anxiety symptoms for both conditions.  In addition, the findings of this 
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study suggest that the intervention has the potential to assist in increasing family 
quality of life. Furthermore, the gains made from pre- to post-treatment were 
maintained at 6-month follow-up. The findings of this study demonstrate that 
following 12-session group CBT adapted for children and adolescents with ASD, a 
significant reduction in participant symptoms and an increase in overall functioning 
can occur.  
5.2.2 Re-statement of the key findings of study two. The purpose of study 
two was to investigate adolescent and parent satisfaction with the Chilled Program. 
Study findings indicated high levels of satisfaction with the Chilled Program, and 
congruent with previous research (Reaven, Blakeley-Smith, Culhane-Shelburne, & 
Hepburn, 2012; White et al., 2013), parents rated the program slightly higher than the 
adolescents. In particular, the findings of this study suggest that parents gained 
knowledge and skills in assisting their adolescent to manage their anxiety, as well as 
support and normalisation of feelings and experiences from participating in a group 
environment. Likewise, the group environment and the normalisation of difficulties 
was a major factor in program satisfaction for the adolescents. Findings from this study 
indicated a reduction in anxiety for the adolescents as well as an accumulation of skills 
in managing symptomology. In terms of program improvement, this study suggests 
that the writing component for adolescents could be changed with many adolescents 
reporting this to be an aspect that they did not like or enjoy. A couple of parents 
reported challenges in making time to complete the home practice tasks.  
5.3 Integrating the two Studies: Theoretical Implications 
The two linked studies in this thesis are complimentary to each other and 
together, provide a clearer picture of the overall research question and findings, while 
highlighting discrepancies and strengthening any links. For example, study two 
findings confirmed a reduction in adolescent anxiety following treatment, a major 
finding from study one. Findings from study two indicated that adolescents and parents 
not only gained skills in managing anxiety, but practised skills, such as deep breathing 
and helpful thoughts, outside of sessions. These findings are congruent with studies 
using CBT with non-ASD clinically anxious children where an increase in positive 
self-statements, a decrease in negative self-statements and an increase in coping 
strategies mediated treatment outcome (Hogendoorn et al., 2014; Kendall & 
Treadwell, 2007; Lau et al., 2010).  
  
158 
158 
In addition, hierarchal exposure was a key element deriving from study two 
and may have been a contributing factor in both anxiety reduction and diagnostic 
remission observed in study one. Furthermore, the ASD program was extended over a 
longer timeframe (five months in the present study compared to three months in the 
standard program) which is likely to have provided more time to practice exposure 
tasks. Similar to the present study, a number of researchers have placed more emphasis 
on exposure components when adapting protocols for youth with ASD and achieved 
successful treatment outcomes (e.g., Chalfant et al., 2007; Wood et al., 2009). With 
behavioural exercises providing concrete feedback, therapeutic progress may have 
been facilitated (Scarpa & Lorenzi, 2013). Kendall (1997) and colleagues did find that 
reliance on cognitive strategies alone did not significantly reduce anxiety in a non-
ASD population until a behavioural component was introduced. It is assumed this 
would be similar for an ASD client group however, anxiety reduction was achieved 
(parent reports only) without an exposure component in Sofronoff and colleagues' 
(2005) protocol with children. It would be useful for future studies to determine 
whether exposure is a mediating factor for anxiety reduction in adolescents with ASD.  
Understanding how the cognitive deficits that commonly underpin ASD may 
contribute to anxiety disorders was not a particular focus of the current study. 
However, with rigid thinking and detail oriented processing believed to derive from 
having weak central coherence, it could be that cognitive restructuring may have 
assisted in reducing rigid thinking, expanding global processing, and therefore 
increasing optimistic and flexible thought, accumulating in reduced anxiety 
symptoms. In addition, parent involvement (as ‘coach’) and engaging in a manualised 
program may have assisted in enabling executive functioning skills (e.g., planning and 
organisation of exposure tasks and implementing anxiety management strategies) 
which could have assisted with anxiety reduction. Assessing whether participants with 
ADHD were less likely to demonstrate reduced anxiety following treatment could 
possibly assist with this theory. Further, being a group program, participants may have 
had the opportunity to develop theory of mind through learning to identify their own 
feelings, and those of others (e.g., through hearing fellow participants talk of their 
feelings and experiences, participating in group discussions, and learning how others 
may be impacted by their own behaviour). It would be helpful for future studies to 
assess these cognitive biases prior to and following anxiety treatment to understand 
how they may be contributing to, or moderating, the possible atypical, or distinct, 
symptoms of anxiety in those with ASD.  
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Consistent with Sofronoff et al's. (2005) findings that parent involvement 
enhanced treatment outcomes, study two showed that parents gained anxiety reduction 
skills while attending the program. In addition, parents reported that they often worked 
with their adolescent between sessions, on both anxiety management skills and 
exposure tasks. This is congruent with Puleo and Kendall's (2011) study findings 
where children in the family CBT condition completed more exposure tasks at home 
compared to the children in the individual CBT condition. In the current study, parent 
involvement may have contributed to the generalisation of adolescents’ skills beyond 
the clinic, and to decreases in psychiatric symptomology and increases in family 
quality of life. It can be hypothesised that because parents felt empowered and more 
skilled to assist their adolescent, in addition to a reduction in anxiety for adolescents, 
improved quality of life for families was experienced.  
A discrepancy between the two studies is apparent in terms of social skill 
development. In study two, many of the adolescents reported on the friendships they 
had made and on the enjoyment they had gained from being with similar aged peers, 
in both the sessions, and the session break times. It could be speculated that increased 
positive social interaction may have been associated with an increase in social skills 
however this was not found in study one. While the current study used the SSIS-RS, 
employing an alternative measure such as the Social Responsiveness Scale 
(Constantino, 2005) and an evidence based measure of core ASD deficits pre- to post- 
treatment/ intervention (e.g., the Autism Diagnostic Observation Schedule) may have 
provided more information on observed changes in core ASD symptoms (Danial & 
Wood, 2013).  
5.4 Clinical Implications 
With a lack of evidence for group treatments singularly targeting anxiety 
reduction in adolescents, the current study findings align with a small group of other 
RCTs indicating support for employing CBT to reduce anxiety in youth with ASD 
(e.g., Chalfant et al., 2007; Murphy et al., 2017; Reaven et al., 2012; Sofronoff et al., 
2005; Sung et al., 2011; White et al., 2009, 2013; Wood, 2009). However, this study 
is innovative and adds information to the current literature area since there hasn’t been 
an evidence base for the Cool Kids ASD protocol with older adolescents previously. 
Overall, while there were a few changes identified that could align this program more 
appropriately to adolescents, it was found to be a feasible intervention to modify and 
implement for adolescents with ASD and clinical anxiety.  
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With an increase in adolescents with ASD presenting to clinics for anxiety 
treatment, group programs can be cost-effective and they have the potential to reduce 
the demand placed on community services. In the present study three therapists 
delivered the group treatment, to a maximum of six adolescents and their parent/s. In 
Chalfant and colleagues (2007) study, two therapists experienced in ASD, presented 
the program, with similar treatment outcomes to the current study. It is unlikely that 
all clinical settings will have the capacity to facilitate programs with two or three 
therapists and therefore this group program may be limited to certain environments. 
However, there is a possibility that it could be delivered with fewer adolescents (for 
example, three or four) and one therapist. Given that it is a manualised program, mental 
health professionals are able to facilitate groups, provided they have completed the 
necessary training. The Emotional Health Centre at Macquarie University have 
recently made the Cool Kids Child Anxiety Program: ASD Adaptation manuals, along 
with Cool Kids Professional Education Training available to therapists both face-to-
face and online. This accessibility narrows the gap between research and practice, an 
element that has been proposed by Ollendick (2014) whereby evidence-based practice 
serves as a strategy to positive treatment outcomes in the clinic or community setting. 
While this group program demonstrated good outcomes, it is imperative that 
practitioners are aware that unique differences inherent in individuals with ASD may 
present certain challenges (Harkema & Coffee, 2014). For example, having children 
with behavioural problems, in addition to ASD and clinical levels of anxiety, within a 
group environment may necessitate particular modifications and a ‘flexible delivery’ 
approach (Chalfant et al., 2007; Mazzucchelli & Sanders, 2010). Selles and Storch 
(2013) suggest that similar to children with ASD who have challenging behaviour, 
incorporating applied behaviour analytic techniques into anxiety reduction programs 
may be useful.  
Overall, the findings of this study provide an attempt to close the gap between 
research and practice. That is, the findings of this research will be available to 
practitioners, along with the experiences and feedback from the families who 
participated in the treatment program. Practitioners could close this gap further by 
providing information and their clinical experiences back to the researchers of this 
program regarding what has worked for them in clinical practice. Here, a consensus 
on what is efficacious in anxiety reduction for older youth with ASD can be 
determined (Ollendick, 2014a). 
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5.5 Strengths and Limitations of Study One and Two 
While this research involved addressing a number of areas that have been 
missing in prior studies, there are several study limitations that need to be taken into 
consideration. The strengths and limitations of study one and two are discussed 
together.  
5.5.1 Participants. A strength of this study was the likely representative 
sample of adolescents with ASD gained through a wider inclusion criterion, 
particularly in terms of age and comorbid diagnoses. Prior research has often excluded 
older youth with ASD, with some researchers additionally excluding participants who 
have presented with particular comorbid behavioural and or emotional disorders (e.g., 
ADHD, OCD, or ODD). In contrast, the intention for this study was to gain 
participants who were as closely representative of a community sample as is possible 
in a RCT. Considering that behavioural and emotional comorbid disorders commonly 
occur for youth with ASD, it made sense to include them for purposes of 
generalisability. As previously mentioned, a major limitation of this study is the small 
sample size and the fact that participants were primarily Caucasian, therefore results 
need to be interpreted with caution (Kraemer, 2006).  
5.5.2 Therapists.  Despite the risk of limiting generalisability of a treatment 
protocol, the primary advantage of having the same primary therapist across 
participant groups was that a consistent and standardised mode of program delivery 
was provided while controlling for therapist effects, such as personality, gender, and 
experience (Sung et al., 2011). While the independent clinical evaluators rated the 
therapists on a number of facilitation and therapeutic factors, it may have been useful 
to assess therapist behaviours more thoroughly in order to inform clinical practice for 
this client group. A recent review by Weston et al., (2016) emphasised the dearth of 
attention given to therapist competence within the ASD treatment literature despite 
factors such as integrity, therapist style, alliance and experience being linked to 
outcomes in numerous non-ASD intervention studies (Brown et al., 2013; Cooper, 
Loades, & Russell, 2018; Hudson et al., 2013; Wergeland et al., 2016). It could be 
useful to determine whether these therapist factors are the same for individuals with 
ASD. Ozsivadjian and Knott, (2011) assert that an in-depth understanding of autism 
spectrum disorders, particularly the neuropsychological processing style inherent in 
these individuals, is arguably the most useful tool that a therapist can bring to an 
intervention. In addition, a pilot study by Murphy et al. (2017) demonstrated that 
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clinicians were as successful in forming positive therapeutic relationships with clients 
with ASD as clinicians were with non-ASD participants in a previous study (McLeod 
& Weisz, 2005). This implies that individuals with ASD are able to form therapeutic 
alliances with therapists, an area that has previously been questioned. Future research 
could investigate whether an understanding of, in addition to experience working with 
individuals with ASD, are predictors of positive treatment outcomes.  
5.5.3 Independent clinical evaluators. The use of blind independent clinical 
assessors was an additional strength of this study, however in reality this was difficult 
to put into practice. On three occasions, independent clinical evaluators reported that 
a parent had revealed whether they had received treatment or not, during the ADIS-P 
interview at post-treatment/ waitlist. Since the ADIS-P interviews were video or audio 
recorded, these three interviews were checked by the supervising clinical psychologist 
for reliability on clinical diagnoses and clinical severity ratings. Although parents were 
asked not to reveal their assigned condition during the interviews, they were not 
requested to sign a formal contract to this effect. Future researchers may want to 
implement ways to control for this potential error. Perhaps independent clinical 
evaluators can remind parents when they make the initial interview time, and then 
again at the commencement of the interview. Since Sung et al. (2011) used an active 
control group, parents were not actively informed of their study condition until the end 
of the research period. This is of course not possible with an intervention/waitlist 
control design but it does offer a solution to a potential problem. 
An additional strength of this study was the blind independent clinical 
evaluators used to examine treatment integrity. Therapist’s adherence to treatment 
gives testament to the fact that it was more than likely the treatment that led to 
successful study outcomes. Given that both intervention and waitlist group sessions 
were randomly viewed by the independent clinical evaluators, it can be suggested that 
no difference occurred in treatment delivery between participants being assessed for 
treatment change (CBT group) and those receiving treatment following the study 
assessment period (WL group).  
5.5.4 Assessment and measures. A limitation of the current study is that the 
study therapists did not conduct the autism diagnostic assessments of the study 
participants. Instead, the researchers relied on retrospective ASD diagnostic data based 
on the previous diagnostic system (DSM-IV).  The limited validated and normed 
measures to assess psychosocial symptoms in children, adolescents, and adults with 
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ASD is another study limitation (Gantman, Kapp, Orenski, & Laugeson, 2012). 
However, the majority of measures assessing treatment response in this RCT were 
chosen from a limited list of measures thought to be appropriate for adolescents with 
ASD and anxiety (White, et al., 2013). A strength of this study was the focus on 
acceptability of the treatment and the attempt to hear the voices of the participants. 
Standardised measures assessing program satisfaction in this client population are 
needed.  
Limitations in child and adolescent self-reports complicate psychiatric 
diagnostic or symptomology information (Mazefsky et al., 2011), and this may be the 
case in the current study. Similar to previous research in this area (e.g., Reaven et al., 
2009; Wood et al., 2009), it could be that accurate self-reporting was diminished by 
ASD deficits such as, communication difficulties and challenges with introspection 
and emotion identification. Furthermore, while two self-report measures were 
employed in the current study, the majority of information gathered through the 
measures relied on parent-reports. Since parents were not blind to condition, those in 
the CBT condition may have been invested in achieving successful outcomes due to 
the time they dedicated to the program (e.g., attending sessions, and assisting their 
child in homework and exposure tasks). In addition, parents may have felt hope that 
positive results would occur for their adolescent, as well an expectancy for change 
(McNally et al., 2013). As McNally and colleagues suggest, even if parents perceive 
change to occur then this may positively impact family quality of life. Future studies 
may take these factors into consideration when designing research. For example, the 
use of a credibility and expectancy questionnaire completed by participants in both 
conditions, prior to the treatment/ waitlist, may ascertain if differences in expectancy 
exist. 
5.5.5 Treatment. A further strength of the current study is the minor adaptation 
of the Cool Kids Child Anxiety Program: ASD Adaptation, to assist in its appeal and 
suitability for adolescents, including older adolescents with ASD. Given the 
qualitative feedback from study two, it is possible that further adaptation could be 
beneficial for the older adolescents. A focus group following group treatment may 
have been effective to advance understanding of the adolescents’ experience of the 
program components and to glean ideas as to how specific components could be 
changed to suit an older audience.  
To date, there is no single established best approach for group treatment for 
youth with ASD and co-occurring anxiety disorders. For children and early 
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adolescents there have however been numerous modification trends to traditional 
CBT, although it is still not known which treatment components are imperative for 
anxiety reduction (Selles & Storch, 2013). It may be that not every treatment 
component is needed for change to occur (Moree & Davis, 2010). In the current study 
it could be suggested that visual tactics, parent involvement, and exposure, assisted in 
psychological change however, there is no certainty of this claim. In addition, 
adolescents with particular types of anxiety may respond better to certain treatments. 
For example, a strength of the current study is the finding that adolescents with a 
primary anxiety diagnosis of GAD and specific phobia responded better to the 
treatment program compared to adolescents with other primary anxiety disorders.  
5.5.6 Study design. While a small number of prior studies incorporating older 
adolescents with ASD, targeting anxiety reduction, have used group CBT in open trial 
(e.g., Ehrenreich-May et al., 2014) or have additionally targeted social skills (e.g., 
White, 2013), a strength of the current study design is that it was a family-based 
randomised controlled trial, using a treatment and a waitlist group. In recent years 
there have been a growing number of RCTs using an active control group. The 
difficulty with this however, has been that active control groups often contain some 
element of CBT, therefore interfering with a pure comparison being made between 
treatment and control groups (Ewing, Monsen, Thompson, Cartright-Hatton, & Field, 
2013). Sung and colleagues (2011) appeared to control for this factor well, offering 
their control group a social recreation program which included age-appropriate 
activities such as puzzles, preparing a meal, and magic tricks. Given that these authors 
did not include parents, or use the ADIS-P to assess anxiety, future group CBT studies 
replicating the use of an active control group and including these missing elements are 
warranted. Additionally, a control waitlist group in conjunction with a treatment and 
active control conditions will assess whether the therapist and/or group contact may 
be contributing to anxiety reduction. A further weakness of the current study design 
was the lack of control group at follow-up due to it being deemed unethical to withhold 
the evidence based treatment (CBT) for longer than the 6-month follow-up period.  
Therapists facilitating the groups sessions were not blinded to treatment 
conditions which may have impacted the results. There is the possibility that therapists 
may have interacted differently with treatment group participants, or that different 
groups may have received different intervention components.  However, the blinded 
independent clinical evaluators ratings did not demonstrate any significant differences 
in adherence to treatment, or in therapist facilitation, across the randomised sample of 
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group sessions that they rated so this appears unlikely. Further limitations were that 
homework compliance was not calculated for participants in this study, nor was 
individual in-session participation evaluated. In study two, program satisfaction 
feedback was only collected at the end of treatment rather than following each session. 
This limited the ability to identify individual session treatment components that may 
have contributed towards positive or negative intervention outcomes.   
An additional strength of the current study was the 6-month follow-up period, 
demonstrating short-term maintenance of treatment gains. However, this follow-up 
period pales in comparison to studies of typically developing children where 
maintenance has been studied for up to 14 years following CBT treatment. Differences 
between the treatment and control groups in the current study could have been better 
determined with a longer follow-up period. 
5.5.7 Analysis. Many previous studies have employed conventional analysis 
of variance which is limited by a number of statistical assumptions. A unique strength 
of this study is the use of the GLMM statistical procedure to analyse the data. This 
sophisticated statistical tool was able to account for the missing data and reduce error 
in the data, thereby increasing the accuracy of the findings (Tabachnick & Fidell, 
2013). Analyses of statistical significant change were supplemented by the Clinical 
Global Impression Scale and Reliable and Clinically Significant Change in order to 
determine whether change transpired to the individual level, a necessity when 
assessing the efficacy of an intervention (Chambless & Hollon, 1998; Jacobson & 
Truax, 1991). Given that multiple statistical comparisons were conducted on a fairly 
small number of participants, caution needs to be taken when interpreting the results.  
5.6 Recommendations for Future Research  
In light of the initial findings suggesting positive treatment outcomes and 
numerous study limitations, the following future research directions are suggested to 
replicate and expand on the present studies.   
5.6.1 Study one: Future research recommendations. In the typically 
developing paediatric population there is a consensus that group and individual 
treatment are fairly equivalent in terms of treatment outcomes  (Reaven et al., 2012). 
To date, such comparisons of CBT have not been made in the ASD population. Future 
research needs to investigate whether there are differences in treatment outcomes 
between individual and group CBT in a head-to-head randomised controlled trial. In 
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addition, identifying whether youth with highly complex psychiatric profiles may be 
more suited to individual therapy. More recently, internet therapy has been studied 
(Weston et al., 2016) and this may be an attractive and more accessible option for some 
individuals with ASD. In addition, most study samples in this area have been fairly 
small and as such multi-site research studies assessing individual, group, and internet 
cognitive behavioural therapy are needed (Ho et al., 2018).  
Furthermore, identifying which cognitive and behavioural treatment 
components are necessary to reduce anxiety will assist in protocol design and may be 
more cost effective and less time consuming then including all program components. 
Danial and Wood (2013) suggest that researchers measure cognitive skills as well as 
behavioural change across assessment points in order to ascertain whether cognitive 
and behavioural change occurs simultaneously for people with ASD, as expected with 
CBT. Such measurement may assist in identifying which CBT components are 
responsible for producing changes in anxiety for this population. Further, identifying 
how specific ASD symptoms affect response to treatment has been stated as a top 
priority by researchers (Vasa, Keefer, Reaven, South, & White, 2018). Additionally, 
isolating the specific CBT components that lead to reduced anxiety, and explicating 
the mediators and moderators of treatment response would be beneficial for program 
developers and therapists (Vasa et al., 2014).  
Furthermore, the need for parent involvement in CBT programs for adolescents 
with ASD is still questioned and future studies could simultaneously study the use of 
CBT with and without parent participation. Broadening the Cool Kids Child Anxiety 
Program: ASD Adaptation to suit individuals with ASD and intellectual disability is 
additionally worth studying. Likewise, adapting the program for young adults (e.g., 
18- to 25-year-olds) may also be beneficial given the proposed high rates of mental 
health problems and poor adult outcomes reported in the literature (Howlin, 2000). 
With researchers focusing heavily on children and early adolescents, this age group 
has been neglected in intervention studies.  
The original study using the Cool Kids Child Anxiety Program: ASD 
Adaptation (Chalfant et al., 2007) lengthened the standard Cool Kids program so that 
the 12 sessions were delivered to children with ASD over a six month period. The 
current research ran the program over five months with similar results. Determining 
whether a longer length of program is necessary, and whether this is related to 
maintenance would be valuable (Vasa et al., 2014). In addition, with feasibility and 
efficacy established in accordance with the NIMH guidelines, it would be beneficial 
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to extend research on the current program to a phase 4 community-effectiveness trial. 
Having the protocol administered by a community agency would enable validation of 
the results within real world conditions (Lopata et al., 2010; Smith, Yule,  Perrin, 
Tranah, Dalgleish, Clark, 2007).  
As mentioned, considerable work is required in the area of screening and 
assessment of psychiatric difficulties in addition to ASD. Currently, with a heavy 
reliance on measures designed for the typically developing youth, it is challenging to 
incorporate outcome measures in clinical trials for individuals with ASD. In addition, 
while some functional measures were included in this study design (e.g., social skills 
and family quality of life), other improvements in symptoms could also be measured, 
such as school attendance, extra-curricular activities, improved social relationships, 
and adaptive behaviours, in order to determine if anxiety reduction is related to 
functional outcomes (Reaven, Blakely-Smith, Culhane-Shelburne, et al., 2012). 
Furthermore, with multi-informants recommended, it could be useful for future studies 
to include teacher-reports. This may assist in further identifying whether anxiety 
reduction is being generalised into the school environment. 
5.6.2 Study two: Future research recommendations. It is recommended that 
weekly participant feedback on treatment acceptability and monitoring of outcomes 
are included in future studies, perhaps incorporating single case experimental design. 
Ideally, this would assist in identifying specific components that may be impacting on 
change within sessions and could assist in future program development. Adolescents 
and their parents could additionally be measured on specific skills for example, anxiety 
knowledge and coping strategies in order to determine what information and skills 
they have mastered over time to achieve intervention effects (Ho, Stephenson, & 
Carter, 2014). Finally, for true social validity it is recommended that people with ASD 
be involved in the design and development of future research studies (Foster & Mash, 
Eric, 1999). For example, in the current study, participants could have been included 
in the adaptation of the manual and could have provided feedback on individual 
components of the program. Inclusive design approaches allow for the authentic 
involvement of individuals with ASD from the beginning of research projects (Parsons 
& Cobb, 2014). This allows for research practices to be facilitative, inclusive and 
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effective in supporting social inclusion and communication (Abascal & Nicolle, 2005; 
Parsons & Cobb, 2014).  
5.7 Conclusion 
This is the first RCT adolescent adaptation of the Cool Kids Child Anxiety 
Program: ASD Adaptation (Chalfant, Lyneham, Rapee, & Carroll, 2011). The findings 
of the present research provides valuable information on the efficacy and social 
validity of this program with older adolescents. A number of treatment effects were 
found, including the primary outcome of anxiety reduction, as well as increases in 
family quality of life. Treatment acceptability of this intervention by the participants 
and parents was also found. Due to these findings and those of Chalfant et al., (2007), 
it is recommended that the current program can be employed to assist this client 
population.  
In more recent years there has been a substantial growth in the study of ASD 
and anxiety. A number of books have been published on this topic alone (e.g., Kerns, 
Renno, Storch, Kendall, & Wood, 2017; Scarpa, White & Attwood, 2013) in addition 
to numerous research studies (e.g., Chalfant et al., 2007; Reaven, 2011; White et al., 
2009; Wood & Gadow, 2010) systematic reviews and meta-analyses (e.g., Ho et al., 
2014, 2018; Ung et al., 2014). Providing children and adolescents with ways to cope 
with and manage anxiety is likely to assist with better mental health and functional 
outcomes across the lifespan. While the dominant focus has been on assisting children 
with ASD, more recently researchers have begun to investigate ways to understand 
how adolescents and young adults are affected by both ASD and affective disorders. 
Developing clinical applications to achieve successful treatment outcomes with this 
population is imperative, due to their obvious complex psychiatric needs and poor 
outcomes.  
The importance of placing the views of the adolescents and their families at the 
centre of this work has been the guiding principle of this research. While this study 
does not claim to achieve “best practice” in this area, it hopes to offer a basis for how 
researchers can continually develop, reflect, and advance components of social 
validity in intervention research (Parsons & Cobb, 2014). Autism families are prone 
to experiencing high levels of stress, and this may be reduced with interventions that 
are both effective and appropriate to participant and family needs. Including the voices 
of people with ASD in research can assist in participant-centred research design, 
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implementation, and evaluation, and is likely to provide benefits and rewards for all 
involved (Parsons & Cobb, 2014).  
While the information provided by the present study will contribute to the 
existent body of work in this area, there is much work needed in order to ascertain best 
practice for adolescents with diagnoses of ASD and clinical anxiety. There are a 
variety of treatment approaches and methodological shortcomings in the current 
literature, and often very idiosyncratic and complex profiles amongst participants. 
Through research and practice, the overall goal is to provide the best treatment to 
individuals with ASD, and their families, in order to improve their psychological well-
being, daily functioning, and quality of life. In striving to understand the relationship 
between ASD, anxiety, and treatment, the continual advancement of knowledge gained 
through research and practice can be drawn upon to assist adolescents with ASD to 
fully realise their life potential.  
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Appendices 
Appendix A: Cover Letter and Flyer 
The Chilled Program 
Dear Parent, 
 
As recently discussed, I have attached the information letters, a demographic form, 
and consent forms for both yourself and your child.  The information letters describe 
the program in more detail and if either you or your child would prefer this 
information given to you verbally then please contact me. I am happy to visit you to 
discuss the program in more detail. Likewise, if there is any aspect of these letters 
that you would like to discuss, or questions regarding the program generally, please 
do not hesitate to contact me.  Please note that I have a new phone number to be 
contacted on: (08) 9266 3436 or I can be contacted by email: 
Theresa.kidd@postgrad.curtin.edu.au 
 
Please ensure that you and your child read the appropriate information letters and if 
you both agree to the information provided, and would like to participate, then please 
complete and return the following forms in the reply paid envelopes enclosed: 
1) Chilled Demographic Form 
2) Consent Form - Parent 
3) Consent Form for Audio and Video Recording 
4) Chilled Consent Form – Adolescents 
Once again, if you have any questions please contact me on (08) 9266 3436.  
 
Thank you for your time and interest in The Chilled Program 
 
Kind regards 
 
Theresa Kidd 
PhD Candidate (Clinical Psychology) 
Curtin University 
School of Psychology and Speech Pathology 
GPO Box U1987 Perth, 
Western Australia 6845  
Phone: 08 9266 3436 
Email: theresa.kidd@postgrad.curtin.edu.au 
  
 
  
202 
202 
Appendix A: Continued 
 
 
 
 
! !
 
12#$#18#year#olds#who#
have#high#functioning#Autism#
Spectrum#Disorder#(ASD)#
or#Asperger’s#Syndrome#and#
experience#anxiety. 
Chilled#is#a#12$
session#group#program#to#help#
adolescents#to#learn#how#to#
reduce#and#manage#their#
anxiety. 
Chilled#
uses#Cognitive#Behavioural#
Therapy#(CBT)#techniques#for#the#
treatment#of#adolescent#anxiety#
and#is#specifically#tailored#to#
meet#the#needs#of#individuals#
with#high#functioning#ASD.##
#
#
This#program#includes:##
• Relaxation#training#
• Identification#of#emotions#
and thoughts#
• Positive#self$talk#
• Coping#skills#
• Social#skills##
• Problem#solving#
• Parent#sessions# 
Contact:#Theresa'Kidd##
School#of#Psychology#and#Speech#
Pathology,#Curtin#University#
Theresa.kidd@postgrad.curtin.edu.au#
Phone:## 0420482053#
Chilled#is#part#
of#a#research#project#at#Curtin#
University#which#means,#if#
eligible,#you#will#be#randomly#
placed#into#one#of#two#groups: 
• The#CBT#group#–#you#will#
begin#group#sessions in 
May,#2013#or##
• The#Waiting#List#Group#–#
you#will#wait#6#months#
before#attending#sessions. 
Adolescents#and#parents#in#both#
groups#will#be#required#to#complete#
questionnaires#throughout#the#study. 
Free!  
#
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Appendix B: Information Letter for Parents 
Introduction 
 
The Chilled Program is based on the Cool Kids® Anxiety Program and has 
been specifically adapted for adolescents with an Autism Spectrum Disorder. Chilled 
is a weekly course designed to teach adolescents how to better manage their anxiety. 
It is a group program involving the participation of one parent and their adolescent, 
and runs for 12 sessions. The first 9 sessions are run once a week and the final 3 
sessions are once a month. Participating in this research program allows families 
access to cutting edge treatment for anxiety. 
 
The sessions teach clear and practical skills based on cognitive behavioural 
therapy (CBT). Sessions have been adapted to suit the visual learning style of 
individuals with ASD. Positive reinforcements will be used to make the sessions 
motivating and enjoyable. 
 
Topics covered in the program include: 
• Learning about feelings 
• Me and my anxiety 
• Learning to Relax  
• Detective thinking, and helpful thoughts 
• Becoming the boss of my fears and worries 
• Dealing with worry 
• Social skills and assertiveness 
 
One parent of the adolescent will attend a concurrent session, which will cover 
educational and informational material relating to helping their adolescent manage 
their anxiety. 
 
Participation is Voluntary 
 
Participation is the study is entirely voluntary and you are free to withdraw 
from the study at any time without prejudice. You do not need to give a reason for not 
completing the study. If you decide not to participate, or want to leave the study at a 
later stage, and would like your adolescent to receive help from outside of the study, 
then we will be happy to provide you with a list of professionals experienced in ASD. 
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What is the Purpose of the Study? 
 
This study will be comparing anxiety levels of adolescents before and after 
group participation, and 6 months following the completion of the sessions.  In 
addition, this research will compare anxiety levels between those that attend the 
sessions during the study and those that are in the waiting list group. If you are 
accepted into the study, you will be placed into one of two groups: 
 
1) The Intervention group. 
In this group adolescents will attend 12 group sessions to help them 
learn to recognize and manage their anxiety levels.  One parent of each 
adolescent will attend concurrent parent information sessions. 
2) The Waiting List group. 
Participants in this group will wait approximately 6 months before 
participating in the treatment sessions however they will be required to 
complete questionnaires three times throughout the study. 
 
What is involved if I decide to participate? 
1) If your adolescent is aged between 12 and 18 years, has a diagnosis of High 
Functioning Autism or Asperger’s Disorder, and suffers from anxiety, then 
they may be eligible to participate in this study.  
2) Contact Theresa Kidd, the chief investigator of this study, on 9266 4149 to 
discuss eligibility and the study further.  
3) Theresa can then make a time to meet with you (at a place and time 
convenient to your family) to discuss the study in more detail and provide 
you and your adolescent with consent forms. If this is not convenient the 
forms can be posted to you and returned to the university in the reply paid 
envelope provided should you and your adolescent wish to participate. 
4) Once the consent forms are signed, a clinical interview with the parent to 
assess their adolescent’s anxiety levels will be conducted. Since this study is 
looking at reducing anxiety levels, adolescents will need to meet an anxiety 
disorder diagnosis to participate in the study.  
5) Study eligibility will then be determined and if eligible, you will be randomly 
placed into one of two groups: Intervention group or Waitlist group. 
6) You and your adolescent will need to be available to attend 12 sessions. The 
first 10 sessions will be held weekly and the final 2 sessions monthly 
thereafter. Sessions will run for approximately 2 hours on a weekday 
afternoon, with the possibility of a Saturday morning sessions. You will be 
asked to specify the days/times suited to you, however it is possible that you 
may not receive your preference. If you cannot attend this first group you 
may be offered a second group the following term. 
7) Parent and adolescent dyads will be required to complete a homework task in 
between sessions. 
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8) Questionnaires packages will be posted to parents and adolescents in both 
groups, 3 times throughout the study, and returned using the provided reply 
paid envelopes. Assistance in completing these can be given if required. The 
first questionnaire package will be completed prior to the commencement of 
the study, once the sessions have been completed and then 6 months later for 
the intervention group only. 
9) In addition to the clinical interview conducted with parents prior to the 
commencement of the study, adolescents’ anxiety levels will additionally be 
assessed upon completion of the sessions and 6 months after the sessions 
have been completed.   
 
Potential risks 
 
This program has been used in a study with younger adolescents, with very 
promising results.  However, no guarantee can be given that your adolescent will 
benefit from treatment. You are able to withdraw from this study at any time.    
 
Medication and Therapy  
Whilst participating in the study we ask you to refrain from participating in any 
other psychological therapy programs, social skills training or parenting programs.  If 
the adolescent is on medication prior to commencing the study they will need to remain 
on the same dosage throughout the study.  If an adolescent is not taking medication 
(e.g., for anxiety) prior to commencing the study then it is preferable that they remain 
medication free for the entirety of the study (including 6 months after sessions are 
completed). Adherence to these conditions will ensure accurate outcomes.  
 
Confidentiality 
 
All personal information collected throughout the study will be kept 
confidential and remain in a locked filing cupboard at Curtin University for 5 years 
following the study. A code will be given to each participant to ensure that the names 
of participants are not documented with interview material or completed 
questionnaires. Information will only be viewed by those connected with the study and 
if the research is published, name of participants will not be used.  
 
Upon completion of the study, general results will be made available to 
participants upon request. 
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What do I do now? 
If you are interested in participating in the Chilled Adolescent Anxiety program: 
ASD Adaptation, please complete the consent form attached, or if you require more 
information, please call myself, Theresa Kidd, directly on (08) 92664149 or email 
me Theresa.kidd@postgrad.curtin.edu.au or my supervisor, Dr Clare Roberts (08) 
9266 7992 or email Clare at C.Roberts@curtin.edu.au 
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Appendix C: Demographic Form 
 
 
 
Parent Name: 
______________________________________________________________ 
 
Age: 
______________________________________________________________ 
 
Address: 
______________________________________________________________ 
 
Relationship Status: 
______________________________________________________________ 
 
Number of Children: 
______________________________________________________________ 
 
Name of Adolescent with ASD: 
______________________________________________________________ 
 
Age of Adolescent: 
______________________________________________________________
______ 
 
Age at time of diagnosis: 
______________________________________________________________ 
 
Diagnosis/Diagnoses:  
______________________________________________________________ 
 
History of Intervention and therapy services child has received:  
______________________________________________________________ 
 
Is your adolescent currently receiving any intervention/therapy?  
______________________________________________________________ 
 
Is your adolescent currently on medication?  If so, what medication?  
______________________________________________________________ 
 
Is English your adolescent’s first language? 
______________________________________________________________ 
 
Does your adolescent have any allergies or diet restrictions? 
______________________________________________________________ 
 
Is there any other information about your adolescent that may be useful for the 
researchers of the study to know? 
______________________________________________________________ 
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Appendix D: Consent Form – Parent 
 
 
Please read the following statements, and sign below if you agree for your 
adolescent to participate: 
 
 
• I understand that the treatment is aimed to reduce anxiety levels however there 
is a chance my child will not benefit from treatment.   
 
• I understand that my adolescent will be assigned to either the Intervention 
group or the Waiting List group and therefore may need to wait 6 months 
before receiving treatment. 
 
• I understand that I will need to attend concurrent sessions (12 in total) to my 
adolescent and that we will need to complete a weekly homework task.  
 
• I acknowledge that my adolescent will not participate in other psychological 
therapy or social skills program for the duration of the study and for 6 months 
following the final session.  
 
• I acknowledge that if my adolescent is on anxiety medication prior to 
commencing the study, this needs to remain at the same dosage throughout the 
study and for 6 months following the final session.  
 
• If my adolescent is not taking medication I understand that they are not to 
commence medication during the course of the study and for 6 months 
following the final session.  
 
• I understand that I am not obliged to participate in this study and I am free to 
withdraw at any time without prejudice. 
 
• I can refuse to answer any question without reason. 
 
• I understand that information gathered will be treated with confidentiality and 
that the research data gathered for the study may be published provided I am 
not identifiable.   
 
• I understand that information relating to the study will remain in locked 
storage at Curtin University for 5 years following the completion of the study.  
 
• I have read and understood the information sheet. 
 
• I have been given the opportunity to ask any questions about the study and 
these have been answered to my satisfaction. 
 
Parent’s name:   ____________________________________  
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Parent’s name:   ____________________________________  
 
Adolescent’s name:  ____________________________________ 
 
Parent’s signature: _____________________________________  
 
Date:    _____________________________________ 
 
Contact telephone number: __________________________________ 
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Appendix E: Consent for Video Recording 
Consent form for video recording for supervision and research purposes 
 
Place of video recording: _________________________ 
 
Participant’s name: ______________________________ 
 
For research and supervision purposes there is a possibility that some sessions will be 
recorded. The video may be used for supervision purposes to ensure that the 
facilitators are meeting the requirements of the program, and for educational and 
teaching purposes.   
 
The video will record group sessions and will be stored in a locked cabinet at Curtin 
University when not in use. You do not have to give consent to your adolescent or 
yourself being video recorded, your choice in this matter will not affect your 
participation in the program. You are able to withdraw your consent to be video 
recorded at any time. 
 
If you consent to your consultation being recorded, please sign below. 
 
To be completed by the parent if the adolescent is under 18 years of age. 
 
I have read and understood the above information and give permission for my 
adolescent and myself to be video recorded in sessions. 
 
Name of adolescent: 
 
________________________________________________ 
 
Name of Parent: 
 
________________________________________________ 
 
Signature of Parent:  
 
________________________________________________ 
 
Date: ___________________________________________ 
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Appendix F: Adolescent Information Letter 
Chilled Information Letter – Adolescent 
 
The Chilled Program is a fun way to learn how to relax and calm your fears 
and worries in a safe, small group setting. 
 
What do I have to do? 
 
§ If you wish to participate please sign the consent form and return it in 
the reply paid envelope.  
 
§ Complete a short questionnaire 3 times throughout the study.  We can 
help you with this. 
 
§ Attend 12 group sessions which will include topics such as: 
 
Ø What is anxiety? 
Ø Me and my anxiety 
Ø Learning about feelings 
Ø Relaxation 
Ø Detective thinking, and learning to think more realistically 
Ø Becoming the boss of fears and worries 
Ø Learning to solve a problem 
Ø Social skills and assertiveness 
 
§ Complete an activity each week between sessions with the help of your 
parent. 
 
§ Be in the draw to win movie vouchers, random prizes during sessions, 
and eat the snacks provided! 
 
§ If you have any questions about participation please ask your parent or 
call Theresa Kidd at Curtin University on (08) 9266 4149. 
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Appendix G: Adolescent Consent Form 
Chilled Consent form – Adolescents 
 
 
• I understand that I am not obliged to participate in this study and I am 
free to withdraw at any time without prejudice. 
 
• I understand that if I participate in this study that I will need to attend 12 
sessions and complete an activity each week between sessions, with 
the help of my parent.  
 
• I can refuse to answer any question without reason. 
 
• I understand that information gathered will be treated with 
confidentiality and that the research data gathered for the study may be 
published provided I am not identifiable.   
 
• I understand that information relating to the study will remain in locked 
storage at Curtin University for 5 years following the completion of the 
study.  
 
• I have read and understood the information sheet. 
 
• I have been given the opportunity to ask any questions about the study 
and these have been answered to my satisfaction. 
 
 
Adolescent’s name:     ____________________________________ 
 
Adolescent’s signature:    ____________________________________ 
 
Date:        ____________________________________ 
 
Contact telephone number: ___________________________________ 
  
213 
213 
 
 
Appendix H: Checklist Examples 
 
Chilled Facilitator Checklist  
Session Checklist:     Facilitator/s: 
Session 1: Program overview / Feelings and worries 
 
Activity 
Tick box if 
covered 
Time spent 
(minutes) 
Notes 
Introduction       
 
Family together      
    
Adolescent’s alone:    
 
 
Feelings Identification      
 
“What is anxiety?      
 
Introducing Calvin and Austin 
    
  
Austin’s list of worries 
    
 
 
 
Healthy vs. unhealthy worries 
    
  
Anxiety and my body 
    
 
 
 
Practice Task 1: My body and my worries      
Practice Task 2: Using my Cool Teens coping 
skills    
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Session 1: Program overview / Feelings and worries 
 
Please rate the following aspects of the lesson:  
 
1. The overall success of the lesson:  
      
 
   
1 2 3 4 5 6 7 8 9 10 
Comments:  
 
 
 
 
2. Your preparation – knowledge of materials, organisation of resources, etc.. 
      
 
   
1 2 3 4 5 6 7 8 9 10 
Comments:  
 
 
 
3. Your presentation – clarity, pacing, thoroughness, etc.. 
      
 
   
1 2 3 4 5 6 7 8 9 10 
Comments:  
 
 
 
4. Your rapport with the class – friendliness, use of names, etc… 
      
 
   
1 2 3 4 5 6 7 8 9 10 
Comments:  
 
 
 
5. The group cohesion and support: 
      
 
   
1 2 3 4 5 6 7 8 9 10 
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Appendix H: Checklist Example 2  
 
Session Checklist:     Facilitator/s: 
Session 5: Becoming the Boss of My Fears and Worries 
 
Activity 
Tick box if 
covered 
Time spent 
(minutes) 
Notes 
    
Family together      
    
Adolescent’s alone:  
 
Overview of group rules/ home tasks 
 
   
Bossing Back!      
 
How Have My Worries Been Bossing Me About? 
    
 
 
 
    
   
 
 
Family Together 
 
Rewards for Being Brave 
 
What are the Fears or Worries that I want to Boss 
Back? 
   
   
 
 
Practice Task 5a:Making a Fears and Worries List 
    
  
 
Practice Task 5b: Using My Chilled Skills                        
 
 
 
 
 
 
Parent Session: 
 
Covered Material 
 
Comments 
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Session 5: Becoming the Boss of My Fears and Worries 
Please rate the following aspects of the lesson:  
 
1. The overall success of the lesson:  
      
 
   
1 2 3 4 5 6 7 8 9 10 
Comments:  
 
 
 
2. Your preparation – knowledge of materials, organisation of resources, etc.. 
      
 
   
1 2 3 4 5 6 7 8 9 10 
Comments:  
 
 
 
3. Your presentation – clarity, pacing, thoroughness, etc.. 
      
 
   
1 2 3 4 5 6 7 8 9 10 
Comments:  
 
 
 
4. Your rapport with the class – friendliness, use of names, etc… 
      
 
   
1 2 3 4 5 6 7 8 9 10 
Comments:  
 
 
 
5. The group cohesion and support: 
      
 
   
1 2 3 4 5 6 7 8 9 10 
 
Comments:  
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Appendix I: Parent Questionnaire 
Program Satisfaction Questionnaire 
Parent Version 
 
This form assesses how effective and appropriate you found the Chilled program. 
Thank you for taking the time to complete this form - your feedback is important. 
 
 
Please describe any changes in your adolescent’s skills or behaviour that you believe 
are directly due to their involvement in the Chilled program: 
 
 
 
 
Since the beginning of the program, what changes have occurred in how you support 
your adolescent (if any)? 
 
 
 
 
Below are a series of questions. Please circle the response that best reflects your 
answer.  
1. Please rate how confident you are in your ability to support your adolescent’s 
future social and       emotional development: 
 
Not at all  
  
  Very much  
1 2 3 4 5 
 
 
2. To what extent did your child enjoy participating in the Chilled Program?  
Not at all  
  
  Very much  
1 2 3 4 5 
 
3. How satisfied were you with the content covered in the program? 
Not at all 
satisfied  
  Very satisfied 
1 2 3 4 5 
 
4. To what extent has your adolescent talked with you about the program? 
None 
 
  A great deal 
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5. From your own observations, as well as comments you may have received 
from others, how effective do you feel the program was in helping your 
adolescent?  
Not at all 
effective  
  Very effective  
1 2 3 4 5 
 
6. To what extent have you noticed positive changes in your adolescent since 
participating in the program? 
None   
 
  A great deal 
1 2 3 4 5 
 
7. To what extent have you noticed negative changes in your adolescent since 
participating in the program? 
None   
 
  A great deal 
1 2 3 4 5 
 
8. How satisfied were you with your parent group facilitator? 
Not at all  
  
  Very much  
1 2 3 4 5 
 
9. Overall, how would you rate the program? 
Not at all 
useful  
  Very useful 
1 2 3 4 5 
 
We would particularly welcome any other comments you have about the program. 
Please write any other comments in the space below:  
 
 
 
 
 
Thank you for your attendance and support.   
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Appendix J: Adolescent Questionnaire 
 
Program Satisfaction Questionnaire 
Adolescent Version  
 
This form will ask you about what you liked and didn’t like about the Chilled 
program. 
If you prefer to be asked the questions instead of writing the answers please let us 
know. 
 
Please rate the following statements about the program on a scale of 1 to 5, 
where 1= “Not at all” and 5= “Very much”  
 
 
Section A Not at 
all   
  Very 
much  
1. I looked forward to the group each week. 1 2 3 4 5 
2. The information was easy to understand.  
 
1 2 3 4 5 
3. The student guide was useful and easy to read.  1 2 3 4 5 
4. The program was useful in my everyday life.  1 2 3 4 5 
5. The program was helpful for getting along with 
friends.  
1 2 3 4 5 
6. The program was helpful for getting along with 
family members.  
1 2 3 4 5 
7. The program helped me have confidence in 
myself.  
1 2 3 4 5 
8. The program helped me to understand my 
feelings.  
1 2 3 4 5 
9. The program helped me cope with stress.  
 
1 2 3 4 5 
10. The program helped me to feel more positive 
about everyday life.   
1 2 3 4 5 
11. I talked about the program to my friends.  
 
1 2 3 4 5 
12. My friends have commented on changes in me 
as a result of the program.  
1 2 3 4 5 
13. I talked about the program with my family.  
 
1 2 3 4 5 
14. My family has commented on changes in me as 
a result of the program.  
1 2 3 4 5 
15. I would recommend the program to my friends.  1 2 3 4 5 
 
Section B Not at 
all   
  Very 
much  
1. Learning about feelings was useful.  
 
1 2 3 4 5 
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2. Learning how to relax and cope with 
difficult situations was useful. 
1 2 3 4 5 
3. Learning how to recognize my anxious 
thoughts was useful.  
1 2 3 4 5 
4. Learning how to use helpful thoughts was 
useful.  
1 2 3 4 5 
5. Learning how create stepladders was 
useful. 
1 2 3 4 5 
6. Learning to be assertive was useful. 1 2 3 4 5 
7. Learning how to improve my         
       relationships with my friends and    
       family was useful. 
1 2 3 4 5 
 
Section C 
The activities I enjoyed most were:  
 
 
 
 
The activities I did not enjoy were:  
 
 
 
 
The skills I use most from the program are:  
 
 
 
 
How would you make the program better?  
 
 
 
 
Is there anything else you would like to say about the program? 
 
 
 
 
 
 
 
 
 
Thank you for participating in the Chilled program 
 
